Background  ||| S:24 E:43 ||| NNP
Expression  ||| S:43 E:54 ||| NNP
profiling  ||| S:54 E:64 ||| NN
is  ||| S:64 E:67 ||| VBZ
an  ||| S:67 E:70 ||| DT
emerging  ||| S:70 E:79 ||| VBG
experimental  ||| S:79 E:92 ||| JJ
method  ||| S:92 E:107 ||| NN
whereby  ||| S:107 E:115 ||| WRB
RNA  ||| S:115 E:119 ||| NNP
accumulation  ||| S:119 E:132 ||| NN
in  ||| S:132 E:135 ||| IN
cells  ||| S:135 E:141 ||| NNS
and  ||| S:141 E:145 ||| CC
tissues  ||| S:145 E:153 ||| NNS
can  ||| S:153 E:157 ||| MD
be  ||| S:157 E:168 ||| VB
assayed  ||| S:168 E:176 ||| VBN
for  ||| S:176 E:180 ||| IN
many  ||| S:180 E:185 ||| JJ
thousands  ||| S:185 E:195 ||| NNS
of  ||| S:195 E:198 ||| IN
genes  ||| S:198 E:204 ||| NNS
simultaneously  ||| S:204 E:219 ||| RB
in  ||| S:219 E:222 ||| IN
a  ||| S:222 E:232 ||| DT
single  ||| S:232 E:239 ||| JJ
experiment ||| S:239 E:249 ||| NN
.  ||| S:249 E:251 ||| .
There  ||| S:251 E:257 ||| EX
are  ||| S:257 E:261 ||| VBP
two  ||| S:261 E:265 ||| CD
common  ||| S:265 E:272 ||| JJ
experimental  ||| S:272 E:293 ||| JJ
platforms  ||| S:293 E:303 ||| NNS
for  ||| S:303 E:307 ||| IN
expression  ||| S:307 E:318 ||| NN
profiling ||| S:318 E:327 ||| NNS
;  ||| S:327 E:329 ||| :
redundant  ||| S:329 E:347 ||| FW
oligonucleotide  ||| S:347 E:363 ||| FW
arrays  ||| S:363 E:370 ||| FW
( ||| S:370 E:371 ||| -LRB-
Affymetrix  ||| S:371 E:382 ||| NNP
GeneChips ||| S:382 E:391 ||| NNP
)  ||| S:391 E:393 ||| -RRB-
[  ||| S:393 E:395 ||| -LRB-
1  ||| S:395 E:397 ||| LS
]  ||| S:397 E:399 ||| -RRB-
,  ||| S:399 E:401 ||| ,
and  ||| S:401 E:413 ||| CC
spotted  ||| S:413 E:421 ||| VBD
cDNA  ||| S:421 E:426 ||| JJ
microarrays  ||| S:426 E:438 ||| NNS
[  ||| S:438 E:440 ||| -LRB-
2  ||| S:440 E:442 ||| CD
3  ||| S:442 E:444 ||| CD
4  ||| S:444 E:446 ||| CD
]  ||| S:446 E:448 ||| -RRB-
.  ||| S:448 E:450 ||| .
The  ||| S:450 E:454 ||| DT
Affymetrix  ||| S:454 E:473 ||| NNP
GeneChips  ||| S:473 E:483 ||| NNP
have  ||| S:483 E:488 ||| VBP
the  ||| S:488 E:492 ||| DT
inherent  ||| S:492 E:501 ||| JJ
advantages  ||| S:501 E:512 ||| NNS
of  ||| S:512 E:515 ||| IN
redundancy ||| S:515 E:525 ||| NN
,  ||| S:525 E:535 ||| ,
specificity ||| S:535 E:546 ||| NN
,  ||| S:546 E:548 ||| ,
and  ||| S:548 E:552 ||| CC
transportability ||| S:552 E:568 ||| NNS
;  ||| S:568 E:570 ||| :
there  ||| S:570 E:576 ||| EX
are  ||| S:576 E:580 ||| VBP
typically  ||| S:580 E:598 ||| RB
30-40  ||| S:598 E:604 ||| CD
oligonucleotide  ||| S:604 E:620 ||| CD
probes  ||| S:620 E:627 ||| NNS
( ||| S:627 E:628 ||| -LRB-
features ||| S:628 E:636 ||| NNS
)  ||| S:636 E:638 ||| -RRB-
designed  ||| S:638 E:647 ||| VBN
against  ||| S:647 E:663 ||| IN
each  ||| S:663 E:668 ||| DT
gene  ||| S:668 E:673 ||| NN
tested  ||| S:673 E:680 ||| VBN
by  ||| S:680 E:683 ||| IN
the  ||| S:683 E:687 ||| DT
array ||| S:687 E:692 ||| NN
,  ||| S:692 E:694 ||| ,
with  ||| S:694 E:699 ||| IN
paired  ||| S:699 E:706 ||| JJ
perfect-match  ||| S:706 E:728 ||| JJ
and  ||| S:728 E:732 ||| CC
mismatch  ||| S:732 E:741 ||| JJ
probes ||| S:741 E:747 ||| NNS
,  ||| S:747 E:749 ||| ,
with  ||| S:749 E:754 ||| IN
standardized  ||| S:754 E:767 ||| JJ
factory  ||| S:767 E:775 ||| NN
synthesis  ||| S:775 E:785 ||| NN
of  ||| S:785 E:796 ||| IN
arrays  ||| S:796 E:803 ||| NNS
[  ||| S:803 E:805 ||| -LRB-
5  ||| S:805 E:807 ||| CD
6  ||| S:807 E:809 ||| CD
]  ||| S:809 E:811 ||| -RRB-
.  ||| S:811 E:813 ||| .
The  ||| S:813 E:817 ||| DT
uniform  ||| S:817 E:825 ||| JJ
nature  ||| S:825 E:832 ||| NN
of  ||| S:832 E:835 ||| IN
the  ||| S:835 E:839 ||| DT
arrays  ||| S:839 E:846 ||| NN
permits  ||| S:846 E:862 ||| VBZ
databasing  ||| S:862 E:873 ||| VBN
of  ||| S:873 E:876 ||| IN
individual  ||| S:876 E:887 ||| JJ
profiles ||| S:887 E:895 ||| NNS
,  ||| S:895 E:897 ||| ,
which  ||| S:897 E:903 ||| WDT
facilitates  ||| S:903 E:923 ||| JJ
comparison  ||| S:923 E:934 ||| NN
of  ||| S:934 E:937 ||| IN
data  ||| S:937 E:942 ||| NNS
generated  ||| S:942 E:952 ||| VBN
by  ||| S:952 E:955 ||| IN
different  ||| S:955 E:965 ||| JJ
laboratories ||| S:965 E:977 ||| NNS
.  ||| S:977 E:987 ||| .
Expression  ||| S:987 E:998 ||| NN
profiling  ||| S:998 E:1008 ||| NN
has  ||| S:1008 E:1012 ||| VBZ
led  ||| S:1012 E:1016 ||| VBN
to  ||| S:1016 E:1019 ||| TO
dramatic  ||| S:1019 E:1028 ||| JJ
advances  ||| S:1028 E:1037 ||| NNS
in  ||| S:1037 E:1048 ||| IN
understanding  ||| S:1048 E:1062 ||| NN
of  ||| S:1062 E:1065 ||| IN
yeast  ||| S:1065 E:1071 ||| NN
biology ||| S:1071 E:1078 ||| NN
,  ||| S:1078 E:1080 ||| ,
where  ||| S:1080 E:1086 ||| WRB
homogeneous  ||| S:1086 E:1098 ||| JJ
cultures  ||| S:1098 E:1115 ||| NNS
can  ||| S:1115 E:1119 ||| MD
be  ||| S:1119 E:1122 ||| VB
grown  ||| S:1122 E:1128 ||| VBN
and  ||| S:1128 E:1132 ||| CC
exposed  ||| S:1132 E:1140 ||| VBN
to  ||| S:1140 E:1143 ||| TO
timed  ||| S:1143 E:1149 ||| VB
environmental  ||| S:1149 E:1163 ||| JJ
variables  ||| S:1163 E:1173 ||| NNS
[  ||| S:1173 E:1183 ||| -LRB-
7  ||| S:1183 E:1185 ||| CD
8  ||| S:1185 E:1187 ||| CD
9  ||| S:1187 E:1189 ||| CD
10  ||| S:1189 E:1192 ||| CD
11  ||| S:1192 E:1195 ||| CD
12  ||| S:1195 E:1198 ||| CD
]  ||| S:1198 E:1200 ||| -RRB-
.  ||| S:1200 E:1202 ||| .
Such  ||| S:1202 E:1207 ||| JJ
studies  ||| S:1207 E:1215 ||| NNS
have  ||| S:1215 E:1220 ||| VBP
led  ||| S:1220 E:1224 ||| VBN
to  ||| S:1224 E:1227 ||| TO
the  ||| S:1227 E:1231 ||| DT
rapid  ||| S:1231 E:1245 ||| JJ
assignment  ||| S:1245 E:1256 ||| NN
of  ||| S:1256 E:1259 ||| IN
function  ||| S:1259 E:1268 ||| NN
to  ||| S:1268 E:1271 ||| TO
a  ||| S:1271 E:1273 ||| DT
large  ||| S:1273 E:1279 ||| JJ
number  ||| S:1279 E:1286 ||| NN
of  ||| S:1286 E:1289 ||| IN
anonymous  ||| S:1289 E:1299 ||| JJ
gene  ||| S:1299 E:1312 ||| NN
sequences ||| S:1312 E:1321 ||| NN
.  ||| S:1321 E:1323 ||| .
Large-scale  ||| S:1323 E:1335 ||| JJ
expression  ||| S:1335 E:1346 ||| NN
profiling  ||| S:1346 E:1356 ||| NN
studies  ||| S:1356 E:1364 ||| NNS
of  ||| S:1364 E:1375 ||| IN
tissues  ||| S:1375 E:1383 ||| NNS
from  ||| S:1383 E:1388 ||| IN
higher  ||| S:1388 E:1395 ||| JJR
vertebrates  ||| S:1395 E:1407 ||| NNS
are  ||| S:1407 E:1411 ||| VBP
more  ||| S:1411 E:1416 ||| RBR
challenging ||| S:1416 E:1427 ||| JJ
,  ||| S:1427 E:1429 ||| ,
due  ||| S:1429 E:1441 ||| JJ
to  ||| S:1441 E:1444 ||| TO
the  ||| S:1444 E:1448 ||| DT
higher  ||| S:1448 E:1455 ||| JJR
complexity  ||| S:1455 E:1466 ||| NN
of  ||| S:1466 E:1469 ||| IN
the  ||| S:1469 E:1473 ||| DT
genome ||| S:1473 E:1479 ||| NN
,  ||| S:1479 E:1481 ||| ,
larger  ||| S:1481 E:1488 ||| JJR
related  ||| S:1488 E:1496 ||| JJ
gene  ||| S:1496 E:1509 ||| NN
families ||| S:1509 E:1517 ||| NNS
,  ||| S:1517 E:1519 ||| ,
and  ||| S:1519 E:1523 ||| CC
incomplete  ||| S:1523 E:1534 ||| JJ
genomic  ||| S:1534 E:1542 ||| JJ
resources ||| S:1542 E:1551 ||| NNS
.  ||| S:1551 E:1553 ||| .
Nevertheless ||| S:1553 E:1565 ||| RB
,  ||| S:1565 E:1575 ||| ,
DNA  ||| S:1575 E:1579 ||| NNP
microarrays  ||| S:1579 E:1591 ||| NNS
have  ||| S:1591 E:1596 ||| VBP
been  ||| S:1596 E:1601 ||| VBN
successfully  ||| S:1601 E:1614 ||| RB
applied  ||| S:1614 E:1622 ||| VBN
in  ||| S:1622 E:1625 ||| IN
the  ||| S:1625 E:1637 ||| DT
analysis  ||| S:1637 E:1646 ||| NN
of  ||| S:1646 E:1649 ||| IN
aging  ||| S:1649 E:1655 ||| VBG
and  ||| S:1655 E:1659 ||| CC
caloric  ||| S:1659 E:1667 ||| JJ
restriction  ||| S:1667 E:1679 ||| NN
[  ||| S:1679 E:1681 ||| -LRB-
13  ||| S:1681 E:1684 ||| CD
]  ||| S:1684 E:1686 ||| -RRB-
and  ||| S:1686 E:1698 ||| CC
pulmonary  ||| S:1698 E:1708 ||| JJ
fibrosis  ||| S:1708 E:1717 ||| NNS
[  ||| S:1717 E:1719 ||| -LRB-
14  ||| S:1719 E:1722 ||| CD
]  ||| S:1722 E:1724 ||| -RRB-
.  ||| S:1724 E:1726 ||| .
And  ||| S:1726 E:1730 ||| CC
many  ||| S:1730 E:1735 ||| JJ
publications ||| S:1735 E:1747 ||| NNS
,  ||| S:1747 E:1757 ||| ,
particularly  ||| S:1757 E:1770 ||| RB
on  ||| S:1770 E:1773 ||| IN
cancer ||| S:1773 E:1779 ||| NN
,  ||| S:1779 E:1781 ||| ,
have  ||| S:1781 E:1786 ||| VBP
appeared  ||| S:1786 E:1795 ||| VBN
[  ||| S:1795 E:1797 ||| -LRB-
14  ||| S:1797 E:1800 ||| CD
15  ||| S:1800 E:1803 ||| CD
16  ||| S:1803 E:1806 ||| CD
17  ||| S:1806 E:1809 ||| CD
18  ||| S:1809 E:1812 ||| CD
19  ||| S:1812 E:1815 ||| CD
]  ||| S:1815 E:1825 ||| -RRB-
.  ||| S:1825 E:1827 ||| .
Affymetrix  ||| S:1827 E:1838 ||| NNP
has  ||| S:1838 E:1842 ||| VBZ
recently  ||| S:1842 E:1851 ||| RB
announced  ||| S:1851 E:1861 ||| VBD
the  ||| S:1861 E:1865 ||| DT
availability  ||| S:1865 E:1878 ||| NN
of  ||| S:1878 E:1881 ||| IN
the  ||| S:1881 E:1893 ||| DT
U133  ||| S:1893 E:1898 ||| JJ
GeneChip  ||| S:1898 E:1907 ||| JJ
series  ||| S:1907 E:1914 ||| NN
with  ||| S:1914 E:1919 ||| IN
33,000  ||| S:1919 E:1926 ||| CD
well-characterized  ||| S:1926 E:1945 ||| JJ
human  ||| S:1945 E:1959 ||| JJ
genes  ||| S:1959 E:1965 ||| NNS
mined  ||| S:1965 E:1971 ||| VBN
from  ||| S:1971 E:1976 ||| IN
genomic  ||| S:1976 E:1984 ||| JJ
sequence ||| S:1984 E:1992 ||| NN
.  ||| S:1992 E:1994 ||| .
The  ||| S:1994 E:1998 ||| DT
nearly  ||| S:1998 E:2005 ||| RB
complete  ||| S:2005 E:2022 ||| JJ
ascertainment  ||| S:2022 E:2036 ||| NN
of  ||| S:2036 E:2039 ||| IN
genes  ||| S:2039 E:2045 ||| NNS
in  ||| S:2045 E:2048 ||| IN
the  ||| S:2048 E:2052 ||| DT
human  ||| S:2052 E:2058 ||| JJ
genome  ||| S:2058 E:2065 ||| NN
should  ||| S:2065 E:2072 ||| MD
make  ||| S:2072 E:2085 ||| VB
expression-profiling  ||| S:2085 E:2106 ||| JJ
studies  ||| S:2106 E:2114 ||| NNS
of  ||| S:2114 E:2117 ||| IN
human  ||| S:2117 E:2123 ||| JJ
tissues  ||| S:2123 E:2131 ||| NNS
particularly  ||| S:2131 E:2152 ||| RB
powerful ||| S:2152 E:2160 ||| JJ
.  ||| S:2160 E:2162 ||| .
However ||| S:2162 E:2169 ||| RB
,  ||| S:2169 E:2171 ||| ,
identification  ||| S:2171 E:2186 ||| NN
of  ||| S:2186 E:2189 ||| IN
the  ||| S:2189 E:2193 ||| DT
sources  ||| S:2193 E:2201 ||| NNS
of  ||| S:2201 E:2212 ||| IN
experimental  ||| S:2212 E:2225 ||| JJ
variability ||| S:2225 E:2236 ||| NN
,  ||| S:2236 E:2238 ||| ,
and  ||| S:2238 E:2242 ||| CC
knowledge  ||| S:2242 E:2252 ||| NN
of  ||| S:2252 E:2255 ||| IN
the  ||| S:2255 E:2259 ||| DT
relative  ||| S:2259 E:2276 ||| JJ
contribution  ||| S:2276 E:2289 ||| NN
of  ||| S:2289 E:2292 ||| IN
variation  ||| S:2292 E:2302 ||| NN
from  ||| S:2302 E:2307 ||| IN
each  ||| S:2307 E:2312 ||| DT
source ||| S:2312 E:2318 ||| NN
,  ||| S:2318 E:2320 ||| ,
is  ||| S:2320 E:2323 ||| VBZ
critical  ||| S:2323 E:2332 ||| JJ
for  ||| S:2332 E:2344 ||| IN
appropriate  ||| S:2344 E:2356 ||| JJ
experimental  ||| S:2356 E:2369 ||| JJ
design  ||| S:2369 E:2376 ||| NN
in  ||| S:2376 E:2379 ||| IN
expression  ||| S:2379 E:2390 ||| NN
profiling  ||| S:2390 E:2408 ||| NN
experiments ||| S:2408 E:2419 ||| NNS
.  ||| S:2419 E:2429 ||| .
Mills  ||| S:2429 E:2435 ||| NNP
and  ||| S:2435 E:2439 ||| CC
Gordon  ||| S:2439 E:2446 ||| NNP
recently  ||| S:2446 E:2455 ||| RB
studied  ||| S:2455 E:2463 ||| VBN
the  ||| S:2463 E:2467 ||| DT
relative  ||| S:2467 E:2484 ||| JJ
contribution  ||| S:2484 E:2497 ||| NN
of  ||| S:2497 E:2500 ||| IN
experimental  ||| S:2500 E:2513 ||| JJ
variability  ||| S:2513 E:2525 ||| NN
of  ||| S:2525 E:2528 ||| IN
probe  ||| S:2528 E:2542 ||| NN
production  ||| S:2542 E:2553 ||| NN
on  ||| S:2553 E:2556 ||| IN
the  ||| S:2556 E:2560 ||| DT
reproducibility  ||| S:2560 E:2576 ||| NN
of  ||| S:2576 E:2579 ||| IN
microarray  ||| S:2579 E:2590 ||| JJ
results  ||| S:2590 E:2606 ||| NNS
using  ||| S:2606 E:2612 ||| VBG
mixed  ||| S:2612 E:2618 ||| JJ
murine  ||| S:2618 E:2625 ||| JJ
tissue  ||| S:2625 E:2632 ||| NN
RNA  ||| S:2632 E:2636 ||| NNP
on  ||| S:2636 E:2639 ||| IN
Affymetrix  ||| S:2639 E:2650 ||| NNP
Mu11K  ||| S:2650 E:2656 ||| NNP
GeneChips  ||| S:2656 E:2674 ||| NNP
[  ||| S:2674 E:2676 ||| -LRB-
20  ||| S:2676 E:2679 ||| CD
]  ||| S:2679 E:2681 ||| -RRB-
.  ||| S:2681 E:2683 ||| .
In  ||| S:2683 E:2686 ||| IN
their  ||| S:2686 E:2692 ||| PRP$
study ||| S:2692 E:2697 ||| NN
,  ||| S:2697 E:2699 ||| ,
the  ||| S:2699 E:2703 ||| DT
same  ||| S:2703 E:2708 ||| JJ
RNA  ||| S:2708 E:2712 ||| NNP
preparation  ||| S:2712 E:2724 ||| NN
was  ||| S:2724 E:2728 ||| VBD
used  ||| S:2728 E:2741 ||| VBN
as  ||| S:2741 E:2744 ||| IN
a  ||| S:2744 E:2746 ||| DT
template  ||| S:2746 E:2755 ||| NN
for  ||| S:2755 E:2759 ||| IN
distinct  ||| S:2759 E:2768 ||| JJ
cDNA ||| S:2768 E:2772 ||| JJ
/ ||| S:2772 E:2773 ||| CD
cRNA  ||| S:2773 E:2778 ||| JJ
amplifications  ||| S:2778 E:2793 ||| NN
and  ||| S:2793 E:2805 ||| CC
hybridizations ||| S:2805 E:2819 ||| NN
.  ||| S:2819 E:2821 ||| .
An  ||| S:2821 E:2824 ||| DT
additional  ||| S:2824 E:2835 ||| JJ
variable  ||| S:2835 E:2844 ||| JJ
studied  ||| S:2844 E:2852 ||| NN
was  ||| S:2852 E:2856 ||| VBD
the  ||| S:2856 E:2868 ||| DT
effect  ||| S:2868 E:2875 ||| NN
of  ||| S:2875 E:2878 ||| IN
different  ||| S:2878 E:2888 ||| JJ
laboratories  ||| S:2888 E:2901 ||| NNS
processing  ||| S:2901 E:2912 ||| VBG
the  ||| S:2912 E:2916 ||| DT
same  ||| S:2916 E:2921 ||| JJ
RNAs ||| S:2921 E:2925 ||| NN
.  ||| S:2925 E:2935 ||| .
The  ||| S:2935 E:2939 ||| DT
authors  ||| S:2939 E:2947 ||| NNS
found  ||| S:2947 E:2953 ||| VBD
relatively  ||| S:2953 E:2964 ||| RB
poor  ||| S:2964 E:2969 ||| JJ
concordance  ||| S:2969 E:2981 ||| NN
between  ||| S:2981 E:2997 ||| IN
duplicate  ||| S:2997 E:3007 ||| JJ
arrays ||| S:3007 E:3013 ||| NN
,  ||| S:3013 E:3015 ||| ,
with  ||| S:3015 E:3020 ||| IN
an  ||| S:3020 E:3023 ||| DT
average  ||| S:3023 E:3031 ||| NN
of  ||| S:3031 E:3034 ||| IN
12 ||| S:3034 E:3036 ||| CD
%  ||| S:3036 E:3038 ||| NN
increase ||| S:3038 E:3046 ||| NN
/ ||| S:3046 E:3047 ||| CD
decrease  ||| S:3047 E:3064 ||| NN
calls  ||| S:3064 E:3070 ||| NNS
between  ||| S:3070 E:3078 ||| IN
the  ||| S:3078 E:3082 ||| DT
same  ||| S:3082 E:3087 ||| JJ
RNA  ||| S:3087 E:3091 ||| NNP
processed  ||| S:3091 E:3101 ||| VBD
in  ||| S:3101 E:3104 ||| IN
parallel  ||| S:3104 E:3113 ||| JJ
and  ||| S:3113 E:3125 ||| CC
hybridized  ||| S:3125 E:3136 ||| JJ
to  ||| S:3136 E:3139 ||| TO
two  ||| S:3139 E:3143 ||| CD
Mu11K-A  ||| S:3143 E:3151 ||| CD
microarrays ||| S:3151 E:3162 ||| NNS
.  ||| S:3162 E:3164 ||| .
The  ||| S:3164 E:3168 ||| DT
authors  ||| S:3168 E:3184 ||| NNS
concluded  ||| S:3184 E:3194 ||| VBD
that  ||| S:3194 E:3199 ||| IN
there  ||| S:3199 E:3205 ||| EX
was  ||| S:3205 E:3209 ||| VBD
substantial  ||| S:3209 E:3221 ||| JJ
experimental  ||| S:3221 E:3242 ||| JJ
variability  ||| S:3242 E:3254 ||| NN
in  ||| S:3254 E:3257 ||| IN
the  ||| S:3257 E:3261 ||| DT
experimental  ||| S:3261 E:3274 ||| JJ
procedure ||| S:3274 E:3283 ||| NN
,  ||| S:3283 E:3285 ||| ,
necessitating  ||| S:3285 E:3307 ||| JJ
extensive  ||| S:3307 E:3317 ||| JJ
filtering  ||| S:3317 E:3327 ||| NN
and  ||| S:3327 E:3331 ||| CC
large  ||| S:3331 E:3337 ||| JJ
numbers  ||| S:3337 E:3345 ||| NNS
of  ||| S:3345 E:3348 ||| IN
arrays  ||| S:3348 E:3355 ||| VBG
to  ||| S:3355 E:3358 ||| TO
detect  ||| S:3358 E:3373 ||| VB
accurate  ||| S:3373 E:3382 ||| JJ
gene  ||| S:3382 E:3387 ||| NN
expression  ||| S:3387 E:3398 ||| NN
changes  ||| S:3398 E:3406 ||| NNS
( ||| S:3406 E:3407 ||| -LRB-
LUT ||| S:3407 E:3410 ||| NNP
:  ||| S:3410 E:3412 ||| :
look-up  ||| S:3412 E:3420 ||| JJ
tables ||| S:3420 E:3426 ||| NNS
)  ||| S:3426 E:3428 ||| -RRB-
[  ||| S:3428 E:3430 ||| -LRB-
20  ||| S:3430 E:3441 ||| CD
]  ||| S:3441 E:3443 ||| -RRB-
.  ||| S:3443 E:3445 ||| .
In  ||| S:3445 E:3448 ||| IN
our  ||| S:3448 E:3452 ||| PRP$
laboratory ||| S:3452 E:3462 ||| NN
,  ||| S:3462 E:3464 ||| ,
we  ||| S:3464 E:3467 ||| PRP
have  ||| S:3467 E:3472 ||| VBP
processed  ||| S:3472 E:3482 ||| VBN
over  ||| S:3482 E:3487 ||| IN
1,200  ||| S:3487 E:3501 ||| CD
Affymetrix  ||| S:3501 E:3512 ||| JJ
arrays ||| S:3512 E:3518 ||| NN
,  ||| S:3518 E:3520 ||| ,
and  ||| S:3520 E:3524 ||| CC
have  ||| S:3524 E:3529 ||| VBP
found  ||| S:3529 E:3535 ||| VBN
significantly  ||| S:3535 E:3549 ||| RB
higher  ||| S:3549 E:3564 ||| RBR
experimental  ||| S:3564 E:3577 ||| JJ
reproducibility  ||| S:3577 E:3593 ||| NNS
( ||| S:3593 E:3594 ||| -LRB-
R  ||| S:3594 E:3596 ||| NNP
2=  ||| S:3596 E:3599 ||| NNP
0.979  ||| S:3599 E:3605 ||| NNP
for  ||| S:3605 E:3609 ||| IN
new  ||| S:3609 E:3613 ||| JJ
generation  ||| S:3613 E:3632 ||| NN
U74A  ||| S:3632 E:3637 ||| CD
version  ||| S:3637 E:3645 ||| NN
2  ||| S:3645 E:3647 ||| CD
murine  ||| S:3647 E:3654 ||| CD
arrays  ||| S:3654 E:3661 ||| NNS
or  ||| S:3661 E:3664 ||| CC
human  ||| S:3664 E:3670 ||| JJ
U95  ||| S:3670 E:3674 ||| CD
series ||| S:3674 E:3680 ||| NN
,  ||| S:3680 E:3682 ||| ,
see  ||| S:3682 E:3694 ||| VB
Result  ||| S:3694 E:3701 ||| NN
and  ||| S:3701 E:3705 ||| CC
Discussion ||| S:3705 E:3715 ||| NNP
) ||| S:3715 E:3716 ||| -RRB-
.  ||| S:3716 E:3718 ||| .
In  ||| S:3718 E:3721 ||| IN
addition ||| S:3721 E:3729 ||| NN
,  ||| S:3729 E:3731 ||| ,
a  ||| S:3731 E:3733 ||| DT
recent  ||| S:3733 E:3740 ||| JJ
publication  ||| S:3740 E:3760 ||| NN
of  ||| S:3760 E:3763 ||| IN
a  ||| S:3763 E:3765 ||| DT
single  ||| S:3765 E:3772 ||| JJ
human  ||| S:3772 E:3778 ||| JJ
patient ||| S:3778 E:3785 ||| NN
,  ||| S:3785 E:3787 ||| ,
where  ||| S:3787 E:3793 ||| WRB
RNA  ||| S:3793 E:3797 ||| NNP
was  ||| S:3797 E:3801 ||| VBD
prepared  ||| S:3801 E:3810 ||| VBN
from  ||| S:3810 E:3815 ||| IN
two  ||| S:3815 E:3827 ||| CD
distinct  ||| S:3827 E:3836 ||| JJ
breast  ||| S:3836 E:3843 ||| NN
tumors ||| S:3843 E:3849 ||| NNS
,  ||| S:3849 E:3851 ||| ,
and  ||| S:3851 E:3855 ||| CC
placed  ||| S:3855 E:3862 ||| VBN
on  ||| S:3862 E:3865 ||| IN
duplicate  ||| S:3865 E:3875 ||| FW
U95A  ||| S:3875 E:3888 ||| FW
GeneChips  ||| S:3888 E:3898 ||| FW
( ||| S:3898 E:3899 ||| -LRB-
four  ||| S:3899 E:3904 ||| CD
chips  ||| S:3904 E:3910 ||| NNS
total ||| S:3910 E:3915 ||| VBP
)  ||| S:3915 E:3917 ||| -RRB-
found  ||| S:3917 E:3923 ||| VBD
a  ||| S:3923 E:3925 ||| DT
very  ||| S:3925 E:3930 ||| RB
low  ||| S:3930 E:3934 ||| JJ
degree  ||| S:3934 E:3941 ||| NN
of  ||| S:3941 E:3952 ||| IN
experimental  ||| S:3952 E:3965 ||| JJ
variability  ||| S:3965 E:3977 ||| NN
between  ||| S:3977 E:3985 ||| IN
microarrays  ||| S:3985 E:3997 ||| NNS
( ||| S:3997 E:3998 ||| -LRB-
R  ||| S:3998 E:4000 ||| NNP
2=  ||| S:4000 E:4003 ||| NNP
0.995 ||| S:4003 E:4008 ||| NNP
) ||| S:4008 E:4009 ||| -RRB-
,  ||| S:4009 E:4019 ||| ,
and  ||| S:4019 E:4023 ||| CC
between  ||| S:4023 E:4031 ||| IN
the  ||| S:4031 E:4035 ||| DT
two  ||| S:4035 E:4039 ||| CD
tumors  ||| S:4039 E:4046 ||| NNS
( ||| S:4046 E:4047 ||| -LRB-
R  ||| S:4047 E:4049 ||| NNP
2=  ||| S:4049 E:4052 ||| NNP
0.987 ||| S:4052 E:4057 ||| NNP
)  ||| S:4057 E:4059 ||| -RRB-
[  ||| S:4059 E:4061 ||| -LRB-
21  ||| S:4061 E:4064 ||| CD
]  ||| S:4064 E:4066 ||| -RRB-
.  ||| S:4066 E:4068 ||| .
The  ||| S:4068 E:4072 ||| DT
marked  ||| S:4072 E:4087 ||| JJ
differences  ||| S:4087 E:4099 ||| NNS
in  ||| S:4099 E:4102 ||| IN
experimental  ||| S:4102 E:4115 ||| JJ
variability  ||| S:4115 E:4127 ||| NN
between  ||| S:4127 E:4143 ||| IN
laboratories  ||| S:4143 E:4156 ||| NNS
could  ||| S:4156 E:4162 ||| MD
be  ||| S:4162 E:4165 ||| VB
due  ||| S:4165 E:4169 ||| JJ
to  ||| S:4169 E:4172 ||| TO
different  ||| S:4172 E:4182 ||| JJ
quality  ||| S:4182 E:4190 ||| NN
control  ||| S:4190 E:4206 ||| NN
protocols  ||| S:4206 E:4216 ||| NNS
( ||| S:4216 E:4217 ||| -LRB-
see  ||| S:4217 E:4221 ||| VB
http://microarray.cnmcresearch.org ||| S:4221 E:4255 ||| CD
) ||| S:4255 E:4256 ||| -RRB-
,  ||| S:4256 E:4258 ||| ,
newer  ||| S:4258 E:4272 ||| VBG
more  ||| S:4272 E:4277 ||| RBR
robust  ||| S:4277 E:4284 ||| JJ
Affymetrix  ||| S:4284 E:4295 ||| NNP
arrays  ||| S:4295 E:4302 ||| VBD
now  ||| S:4302 E:4306 ||| RB
available  ||| S:4306 E:4316 ||| JJ
( ||| S:4316 E:4317 ||| -LRB-
murine  ||| S:4317 E:4324 ||| FW
Mu11K  ||| S:4324 E:4338 ||| FW
versus  ||| S:4338 E:4345 ||| FW
U74A  ||| S:4345 E:4350 ||| FW
version  ||| S:4350 E:4358 ||| NN
2  ||| S:4358 E:4360 ||| CD
and  ||| S:4360 E:4364 ||| CC
new  ||| S:4364 E:4368 ||| JJ
generation  ||| S:4368 E:4379 ||| NN
human  ||| S:4379 E:4385 ||| JJ
U95  ||| S:4385 E:4389 ||| CD
series ||| S:4389 E:4395 ||| NN
) ||| S:4395 E:4396 ||| -RRB-
,  ||| S:4396 E:4406 ||| ,
use  ||| S:4406 E:4410 ||| NN
of  ||| S:4410 E:4413 ||| IN
more  ||| S:4413 E:4418 ||| RBR
recent  ||| S:4418 E:4425 ||| JJ
algorithms  ||| S:4425 E:4436 ||| NN
for  ||| S:4436 E:4440 ||| IN
data  ||| S:4440 E:4445 ||| NN
interpretation ||| S:4445 E:4459 ||| NN
,  ||| S:4459 E:4461 ||| ,
or  ||| S:4461 E:4472 ||| CC
due  ||| S:4472 E:4476 ||| JJ
to  ||| S:4476 E:4479 ||| TO
more  ||| S:4479 E:4484 ||| RBR
consistent  ||| S:4484 E:4495 ||| JJ
processing  ||| S:4495 E:4506 ||| NN
of  ||| S:4506 E:4509 ||| IN
RNA ||| S:4509 E:4512 ||| NNP
,  ||| S:4512 E:4514 ||| ,
cDNA ||| S:4514 E:4518 ||| NNP
,  ||| S:4518 E:4520 ||| ,
and  ||| S:4520 E:4524 ||| CC
cRNA  ||| S:4524 E:4529 ||| JJ
in  ||| S:4529 E:4540 ||| IN
the  ||| S:4540 E:4544 ||| DT
same  ||| S:4544 E:4549 ||| JJ
laboratory ||| S:4549 E:4559 ||| NN
.  ||| S:4559 E:4569 ||| .
The  ||| S:4569 E:4573 ||| DT
previous  ||| S:4573 E:4582 ||| JJ
studies  ||| S:4582 E:4590 ||| NNS
did  ||| S:4590 E:4594 ||| VBD
not  ||| S:4594 E:4598 ||| RB
systematically  ||| S:4598 E:4613 ||| RB
address  ||| S:4613 E:4621 ||| VB
the  ||| S:4621 E:4633 ||| DT
reproducibility  ||| S:4633 E:4649 ||| NN
of  ||| S:4649 E:4652 ||| IN
GeneChip  ||| S:4652 E:4661 ||| JJ
hybridization  ||| S:4661 E:4675 ||| NNS
( ||| S:4675 E:4676 ||| -LRB-
e.g.  ||| S:4676 E:4681 ||| CD
the  ||| S:4681 E:4685 ||| DT
same  ||| S:4685 E:4698 ||| JJ
biotinylated  ||| S:4698 E:4711 ||| JJ
cRNA  ||| S:4711 E:4716 ||| NN
on  ||| S:4716 E:4719 ||| IN
two  ||| S:4719 E:4723 ||| CD
different  ||| S:4723 E:4733 ||| JJ
microarrays ||| S:4733 E:4744 ||| NN
) ||| S:4744 E:4745 ||| -RRB-
.  ||| S:4745 E:4747 ||| .
In  ||| S:4747 E:4758 ||| IN
addition  ||| S:4758 E:4767 ||| NN
to  ||| S:4767 E:4770 ||| TO
lingering  ||| S:4770 E:4780 ||| VB
questions  ||| S:4780 E:4790 ||| NNS
concerning  ||| S:4790 E:4801 ||| VBG
variability  ||| S:4801 E:4813 ||| JJ
due  ||| S:4813 E:4825 ||| JJ
to  ||| S:4825 E:4828 ||| TO
specific  ||| S:4828 E:4837 ||| JJ
experimental  ||| S:4837 E:4850 ||| JJ
procedures ||| S:4850 E:4860 ||| NNS
,  ||| S:4860 E:4862 ||| ,
there  ||| S:4862 E:4868 ||| EX
are  ||| S:4868 E:4872 ||| VBP
other  ||| S:4872 E:4886 ||| JJ
possible  ||| S:4886 E:4895 ||| JJ
sources  ||| S:4895 E:4903 ||| NNS
of  ||| S:4903 E:4906 ||| IN
variability  ||| S:4906 E:4918 ||| NNS
that  ||| S:4918 E:4923 ||| WDT
have  ||| S:4923 E:4928 ||| VBP
not  ||| S:4928 E:4932 ||| RB
yet  ||| S:4932 E:4936 ||| RB
been  ||| S:4936 E:4949 ||| VBN
investigated ||| S:4949 E:4961 ||| VBN
,  ||| S:4961 E:4963 ||| ,
specifically  ||| S:4963 E:4976 ||| RB
tissue  ||| S:4976 E:4983 ||| JJ
heterogeneity  ||| S:4983 E:4997 ||| NN
and  ||| S:4997 E:5009 ||| CC
inter-individual  ||| S:5009 E:5026 ||| JJ
variation ||| S:5026 E:5035 ||| NN
.  ||| S:5035 E:5037 ||| .
The  ||| S:5037 E:5041 ||| DT
latter  ||| S:5041 E:5048 ||| JJ
two  ||| S:5048 E:5052 ||| CD
sources  ||| S:5052 E:5060 ||| NNS
of  ||| S:5060 E:5071 ||| IN
variability  ||| S:5071 E:5083 ||| NNS
are  ||| S:5083 E:5087 ||| VBP
particularly  ||| S:5087 E:5100 ||| RB
important  ||| S:5100 E:5110 ||| JJ
in  ||| S:5110 E:5113 ||| IN
human  ||| S:5113 E:5119 ||| JJ
expression  ||| S:5119 E:5138 ||| NN
profiling  ||| S:5138 E:5148 ||| NN
studies ||| S:5148 E:5155 ||| NNS
.  ||| S:5155 E:5157 ||| .
The  ||| S:5157 E:5161 ||| DT
study  ||| S:5161 E:5167 ||| NN
of  ||| S:5167 E:5170 ||| IN
human  ||| S:5170 E:5176 ||| JJ
tissues  ||| S:5176 E:5184 ||| NNS
often  ||| S:5184 E:5198 ||| RB
involves  ||| S:5198 E:5207 ||| VBZ
the  ||| S:5207 E:5211 ||| DT
use  ||| S:5211 E:5215 ||| NN
of  ||| S:5215 E:5218 ||| IN
tissue  ||| S:5218 E:5225 ||| NN
biopsies ||| S:5225 E:5233 ||| NNS
,  ||| S:5233 E:5235 ||| ,
where  ||| S:5235 E:5241 ||| WRB
a  ||| S:5241 E:5243 ||| DT
relatively  ||| S:5243 E:5262 ||| RB
limited  ||| S:5262 E:5270 ||| JJ
region  ||| S:5270 E:5277 ||| NN
of  ||| S:5277 E:5280 ||| IN
an  ||| S:5280 E:5283 ||| DT
organ  ||| S:5283 E:5289 ||| NN
is  ||| S:5289 E:5292 ||| VBZ
sampled ||| S:5292 E:5299 ||| VBN
.  ||| S:5299 E:5301 ||| .
Tissue  ||| S:5301 E:5308 ||| NN
heterogeneity  ||| S:5308 E:5330 ||| NNS
and  ||| S:5330 E:5334 ||| CC
sampling  ||| S:5334 E:5343 ||| JJ
error  ||| S:5343 E:5349 ||| NN
might  ||| S:5349 E:5355 ||| MD
be  ||| S:5355 E:5358 ||| VB
expected  ||| S:5358 E:5367 ||| VBN
to  ||| S:5367 E:5370 ||| TO
introduce  ||| S:5370 E:5388 ||| VB
significant  ||| S:5388 E:5400 ||| JJ
variability  ||| S:5400 E:5412 ||| NN
in  ||| S:5412 E:5415 ||| IN
expression  ||| S:5415 E:5426 ||| NN
profiles ||| S:5426 E:5434 ||| NNS
.  ||| S:5434 E:5436 ||| .
Second ||| S:5436 E:5442 ||| LS
,  ||| S:5442 E:5452 ||| ,
tissues  ||| S:5452 E:5460 ||| NNS
may  ||| S:5460 E:5464 ||| MD
derive  ||| S:5464 E:5471 ||| VB
from  ||| S:5471 E:5476 ||| IN
individuals  ||| S:5476 E:5488 ||| NNS
from  ||| S:5488 E:5493 ||| IN
different  ||| S:5493 E:5503 ||| JJ
ethnic  ||| S:5503 E:5518 ||| JJ
backgrounds ||| S:5518 E:5529 ||| NNS
;  ||| S:5529 E:5531 ||| :
humans  ||| S:5531 E:5538 ||| NNS
are  ||| S:5538 E:5542 ||| VBP
highly  ||| S:5542 E:5549 ||| RB
outbred ||| S:5549 E:5556 ||| JJ
,  ||| S:5556 E:5558 ||| ,
leading  ||| S:5558 E:5566 ||| VBG
to  ||| S:5566 E:5569 ||| TO
the  ||| S:5569 E:5581 ||| DT
potential  ||| S:5581 E:5591 ||| NN
of  ||| S:5591 E:5594 ||| IN
significant  ||| S:5594 E:5606 ||| JJ
polymorphic  ||| S:5606 E:5618 ||| JJ
noise  ||| S:5618 E:5624 ||| NN
( ||| S:5624 E:5625 ||| -LRB-
herein  ||| S:5625 E:5632 ||| FW
called  ||| S:5632 E:5647 ||| FW
"SNP  ||| S:5647 E:5652 ||| FW
noise ||| S:5652 E:5657 ||| FW
" ||| S:5657 E:5658 ||| ''
)  ||| S:5658 E:5660 ||| -RRB-
between  ||| S:5660 E:5668 ||| IN
individuals  ||| S:5668 E:5680 ||| NNS
unrelated  ||| S:5680 E:5690 ||| JJ
to  ||| S:5690 E:5693 ||| TO
the  ||| S:5693 E:5697 ||| DT
disease  ||| S:5697 E:5713 ||| NN
or  ||| S:5713 E:5716 ||| CC
variable  ||| S:5716 E:5725 ||| NN
under  ||| S:5725 E:5731 ||| IN
study ||| S:5731 E:5736 ||| NN
.  ||| S:5736 E:5738 ||| .
SNP  ||| S:5738 E:5742 ||| NNP
noise  ||| S:5742 E:5748 ||| NN
also  ||| S:5748 E:5753 ||| RB
exists  ||| S:5753 E:5760 ||| VBZ
between  ||| S:5760 E:5776 ||| IN
different  ||| S:5776 E:5786 ||| JJ
inbred  ||| S:5786 E:5793 ||| JJ
mouse  ||| S:5793 E:5799 ||| NN
strains ||| S:5799 E:5806 ||| NNS
,  ||| S:5806 E:5808 ||| ,
and  ||| S:5808 E:5812 ||| CC
some  ||| S:5812 E:5817 ||| DT
experiments  ||| S:5817 E:5829 ||| NNS
have  ||| S:5829 E:5842 ||| VBP
normalized  ||| S:5842 E:5853 ||| VBG
this  ||| S:5853 E:5858 ||| DT
effect  ||| S:5858 E:5865 ||| NN
by  ||| S:5865 E:5868 ||| IN
breeding  ||| S:5868 E:5877 ||| VBG
the  ||| S:5877 E:5881 ||| DT
same  ||| S:5881 E:5886 ||| JJ
mutation  ||| S:5886 E:5895 ||| NN
on  ||| S:5895 E:5906 ||| IN
different  ||| S:5906 E:5916 ||| JJ
strains ||| S:5916 E:5923 ||| NNS
,  ||| S:5923 E:5925 ||| ,
and  ||| S:5925 E:5929 ||| CC
profiling  ||| S:5929 E:5939 ||| VBG
each  ||| S:5939 E:5944 ||| DT
individually  ||| S:5944 E:5957 ||| NN
[  ||| S:5957 E:5959 ||| -LRB-
22  ||| S:5959 E:5962 ||| CD
]  ||| S:5962 E:5964 ||| -RRB-
.  ||| S:5964 E:5974 ||| .
Knowledge  ||| S:5974 E:5984 ||| NN
of  ||| S:5984 E:5987 ||| IN
the  ||| S:5987 E:5991 ||| DT
relative  ||| S:5991 E:6000 ||| JJ
effect  ||| S:6000 E:6007 ||| NN
of  ||| S:6007 E:6010 ||| IN
each  ||| S:6010 E:6015 ||| DT
experimental ||| S:6015 E:6027 ||| JJ
,  ||| S:6027 E:6037 ||| ,
tissue ||| S:6037 E:6043 ||| NN
,  ||| S:6043 E:6045 ||| ,
and  ||| S:6045 E:6049 ||| CC
patient  ||| S:6049 E:6057 ||| JJ
variable  ||| S:6057 E:6066 ||| NN
on  ||| S:6066 E:6069 ||| IN
expression  ||| S:6069 E:6080 ||| NN
profiling  ||| S:6080 E:6098 ||| NN
results  ||| S:6098 E:6106 ||| NNS
in  ||| S:6106 E:6109 ||| IN
humans  ||| S:6109 E:6116 ||| NNS
is  ||| S:6116 E:6119 ||| VBZ
important ||| S:6119 E:6128 ||| JJ
,  ||| S:6128 E:6130 ||| ,
so  ||| S:6130 E:6133 ||| RB
that  ||| S:6133 E:6138 ||| IN
appropriate  ||| S:6138 E:6158 ||| JJ
experimental  ||| S:6158 E:6171 ||| JJ
designs  ||| S:6171 E:6179 ||| NNS
can  ||| S:6179 E:6183 ||| MD
be  ||| S:6183 E:6186 ||| VB
employed ||| S:6186 E:6194 ||| VBN
.  ||| S:6194 E:6204 ||| .
We  ||| S:6204 E:6207 ||| PRP
recently  ||| S:6207 E:6216 ||| RB
reported  ||| S:6216 E:6225 ||| VBD
the  ||| S:6225 E:6229 ||| DT
design  ||| S:6229 E:6236 ||| NN
and  ||| S:6236 E:6240 ||| CC
production  ||| S:6240 E:6251 ||| NN
of  ||| S:6251 E:6254 ||| IN
a  ||| S:6254 E:6264 ||| DT
highly  ||| S:6264 E:6271 ||| RB
redundant  ||| S:6271 E:6281 ||| JJ
oligonucleotide  ||| S:6281 E:6297 ||| JJ
microarray  ||| S:6297 E:6308 ||| NN
for  ||| S:6308 E:6312 ||| IN
analysis  ||| S:6312 E:6321 ||| NN
of  ||| S:6321 E:6332 ||| IN
human  ||| S:6332 E:6338 ||| JJ
muscle  ||| S:6338 E:6345 ||| NN
biopsies  ||| S:6345 E:6354 ||| NNS
( ||| S:6354 E:6355 ||| -LRB-
Borup  ||| S:6355 E:6361 ||| FW
et  ||| S:6361 E:6364 ||| FW
al.  ||| S:6364 E:6377 ||| FW
submitted  ||| S:6377 E:6387 ||| FW
) ||| S:6387 E:6388 ||| -RRB-
.  ||| S:6388 E:6390 ||| .
This  ||| S:6390 E:6395 ||| DT
MuscleChip  ||| S:6395 E:6406 ||| NN
contains  ||| S:6406 E:6423 ||| VBZ
4,601  ||| S:6423 E:6429 ||| CD
probe  ||| S:6429 E:6435 ||| NN
sets  ||| S:6435 E:6440 ||| VBZ
corresponding  ||| S:6440 E:6454 ||| JJ
to  ||| S:6454 E:6457 ||| TO
3,369  ||| S:6457 E:6463 ||| CD
distinct  ||| S:6463 E:6472 ||| JJ
genes  ||| S:6472 E:6478 ||| NNS
and  ||| S:6478 E:6490 ||| CC
ESTs  ||| S:6490 E:6495 ||| NNP
expressed  ||| S:6495 E:6505 ||| VBD
in  ||| S:6505 E:6508 ||| IN
human  ||| S:6508 E:6514 ||| JJ
muscle ||| S:6514 E:6520 ||| NN
.  ||| S:6520 E:6522 ||| .
Each  ||| S:6522 E:6527 ||| DT
probe  ||| S:6527 E:6533 ||| NN
set  ||| S:6533 E:6537 ||| NN
contains  ||| S:6537 E:6554 ||| VBZ
between  ||| S:6554 E:6562 ||| IN
16  ||| S:6562 E:6565 ||| CD
to  ||| S:6565 E:6568 ||| TO
40  ||| S:6568 E:6571 ||| CD
oligonucleotides ||| S:6571 E:6587 ||| NN
,  ||| S:6587 E:6589 ||| ,
such  ||| S:6589 E:6594 ||| JJ
that  ||| S:6594 E:6599 ||| IN
the  ||| S:6599 E:6603 ||| DT
number  ||| S:6603 E:6610 ||| NN
of  ||| S:6610 E:6621 ||| IN
specific  ||| S:6621 E:6630 ||| JJ
oligonucleotide  ||| S:6630 E:6646 ||| JJ
probes  ||| S:6646 E:6653 ||| NNS
on  ||| S:6653 E:6656 ||| IN
the  ||| S:6656 E:6660 ||| DT
array  ||| S:6660 E:6666 ||| NN
was  ||| S:6666 E:6678 ||| VBD
138,000 ||| S:6678 E:6685 ||| CD
.  ||| S:6685 E:6695 ||| .
Here ||| S:6695 E:6699 ||| RB
,  ||| S:6699 E:6701 ||| ,
we  ||| S:6701 E:6704 ||| PRP
utilize  ||| S:6704 E:6712 ||| VBD
this  ||| S:6712 E:6717 ||| DT
MuscleChip  ||| S:6717 E:6728 ||| JJ
to  ||| S:6728 E:6731 ||| TO
investigate  ||| S:6731 E:6743 ||| VB
the  ||| S:6743 E:6755 ||| DT
relative  ||| S:6755 E:6764 ||| JJ
significance  ||| S:6764 E:6777 ||| NN
of  ||| S:6777 E:6780 ||| IN
variables  ||| S:6780 E:6790 ||| NNS
affecting  ||| S:6790 E:6800 ||| VBG
expression  ||| S:6800 E:6819 ||| NN
profiling  ||| S:6819 E:6829 ||| NN
data  ||| S:6829 E:6834 ||| NNS
and  ||| S:6834 E:6838 ||| CC
interpretation ||| S:6838 E:6852 ||| NN
.  ||| S:6852 E:6854 ||| .
Specifically ||| S:6854 E:6866 ||| RB
,  ||| S:6866 E:6868 ||| ,
we  ||| S:6868 E:6871 ||| PRP
studied  ||| S:6871 E:6887 ||| VBD
the  ||| S:6887 E:6891 ||| DT
correlation  ||| S:6891 E:6903 ||| JJ
coefficients  ||| S:6903 E:6916 ||| NN
of  ||| S:6916 E:6919 ||| IN
profiles  ||| S:6919 E:6928 ||| NNS
considering  ||| S:6928 E:6940 ||| VBG
the  ||| S:6940 E:6952 ||| DT
following  ||| S:6952 E:6962 ||| JJ
variables ||| S:6962 E:6971 ||| NNS
:  ||| S:6971 E:6973 ||| :
1.  ||| S:6973 E:6976 ||| CD
variation  ||| S:6976 E:6986 ||| NN
due  ||| S:6986 E:6990 ||| JJ
to  ||| S:6990 E:6993 ||| TO
probe  ||| S:6993 E:6999 ||| VB
production  ||| S:6999 E:7018 ||| NN
( ||| S:7018 E:7019 ||| -LRB-
same  ||| S:7019 E:7024 ||| JJ
RNA ||| S:7024 E:7027 ||| NNP
) ||| S:7027 E:7028 ||| -RRB-
;  ||| S:7028 E:7030 ||| :
2.  ||| S:7030 E:7033 ||| CD
variation  ||| S:7033 E:7043 ||| NN
due  ||| S:7043 E:7047 ||| JJ
to  ||| S:7047 E:7050 ||| TO
the  ||| S:7050 E:7054 ||| DT
microarray  ||| S:7054 E:7065 ||| NN
itself  ||| S:7065 E:7072 ||| PRP
( ||| S:7072 E:7073 ||| -LRB-
same  ||| S:7073 E:7086 ||| JJ
cRNA  ||| S:7086 E:7091 ||| NN
on  ||| S:7091 E:7094 ||| IN
different  ||| S:7094 E:7104 ||| JJ
GeneChips ||| S:7104 E:7113 ||| NN
) ||| S:7113 E:7114 ||| -RRB-
;  ||| S:7114 E:7116 ||| :
3.  ||| S:7116 E:7119 ||| CD
tissue  ||| S:7119 E:7126 ||| NN
heterogeneity  ||| S:7126 E:7148 ||| NNS
( ||| S:7148 E:7149 ||| -LRB-
different  ||| S:7149 E:7159 ||| JJ
regions  ||| S:7159 E:7167 ||| NNS
of  ||| S:7167 E:7170 ||| IN
the  ||| S:7170 E:7174 ||| DT
same  ||| S:7174 E:7179 ||| JJ
muscle  ||| S:7179 E:7186 ||| NN
biopsy ||| S:7186 E:7192 ||| NN
) ||| S:7192 E:7193 ||| -RRB-
;  ||| S:7193 E:7195 ||| :
4.  ||| S:7195 E:7206 ||| CD
inter-patient  ||| S:7206 E:7220 ||| JJ
variability  ||| S:7220 E:7232 ||| NNS
( ||| S:7232 E:7233 ||| -LRB-
SNP  ||| S:7233 E:7237 ||| NNP
noise ||| S:7237 E:7242 ||| NN
) ||| S:7242 E:7243 ||| -RRB-
;  ||| S:7243 E:7245 ||| :
5.  ||| S:7245 E:7248 ||| CD
diagnosis  ||| S:7248 E:7266 ||| NN
( ||| S:7266 E:7267 ||| -LRB-
underlying  ||| S:7267 E:7278 ||| FW
pathological  ||| S:7278 E:7291 ||| FW
variable ||| S:7291 E:7299 ||| FW
) ||| S:7299 E:7300 ||| -RRB-
;  ||| S:7300 E:7302 ||| :
and  ||| S:7302 E:7306 ||| CC
6.  ||| S:7306 E:7309 ||| CD
patient  ||| S:7309 E:7317 ||| NN
age ||| S:7317 E:7320 ||| NN
.  ||| S:7320 E:7330 ||| .
We  ||| S:7330 E:7333 ||| PRP
have  ||| S:7333 E:7338 ||| VBP
recently  ||| S:7338 E:7347 ||| RB
reported  ||| S:7347 E:7356 ||| VBN
generation  ||| S:7356 E:7367 ||| NN
of  ||| S:7367 E:7370 ||| IN
expression  ||| S:7370 E:7389 ||| NN
profiling  ||| S:7389 E:7399 ||| NN
results  ||| S:7399 E:7407 ||| NNS
using  ||| S:7407 E:7413 ||| VBG
mixed  ||| S:7413 E:7419 ||| JJ
patient  ||| S:7419 E:7427 ||| NN
samples  ||| S:7427 E:7435 ||| NNS
[  ||| S:7435 E:7437 ||| -LRB-
23  ||| S:7437 E:7440 ||| CD
]  ||| S:7440 E:7442 ||| -RRB-
.  ||| S:7442 E:7444 ||| .
Our  ||| S:7444 E:7456 ||| PRP$
hypothesis  ||| S:7456 E:7467 ||| NN
was  ||| S:7467 E:7471 ||| VBD
that  ||| S:7471 E:7476 ||| IN
mixing  ||| S:7476 E:7483 ||| VBG
of  ||| S:7483 E:7486 ||| IN
RNA  ||| S:7486 E:7490 ||| NNP
samples  ||| S:7490 E:7498 ||| NNS
from  ||| S:7498 E:7503 ||| IN
multiple  ||| S:7503 E:7520 ||| JJ
regions  ||| S:7520 E:7528 ||| NNS
of  ||| S:7528 E:7531 ||| IN
muscle  ||| S:7531 E:7538 ||| NN
biopsies ||| S:7538 E:7546 ||| NNS
,  ||| S:7546 E:7548 ||| ,
and  ||| S:7548 E:7552 ||| CC
from  ||| S:7552 E:7557 ||| IN
multiple  ||| S:7557 E:7566 ||| JJ
patients  ||| S:7566 E:7583 ||| NNS
matched  ||| S:7583 E:7591 ||| VBN
for  ||| S:7591 E:7595 ||| IN
most  ||| S:7595 E:7600 ||| JJS
variables  ||| S:7600 E:7610 ||| NNS
( ||| S:7610 E:7611 ||| -LRB-
disease ||| S:7611 E:7618 ||| NN
,  ||| S:7618 E:7620 ||| ,
age ||| S:7620 E:7623 ||| NN
,  ||| S:7623 E:7625 ||| ,
sex ||| S:7625 E:7628 ||| NN
) ||| S:7628 E:7629 ||| -RRB-
,  ||| S:7629 E:7631 ||| ,
would  ||| S:7631 E:7645 ||| MD
effectively  ||| S:7645 E:7657 ||| RB
normalize  ||| S:7657 E:7667 ||| VB
both  ||| S:7667 E:7672 ||| DT
intra-patient  ||| S:7672 E:7686 ||| JJ
variability  ||| S:7686 E:7706 ||| NNS
( ||| S:7706 E:7707 ||| -LRB-
tissue  ||| S:7707 E:7714 ||| FW
heterogeneity ||| S:7714 E:7727 ||| FW
) ||| S:7727 E:7728 ||| -RRB-
,  ||| S:7728 E:7730 ||| ,
and  ||| S:7730 E:7734 ||| CC
inter-patient  ||| S:7734 E:7748 ||| JJ
variability  ||| S:7748 E:7760 ||| NNS
( ||| S:7760 E:7761 ||| -LRB-
SNP  ||| S:7761 E:7773 ||| NNP
noise ||| S:7773 E:7778 ||| NN
;  ||| S:7778 E:7780 ||| :
e.g.  ||| S:7780 E:7785 ||| CD
normal  ||| S:7785 E:7792 ||| JJ
human  ||| S:7792 E:7798 ||| JJ
polymorphic  ||| S:7798 E:7810 ||| JJ
variation  ||| S:7810 E:7820 ||| NN
unrelated  ||| S:7820 E:7830 ||| JJ
to  ||| S:7830 E:7841 ||| TO
the  ||| S:7841 E:7845 ||| DT
primary  ||| S:7845 E:7853 ||| JJ
defect ||| S:7853 E:7859 ||| NN
) ||| S:7859 E:7860 ||| -RRB-
.  ||| S:7860 E:7862 ||| .
Here ||| S:7862 E:7866 ||| RB
,  ||| S:7866 E:7868 ||| ,
we  ||| S:7868 E:7871 ||| PRP
test  ||| S:7871 E:7876 ||| VBP
this  ||| S:7876 E:7881 ||| DT
hypothesis  ||| S:7881 E:7900 ||| NN
directly ||| S:7900 E:7908 ||| RB
,  ||| S:7908 E:7910 ||| ,
and  ||| S:7910 E:7914 ||| CC
show  ||| S:7914 E:7919 ||| VB
that  ||| S:7919 E:7924 ||| DT
sample  ||| S:7924 E:7931 ||| NN
mixing  ||| S:7931 E:7938 ||| NN
does  ||| S:7938 E:7943 ||| VBZ
indeed  ||| S:7943 E:7950 ||| RB
result  ||| S:7950 E:7957 ||| VB
in  ||| S:7957 E:7968 ||| IN
relatively  ||| S:7968 E:7979 ||| RB
high  ||| S:7979 E:7984 ||| JJ
sensitivity  ||| S:7984 E:7996 ||| NN
and  ||| S:7996 E:8000 ||| CC
specificity  ||| S:8000 E:8012 ||| NN
for  ||| S:8012 E:8016 ||| IN
gene  ||| S:8016 E:8029 ||| NN
expression  ||| S:8029 E:8040 ||| NN
changes  ||| S:8040 E:8048 ||| NNS
that  ||| S:8048 E:8053 ||| WDT
would  ||| S:8053 E:8059 ||| MD
be  ||| S:8059 E:8062 ||| VB
detected  ||| S:8062 E:8071 ||| VBN
by  ||| S:8071 E:8074 ||| IN
many  ||| S:8074 E:8087 ||| JJ
individual  ||| S:8087 E:8098 ||| JJ
expression  ||| S:8098 E:8109 ||| NN
profiles ||| S:8109 E:8117 ||| NNS
.  ||| S:8117 E:8119 ||| .
Thus ||| S:8119 E:8123 ||| RB
,  ||| S:8123 E:8125 ||| ,
sample  ||| S:8125 E:8132 ||| NN
mixing  ||| S:8132 E:8139 ||| NN
appears  ||| S:8139 E:8155 ||| VBZ
to  ||| S:8155 E:8158 ||| TO
be  ||| S:8158 E:8161 ||| VB
an  ||| S:8161 E:8164 ||| DT
appropriate  ||| S:8164 E:8176 ||| JJ
first-pass  ||| S:8176 E:8187 ||| JJ
method  ||| S:8187 E:8194 ||| NN
to  ||| S:8194 E:8197 ||| TO
obtain  ||| S:8197 E:8204 ||| VB
the  ||| S:8204 E:8208 ||| DT
most  ||| S:8208 E:8221 ||| RBS
significant  ||| S:8221 E:8233 ||| JJ
expression  ||| S:8233 E:8244 ||| NN
changes ||| S:8244 E:8251 ||| NNS
,  ||| S:8251 E:8253 ||| ,
while  ||| S:8253 E:8259 ||| IN
using  ||| S:8259 E:8265 ||| VBG
small  ||| S:8265 E:8271 ||| JJ
numbers  ||| S:8271 E:8287 ||| NNS
of  ||| S:8287 E:8290 ||| IN
arrays ||| S:8290 E:8296 ||| NN
.  ||| S:8296 E:8320 ||| .
Results  ||| S:8320 E:8328 ||| NNS
and  ||| S:8328 E:8332 ||| CC
discussion  ||| S:8332 E:8351 ||| NN
Fifty  ||| S:8351 E:8357 ||| NNP
six  ||| S:8357 E:8361 ||| CD
( ||| S:8361 E:8362 ||| -LRB-
56 ||| S:8362 E:8364 ||| CD
)  ||| S:8364 E:8366 ||| -RRB-
different  ||| S:8366 E:8376 ||| JJ
RNA  ||| S:8376 E:8380 ||| NNP
samples  ||| S:8380 E:8388 ||| NNS
were  ||| S:8388 E:8393 ||| VBD
prepared  ||| S:8393 E:8402 ||| VBN
from  ||| S:8402 E:8415 ||| IN
different  ||| S:8415 E:8425 ||| JJ
regions  ||| S:8425 E:8433 ||| NNS
of  ||| S:8433 E:8436 ||| IN
muscle  ||| S:8436 E:8443 ||| NN
biopsies  ||| S:8443 E:8452 ||| NNS
from  ||| S:8452 E:8457 ||| IN
28  ||| S:8457 E:8460 ||| CD
individuals  ||| S:8460 E:8480 ||| NNS
( ||| S:8480 E:8481 ||| -LRB-
15  ||| S:8481 E:8484 ||| CD
Duchenne  ||| S:8484 E:8493 ||| FW
muscular  ||| S:8493 E:8502 ||| FW
dystrophy  ||| S:8502 E:8512 ||| FW
( ||| S:8512 E:8513 ||| -LRB-
DMD ||| S:8513 E:8516 ||| NNP
)  ||| S:8516 E:8518 ||| -RRB-
patients ||| S:8518 E:8526 ||| NNS
,  ||| S:8526 E:8528 ||| ,
13  ||| S:8528 E:8531 ||| CD
normal  ||| S:8531 E:8546 ||| JJ
controls ||| S:8546 E:8554 ||| NNS
) ||| S:8554 E:8555 ||| -RRB-
.  ||| S:8555 E:8557 ||| .
The  ||| S:8557 E:8561 ||| DT
profiles  ||| S:8561 E:8570 ||| NN
of  ||| S:8570 E:8573 ||| IN
five  ||| S:8573 E:8578 ||| CD
of  ||| S:8578 E:8581 ||| IN
the  ||| S:8581 E:8585 ||| DT
DMD  ||| S:8585 E:8589 ||| NNP
patients  ||| S:8589 E:8598 ||| NNS
and  ||| S:8598 E:8602 ||| CC
the  ||| S:8602 E:8614 ||| DT
five  ||| S:8614 E:8619 ||| CD
controls  ||| S:8619 E:8628 ||| NNS
have  ||| S:8628 E:8633 ||| VBP
been  ||| S:8633 E:8638 ||| VBN
previously  ||| S:8638 E:8649 ||| RB
reported  ||| S:8649 E:8658 ||| VBD
using  ||| S:8658 E:8664 ||| VBG
the  ||| S:8664 E:8676 ||| DT
Affymetrix  ||| S:8676 E:8687 ||| JJ
HuFL  ||| S:8687 E:8692 ||| JJ
microarray  ||| S:8692 E:8703 ||| NNS
[  ||| S:8703 E:8705 ||| -LRB-
23  ||| S:8705 E:8708 ||| CD
]  ||| S:8708 E:8710 ||| -RRB-
;  ||| S:8710 E:8712 ||| :
however ||| S:8712 E:8719 ||| RB
,  ||| S:8719 E:8721 ||| ,
we  ||| S:8721 E:8724 ||| PRP
re-tested  ||| S:8724 E:8742 ||| VBD
these  ||| S:8742 E:8748 ||| DT
same  ||| S:8748 E:8753 ||| JJ
samples  ||| S:8753 E:8761 ||| NNS
on  ||| S:8761 E:8764 ||| IN
the  ||| S:8764 E:8768 ||| DT
custom  ||| S:8768 E:8775 ||| NN
MuscleChip  ||| S:8775 E:8786 ||| NNS
( ||| S:8786 E:8787 ||| -LRB-
Borup  ||| S:8787 E:8793 ||| FW
et  ||| S:8793 E:8796 ||| FW
al.  ||| S:8796 E:8809 ||| FW
submitted  ||| S:8809 E:8819 ||| FW
)  ||| S:8819 E:8821 ||| -RRB-
for  ||| S:8821 E:8825 ||| IN
comparison  ||| S:8825 E:8836 ||| NN
to  ||| S:8836 E:8839 ||| TO
the  ||| S:8839 E:8851 ||| DT
other  ||| S:8851 E:8857 ||| JJ
patients  ||| S:8857 E:8866 ||| NNS
here ||| S:8866 E:8870 ||| RB
.  ||| S:8870 E:8872 ||| .
All  ||| S:8872 E:8876 ||| DT
RNAs  ||| S:8876 E:8881 ||| NN
were  ||| S:8881 E:8886 ||| VBD
converted  ||| S:8886 E:8896 ||| VBN
to  ||| S:8896 E:8907 ||| TO
double-stranded  ||| S:8907 E:8923 ||| JJ
cDNA ||| S:8923 E:8927 ||| NN
,  ||| S:8927 E:8929 ||| ,
and  ||| S:8929 E:8933 ||| CC
then  ||| S:8933 E:8938 ||| RB
to  ||| S:8938 E:8941 ||| TO
biotinylated  ||| S:8941 E:8954 ||| VB
cRNA ||| S:8954 E:8958 ||| JJ
.  ||| S:8958 E:8960 ||| .
The  ||| S:8960 E:8972 ||| DT
cRNAs  ||| S:8972 E:8978 ||| NN
were  ||| S:8978 E:8983 ||| VBD
then  ||| S:8983 E:8988 ||| RB
hybridized  ||| S:8988 E:8999 ||| VBN
to  ||| S:8999 E:9002 ||| TO
the  ||| S:9002 E:9006 ||| DT
MuscleChip  ||| S:9006 E:9017 ||| JJ
either  ||| S:9017 E:9024 ||| CC
singly ||| S:9024 E:9030 ||| RB
,  ||| S:9030 E:9040 ||| ,
in  ||| S:9040 E:9043 ||| IN
mixed  ||| S:9043 E:9049 ||| JJ
groups ||| S:9049 E:9055 ||| NNS
,  ||| S:9055 E:9057 ||| ,
or  ||| S:9057 E:9060 ||| CC
both ||| S:9060 E:9064 ||| DT
,  ||| S:9064 E:9066 ||| ,
as  ||| S:9066 E:9069 ||| RB
described  ||| S:9069 E:9079 ||| VBN
below ||| S:9079 E:9084 ||| RB
.  ||| S:9084 E:9086 ||| .
In  ||| S:9086 E:9089 ||| IN
total ||| S:9089 E:9094 ||| NN
,  ||| S:9094 E:9096 ||| ,
34  ||| S:9096 E:9107 ||| CD
hybridizations  ||| S:9107 E:9122 ||| NNS
were  ||| S:9122 E:9127 ||| VBD
performed ||| S:9127 E:9136 ||| VBN
,  ||| S:9136 E:9138 ||| ,
scanned ||| S:9138 E:9145 ||| NN
,  ||| S:9145 E:9147 ||| ,
and  ||| S:9147 E:9151 ||| CC
the  ||| S:9151 E:9155 ||| DT
data  ||| S:9155 E:9168 ||| NNS
statistically  ||| S:9168 E:9182 ||| RB
analyzed  ||| S:9182 E:9191 ||| VBD
using  ||| S:9191 E:9197 ||| VBG
Affymetrix  ||| S:9197 E:9208 ||| NNP
Microarray  ||| S:9208 E:9219 ||| NNP
Suite  ||| S:9219 E:9233 ||| NNP
and  ||| S:9233 E:9237 ||| CC
Excel ||| S:9237 E:9242 ||| NNP
.  ||| S:9242 E:9244 ||| .
Quality  ||| S:9244 E:9252 ||| NN
control  ||| S:9252 E:9260 ||| NN
criteria  ||| S:9260 E:9269 ||| NNS
were  ||| S:9269 E:9274 ||| VBD
as  ||| S:9274 E:9277 ||| RB
described  ||| S:9277 E:9287 ||| VBN
on  ||| S:9287 E:9298 ||| IN
our  ||| S:9298 E:9302 ||| PRP$
web  ||| S:9302 E:9306 ||| JJ
site  ||| S:9306 E:9311 ||| NN
(  ||| S:9311 E:9313 ||| -LRB-
http://microarray.cnmcresearch.org ||| S:9313 E:9347 ||| NNP
,  ||| S:9347 E:9349 ||| ,
link  ||| S:9349 E:9354 ||| NN
to  ||| S:9354 E:9365 ||| TO
"programs  ||| S:9365 E:9375 ||| CD
in  ||| S:9375 E:9378 ||| IN
genomic  ||| S:9378 E:9386 ||| JJ
applications ||| S:9386 E:9398 ||| NNS
" ||| S:9398 E:9399 ||| ''
) ||| S:9399 E:9400 ||| -RRB-
,  ||| S:9400 E:9402 ||| ,
and  ||| S:9402 E:9406 ||| CC
included  ||| S:9406 E:9423 ||| VBD
sufficient  ||| S:9423 E:9434 ||| JJ
cRNA  ||| S:9434 E:9439 ||| JJ
amplification ||| S:9439 E:9452 ||| NN
,  ||| S:9452 E:9454 ||| ,
and  ||| S:9454 E:9458 ||| CC
adequate  ||| S:9458 E:9475 ||| JJ
post-hybridization  ||| S:9475 E:9494 ||| JJ
scaling  ||| S:9494 E:9502 ||| NN
factors ||| S:9502 E:9509 ||| NNS
.  ||| S:9509 E:9511 ||| .
Scaling  ||| S:9511 E:9519 ||| JJ
factors  ||| S:9519 E:9535 ||| NNS
( ||| S:9535 E:9536 ||| -LRB-
normalization  ||| S:9536 E:9550 ||| VB
needed  ||| S:9550 E:9557 ||| VBN
to  ||| S:9557 E:9560 ||| TO
reach  ||| S:9560 E:9566 ||| VB
a  ||| S:9566 E:9568 ||| DT
common  ||| S:9568 E:9575 ||| JJ
target  ||| S:9575 E:9582 ||| NN
intensity ||| S:9582 E:9591 ||| NN
)  ||| S:9591 E:9601 ||| -RRB-
ranged  ||| S:9601 E:9608 ||| VBD
from  ||| S:9608 E:9613 ||| IN
0.46  ||| S:9613 E:9618 ||| CD
to  ||| S:9618 E:9621 ||| TO
3.28  ||| S:9621 E:9626 ||| CD
( ||| S:9626 E:9627 ||| -LRB-
Table  ||| S:9627 E:9633 ||| NNP
1 ||| S:9633 E:9634 ||| CD
) ||| S:9634 E:9635 ||| -RRB-
.  ||| S:9635 E:9637 ||| .
All  ||| S:9637 E:9641 ||| DT
raw  ||| S:9641 E:9645 ||| JJ
image  ||| S:9645 E:9651 ||| NN
files ||| S:9651 E:9656 ||| NNS
,  ||| S:9656 E:9666 ||| ,
processed  ||| S:9666 E:9676 ||| VBN
image  ||| S:9676 E:9682 ||| NN
files ||| S:9682 E:9687 ||| NNS
,  ||| S:9687 E:9689 ||| ,
and  ||| S:9689 E:9693 ||| CC
difference  ||| S:9693 E:9704 ||| NN
analyses  ||| S:9704 E:9713 ||| NNS
are  ||| S:9713 E:9717 ||| VBP
posted  ||| S:9717 E:9732 ||| VBN
on  ||| S:9732 E:9735 ||| IN
a  ||| S:9735 E:9737 ||| DT
web-queried  ||| S:9737 E:9749 ||| JJ
SQL  ||| S:9749 E:9753 ||| NNP
database  ||| S:9753 E:9762 ||| NN
interface  ||| S:9762 E:9772 ||| NN
to  ||| S:9772 E:9775 ||| TO
our  ||| S:9775 E:9779 ||| PRP$
Affymetrix  ||| S:9779 E:9798 ||| NNP
LIMS  ||| S:9798 E:9803 ||| NNP
Oracle  ||| S:9803 E:9810 ||| NNP
warehouse  ||| S:9810 E:9820 ||| NN
( ||| S:9820 E:9821 ||| -LRB-
see  ||| S:9821 E:9833 ||| VB
http://microarray.cnmcresearch.org ||| S:9833 E:9867 ||| CD
:  ||| S:9867 E:9869 ||| :
link  ||| S:9869 E:9874 ||| NN
to  ||| S:9874 E:9877 ||| TO
"programs  ||| S:9877 E:9887 ||| CD
in  ||| S:9887 E:9898 ||| IN
genomic  ||| S:9898 E:9906 ||| JJ
applications ||| S:9906 E:9918 ||| NNS
" ||| S:9918 E:9919 ||| ''
,  ||| S:9919 E:9921 ||| ,
"data ||| S:9921 E:9926 ||| NNP
" ||| S:9926 E:9927 ||| ''
,  ||| S:9927 E:9929 ||| ,
"human ||| S:9929 E:9935 ||| NNP
" ||| S:9935 E:9936 ||| ''
) ||| S:9936 E:9937 ||| -RRB-
.  ||| S:9937 E:9947 ||| .
Among  ||| S:9947 E:9953 ||| IN
the  ||| S:9953 E:9957 ||| DT
4,601  ||| S:9957 E:9963 ||| JJ
probe  ||| S:9963 E:9969 ||| NN
sets  ||| S:9969 E:9974 ||| NNS
on  ||| S:9974 E:9977 ||| IN
the  ||| S:9977 E:9981 ||| DT
Affymetrix  ||| S:9981 E:9992 ||| JJ
custom  ||| S:9992 E:10007 ||| NN
muscle  ||| S:10007 E:10014 ||| NN
microarray ||| S:10014 E:10024 ||| NN
,  ||| S:10024 E:10026 ||| ,
we  ||| S:10026 E:10029 ||| PRP
found  ||| S:10029 E:10035 ||| VBD
a  ||| S:10035 E:10037 ||| DT
consistent  ||| S:10037 E:10048 ||| JJ
percentage  ||| S:10048 E:10059 ||| NN
of  ||| S:10059 E:10070 ||| IN
"present ||| S:10070 E:10078 ||| NNP
"  ||| S:10078 E:10080 ||| ''
calls  ||| S:10080 E:10086 ||| VBZ
for  ||| S:10086 E:10090 ||| IN
each  ||| S:10090 E:10095 ||| DT
of  ||| S:10095 E:10098 ||| IN
the  ||| S:10098 E:10102 ||| DT
34  ||| S:10102 E:10105 ||| CD
cRNA  ||| S:10105 E:10110 ||| JJ
samples  ||| S:10110 E:10118 ||| NNS
tested  ||| S:10118 E:10133 ||| VBD
( ||| S:10133 E:10134 ||| -LRB-
Duchenne  ||| S:10134 E:10143 ||| NNP
dystrophy ||| S:10143 E:10152 ||| NN
,  ||| S:10152 E:10154 ||| ,
28  ||| S:10154 E:10157 ||| CD
arrays ||| S:10157 E:10163 ||| NN
,  ||| S:10163 E:10165 ||| ,
48.2 ||| S:10165 E:10169 ||| CD
%  ||| S:10169 E:10171 ||| NN
±  ||| S:10171 E:10173 ||| CD
6.1 ||| S:10173 E:10176 ||| CD
% ||| S:10176 E:10177 ||| NN
;  ||| S:10177 E:10179 ||| :
controls  ||| S:10179 E:10188 ||| VBZ
6  ||| S:10188 E:10198 ||| CD
arrays ||| S:10198 E:10204 ||| NN
,  ||| S:10204 E:10206 ||| ,
53.3 ||| S:10206 E:10210 ||| CD
%  ||| S:10210 E:10212 ||| NN
±  ||| S:10212 E:10214 ||| CD
1.4 ||| S:10214 E:10217 ||| CD
% ||| S:10217 E:10218 ||| NN
) ||| S:10218 E:10219 ||| -RRB-
.  ||| S:10219 E:10221 ||| .
To  ||| S:10221 E:10224 ||| TO
test  ||| S:10224 E:10229 ||| VB
for  ||| S:10229 E:10233 ||| IN
inter-array  ||| S:10233 E:10245 ||| JJ
variability ||| S:10245 E:10256 ||| NN
,  ||| S:10256 E:10266 ||| ,
two  ||| S:10266 E:10270 ||| CD
different  ||| S:10270 E:10280 ||| JJ
hybridization  ||| S:10280 E:10294 ||| JJ
solutions  ||| S:10294 E:10304 ||| NNS
were  ||| S:10304 E:10309 ||| VBD
applied  ||| S:10309 E:10317 ||| VBN
to  ||| S:10317 E:10328 ||| TO
duplicate  ||| S:10328 E:10338 ||| VB
arrays ||| S:10338 E:10344 ||| NNS
,  ||| S:10344 E:10346 ||| ,
and  ||| S:10346 E:10350 ||| CC
correlation  ||| S:10350 E:10362 ||| NNS
coefficients  ||| S:10362 E:10375 ||| VBP
determined ||| S:10375 E:10385 ||| VBN
.  ||| S:10385 E:10395 ||| .
A  ||| S:10395 E:10397 ||| DT
high  ||| S:10397 E:10402 ||| JJ
correlation  ||| S:10402 E:10414 ||| NN
coefficient  ||| S:10414 E:10426 ||| NNS
was  ||| S:10426 E:10430 ||| VBD
found  ||| S:10430 E:10436 ||| VBN
in  ||| S:10436 E:10439 ||| IN
this  ||| S:10439 E:10444 ||| DT
analysis ||| S:10444 E:10452 ||| NN
,  ||| S:10452 E:10462 ||| ,
suggesting  ||| S:10462 E:10473 ||| VBG
that  ||| S:10473 E:10478 ||| IN
inter-array  ||| S:10478 E:10490 ||| JJ
variability  ||| S:10490 E:10502 ||| NN
of  ||| S:10502 E:10505 ||| IN
the  ||| S:10505 E:10509 ||| DT
MuscleChip  ||| S:10509 E:10528 ||| JJ
used  ||| S:10528 E:10533 ||| NN
was  ||| S:10533 E:10537 ||| VBD
a  ||| S:10537 E:10539 ||| DT
relatively  ||| S:10539 E:10550 ||| RB
minor  ||| S:10550 E:10556 ||| JJ
variable  ||| S:10556 E:10565 ||| NNS
( ||| S:10565 E:10566 ||| -LRB-
Patient  ||| S:10566 E:10574 ||| NNP
3  ||| S:10574 E:10576 ||| CD
a  ||| S:10576 E:10578 ||| DT
and  ||| S:10578 E:10590 ||| CC
3a-duplicate  ||| S:10590 E:10603 ||| NNP
R  ||| S:10603 E:10605 ||| NNP
2=  ||| S:10605 E:10608 ||| NNP
0.96  ||| S:10608 E:10613 ||| NNP
and  ||| S:10613 E:10617 ||| CC
percent  ||| S:10617 E:10625 ||| NN
shared  ||| S:10625 E:10632 ||| VBN
[ ||| S:10632 E:10633 ||| -LRB-
No  ||| S:10633 E:10636 ||| DT
Change  ||| S:10636 E:10643 ||| NNP
( ||| S:10643 E:10644 ||| -LRB-
NC ||| S:10644 E:10646 ||| NNP
) ||| S:10646 E:10647 ||| -RRB-
]  ||| S:10647 E:10657 ||| -RRB-
calls  ||| S:10657 E:10663 ||| VBZ
by  ||| S:10663 E:10666 ||| IN
Microarray  ||| S:10666 E:10677 ||| NNP
Suite  ||| S:10677 E:10683 ||| NNP
software  ||| S:10683 E:10692 ||| NN
was  ||| S:10692 E:10696 ||| VBD
99 ||| S:10696 E:10698 ||| CD
% ||| S:10698 E:10699 ||| NN
;  ||| S:10699 E:10701 ||| :
Patient  ||| S:10701 E:10709 ||| NNP
3b  ||| S:10709 E:10712 ||| NNP
and  ||| S:10712 E:10724 ||| CC
3b-duplicate  ||| S:10724 E:10737 ||| NNP
R  ||| S:10737 E:10739 ||| NNP
2=  ||| S:10739 E:10742 ||| NNP
0.98  ||| S:10742 E:10747 ||| NNP
and  ||| S:10747 E:10751 ||| CC
percent  ||| S:10751 E:10759 ||| NN
NC  ||| S:10759 E:10762 ||| NNP
was  ||| S:10762 E:10766 ||| VBD
98 ||| S:10766 E:10768 ||| CD
% ||| S:10768 E:10769 ||| NN
;  ||| S:10769 E:10771 ||| :
Table  ||| S:10771 E:10777 ||| NNP
1 ||| S:10777 E:10778 ||| CD
) ||| S:10778 E:10779 ||| -RRB-
.  ||| S:10779 E:10789 ||| .
The  ||| S:10789 E:10793 ||| DT
high  ||| S:10793 E:10798 ||| JJ
reproducibility  ||| S:10798 E:10814 ||| NN
of  ||| S:10814 E:10817 ||| IN
Affymetrix  ||| S:10817 E:10828 ||| NNP
array  ||| S:10828 E:10834 ||| NN
results  ||| S:10834 E:10842 ||| NNS
is  ||| S:10842 E:10853 ||| VBZ
consistent  ||| S:10853 E:10864 ||| JJ
with  ||| S:10864 E:10869 ||| IN
other  ||| S:10869 E:10875 ||| JJ
data  ||| S:10875 E:10880 ||| NNS
in  ||| S:10880 E:10883 ||| IN
our  ||| S:10883 E:10887 ||| PRP$
laboratory ||| S:10887 E:10897 ||| NN
,  ||| S:10897 E:10899 ||| ,
and  ||| S:10899 E:10903 ||| CC
from  ||| S:10903 E:10916 ||| IN
previously  ||| S:10916 E:10927 ||| RB
published  ||| S:10927 E:10937 ||| VBN
data  ||| S:10937 E:10942 ||| NNS
[  ||| S:10942 E:10944 ||| -LRB-
6  ||| S:10944 E:10946 ||| CD
21  ||| S:10946 E:10949 ||| CD
23  ||| S:10949 E:10952 ||| CD
24  ||| S:10952 E:10955 ||| CD
]  ||| S:10955 E:10957 ||| -RRB-
,  ||| S:10957 E:10959 ||| ,
and  ||| S:10959 E:10963 ||| CC
shows  ||| S:10963 E:10969 ||| NNS
that  ||| S:10969 E:10982 ||| IN
experimental  ||| S:10982 E:10995 ||| JJ
variability  ||| S:10995 E:11007 ||| NNS
associated  ||| S:11007 E:11018 ||| VBN
with  ||| S:11018 E:11023 ||| IN
hybridization  ||| S:11023 E:11037 ||| NN
and  ||| S:11037 E:11049 ||| CC
scanning  ||| S:11049 E:11058 ||| VBG
of  ||| S:11058 E:11061 ||| IN
highly  ||| S:11061 E:11068 ||| RB
redundant  ||| S:11068 E:11078 ||| JJ
oligonucleotide  ||| S:11078 E:11094 ||| JJ
GeneChips  ||| S:11094 E:11104 ||| NN
is  ||| S:11104 E:11115 ||| VBZ
not  ||| S:11115 E:11119 ||| RB
a  ||| S:11119 E:11121 ||| DT
major  ||| S:11121 E:11127 ||| JJ
source  ||| S:11127 E:11134 ||| NN
of  ||| S:11134 E:11137 ||| IN
experimental  ||| S:11137 E:11150 ||| JJ
variability ||| S:11150 E:11161 ||| NN
.  ||| S:11161 E:11171 ||| .
Given  ||| S:11171 E:11177 ||| VBN
the  ||| S:11177 E:11181 ||| DT
previous  ||| S:11181 E:11190 ||| JJ
report  ||| S:11190 E:11197 ||| NN
suggesting  ||| S:11197 E:11208 ||| VBG
that  ||| S:11208 E:11213 ||| IN
the  ||| S:11213 E:11217 ||| DT
conversion  ||| S:11217 E:11236 ||| NN
of  ||| S:11236 E:11239 ||| IN
RNA  ||| S:11239 E:11243 ||| NNP
to  ||| S:11243 E:11246 ||| TO
biotinylated  ||| S:11246 E:11259 ||| VB
cRNA  ||| S:11259 E:11264 ||| JJ
probe  ||| S:11264 E:11270 ||| NN
was  ||| S:11270 E:11274 ||| VBD
a  ||| S:11274 E:11276 ||| DT
major  ||| S:11276 E:11282 ||| JJ
source  ||| S:11282 E:11289 ||| NN
of  ||| S:11289 E:11300 ||| IN
variability  ||| S:11300 E:11312 ||| NN
in  ||| S:11312 E:11315 ||| IN
murine  ||| S:11315 E:11322 ||| JJ
array  ||| S:11322 E:11328 ||| NN
experiments  ||| S:11328 E:11340 ||| NNS
[  ||| S:11340 E:11342 ||| -LRB-
20  ||| S:11342 E:11345 ||| CD
]  ||| S:11345 E:11347 ||| -RRB-
,  ||| S:11347 E:11349 ||| ,
we  ||| S:11349 E:11352 ||| PRP
tested  ||| S:11352 E:11367 ||| VBD
a  ||| S:11367 E:11369 ||| DT
series  ||| S:11369 E:11376 ||| NN
of  ||| S:11376 E:11379 ||| IN
murine  ||| S:11379 E:11386 ||| JJ
RNA  ||| S:11386 E:11390 ||| NNP
from  ||| S:11390 E:11395 ||| IN
different  ||| S:11395 E:11405 ||| JJ
sources ||| S:11405 E:11412 ||| NNS
,  ||| S:11412 E:11414 ||| ,
using  ||| S:11414 E:11420 ||| VBG
the  ||| S:11420 E:11432 ||| DT
newer  ||| S:11432 E:11438 ||| JJR
generation  ||| S:11438 E:11449 ||| NN
U74Av2  ||| S:11449 E:11456 ||| NNP
GeneChips ||| S:11456 E:11465 ||| NNP
.  ||| S:11465 E:11467 ||| .
One  ||| S:11467 E:11471 ||| CD
series  ||| S:11471 E:11478 ||| NN
of  ||| S:11478 E:11481 ||| IN
samples  ||| S:11481 E:11497 ||| NNS
was  ||| S:11497 E:11501 ||| VBD
from  ||| S:11501 E:11506 ||| IN
murine  ||| S:11506 E:11513 ||| JJ
spleens ||| S:11513 E:11520 ||| NN
,  ||| S:11520 E:11522 ||| ,
where  ||| S:11522 E:11528 ||| WRB
spleens  ||| S:11528 E:11536 ||| NNS
from  ||| S:11536 E:11541 ||| IN
multiple  ||| S:11541 E:11558 ||| JJ
animals  ||| S:11558 E:11566 ||| NNS
for  ||| S:11566 E:11570 ||| IN
each  ||| S:11570 E:11575 ||| DT
variable  ||| S:11575 E:11584 ||| NN
under  ||| S:11584 E:11590 ||| IN
study  ||| S:11590 E:11596 ||| NN
were  ||| S:11596 E:11601 ||| VBD
mixed ||| S:11601 E:11606 ||| VBN
,  ||| S:11606 E:11608 ||| ,
RNA  ||| S:11608 E:11620 ||| NNP
isolated ||| S:11620 E:11628 ||| VBD
,  ||| S:11628 E:11630 ||| ,
RNA  ||| S:11630 E:11634 ||| NNP
samples  ||| S:11634 E:11642 ||| NNS
split ||| S:11642 E:11647 ||| NN
,  ||| S:11647 E:11649 ||| ,
and  ||| S:11649 E:11653 ||| CC
duplicate  ||| S:11653 E:11663 ||| JJ
cDNA ||| S:11663 E:11667 ||| NN
,  ||| S:11667 E:11669 ||| ,
cRNA ||| S:11669 E:11673 ||| NNP
,  ||| S:11673 E:11675 ||| ,
and  ||| S:11675 E:11687 ||| CC
hybridizations  ||| S:11687 E:11702 ||| VB
processed  ||| S:11702 E:11712 ||| VBN
in  ||| S:11712 E:11715 ||| IN
parallel  ||| S:11715 E:11724 ||| NN
for  ||| S:11724 E:11728 ||| IN
each  ||| S:11728 E:11733 ||| DT
RNA  ||| S:11733 E:11737 ||| NNP
( ||| S:11737 E:11738 ||| -LRB-
Fig.  ||| S:11738 E:11743 ||| CD
1 ||| S:11743 E:11744 ||| CD
,  ||| S:11744 E:11754 ||| ,
"KNagaraju ||| S:11754 E:11764 ||| NNP
"  ||| S:11764 E:11766 ||| ''
samples ||| S:11766 E:11773 ||| NNS
) ||| S:11773 E:11774 ||| -RRB-
.  ||| S:11774 E:11776 ||| .
We  ||| S:11776 E:11779 ||| PRP
also  ||| S:11779 E:11784 ||| RB
compared  ||| S:11784 E:11793 ||| VBN
RNAs  ||| S:11793 E:11798 ||| JJ
processed  ||| S:11798 E:11808 ||| NN
from  ||| S:11808 E:11821 ||| IN
parallel  ||| S:11821 E:11830 ||| JJ
murine  ||| S:11830 E:11837 ||| JJ
myogenic  ||| S:11837 E:11846 ||| JJ
cell  ||| S:11846 E:11851 ||| NN
cultures  ||| S:11851 E:11860 ||| NNS
( ||| S:11860 E:11861 ||| -LRB-
Fig.  ||| S:11861 E:11866 ||| CD
1 ||| S:11866 E:11867 ||| CD
,  ||| S:11867 E:11869 ||| ,
"VSM ||| S:11869 E:11873 ||| NNP
"  ||| S:11873 E:11883 ||| ''
samples ||| S:11883 E:11890 ||| NNS
) ||| S:11890 E:11891 ||| -RRB-
,  ||| S:11891 E:11893 ||| ,
where  ||| S:11893 E:11899 ||| WRB
each  ||| S:11899 E:11904 ||| DT
profile  ||| S:11904 E:11912 ||| NN
was  ||| S:11912 E:11916 ||| VBD
from  ||| S:11916 E:11921 ||| IN
a  ||| S:11921 E:11923 ||| DT
different  ||| S:11923 E:11933 ||| JJ
cell  ||| S:11933 E:11946 ||| NN
culture ||| S:11946 E:11953 ||| NN
.  ||| S:11953 E:11955 ||| .
Finally ||| S:11955 E:11962 ||| RB
,  ||| S:11962 E:11964 ||| ,
we  ||| S:11964 E:11967 ||| PRP
used  ||| S:11967 E:11972 ||| VBD
a  ||| S:11972 E:11974 ||| DT
series  ||| S:11974 E:11981 ||| NN
of  ||| S:11981 E:11984 ||| IN
murine  ||| S:11984 E:11991 ||| JJ
muscle  ||| S:11991 E:11998 ||| NN
tissues  ||| S:11998 E:12014 ||| NNS
from  ||| S:12014 E:12019 ||| IN
normal  ||| S:12019 E:12026 ||| JJ
and  ||| S:12026 E:12030 ||| CC
dystrophin-deficient  ||| S:12030 E:12051 ||| JJ
mice ||| S:12051 E:12055 ||| NNS
,  ||| S:12055 E:12057 ||| ,
where  ||| S:12057 E:12063 ||| WRB
each  ||| S:12063 E:12076 ||| DT
profile  ||| S:12076 E:12084 ||| NN
was  ||| S:12084 E:12088 ||| VBD
from  ||| S:12088 E:12093 ||| IN
a  ||| S:12093 E:12095 ||| DT
different  ||| S:12095 E:12105 ||| JJ
series  ||| S:12105 E:12112 ||| NN
of  ||| S:12112 E:12115 ||| IN
complete  ||| S:12115 E:12132 ||| JJ
gastrocnemius  ||| S:12132 E:12146 ||| JJ
muscles  ||| S:12146 E:12154 ||| NNS
( ||| S:12154 E:12155 ||| -LRB-
Fig.  ||| S:12155 E:12160 ||| CD
1 ||| S:12160 E:12161 ||| CD
,  ||| S:12161 E:12163 ||| ,
"FBooth ||| S:12163 E:12170 ||| NNP
"  ||| S:12170 E:12172 ||| ''
samples ||| S:12172 E:12179 ||| NNS
) ||| S:12179 E:12180 ||| -RRB-
.  ||| S:12180 E:12182 ||| .
The  ||| S:12182 E:12186 ||| DT
data  ||| S:12186 E:12199 ||| NNS
from  ||| S:12199 E:12204 ||| IN
these  ||| S:12204 E:12210 ||| DT
42  ||| S:12210 E:12213 ||| CD
murine  ||| S:12213 E:12220 ||| CD
U74Av2  ||| S:12220 E:12227 ||| CD
profiles  ||| S:12227 E:12236 ||| NNS
were  ||| S:12236 E:12241 ||| VBD
then  ||| S:12241 E:12246 ||| RB
analyzed  ||| S:12246 E:12255 ||| VBN
by  ||| S:12255 E:12266 ||| IN
unsupervised  ||| S:12266 E:12279 ||| JJ
clustering  ||| S:12279 E:12290 ||| NNS
[  ||| S:12290 E:12292 ||| -LRB-
25  ||| S:12292 E:12295 ||| CD
]  ||| S:12295 E:12297 ||| -RRB-
to  ||| S:12297 E:12300 ||| TO
determine  ||| S:12300 E:12310 ||| VB
which  ||| S:12310 E:12316 ||| WDT
profiles  ||| S:12316 E:12333 ||| NNS
were  ||| S:12333 E:12338 ||| VBD
most  ||| S:12338 E:12343 ||| RBS
closely  ||| S:12343 E:12351 ||| RB
related  ||| S:12351 E:12359 ||| VBN
to  ||| S:12359 E:12362 ||| TO
each  ||| S:12362 E:12367 ||| DT
other  ||| S:12367 E:12373 ||| JJ
( ||| S:12373 E:12374 ||| -LRB-
Fig.  ||| S:12374 E:12379 ||| CD
1 ||| S:12379 E:12380 ||| CD
) ||| S:12380 E:12381 ||| -RRB-
.  ||| S:12381 E:12383 ||| .
This  ||| S:12383 E:12396 ||| DT
analysis  ||| S:12396 E:12405 ||| NN
shows  ||| S:12405 E:12411 ||| NNS
that  ||| S:12411 E:12416 ||| IN
the  ||| S:12416 E:12420 ||| DT
different  ||| S:12420 E:12430 ||| JJ
sources  ||| S:12430 E:12438 ||| NNS
of  ||| S:12438 E:12441 ||| IN
RNA  ||| S:12441 E:12445 ||| NNP
cluster  ||| S:12445 E:12461 ||| VBD
together ||| S:12461 E:12469 ||| RB
,  ||| S:12469 E:12471 ||| ,
as  ||| S:12471 E:12474 ||| RB
expected ||| S:12474 E:12482 ||| VBN
.  ||| S:12482 E:12484 ||| .
Importantly ||| S:12484 E:12495 ||| RB
,  ||| S:12495 E:12497 ||| ,
the  ||| S:12497 E:12501 ||| DT
same  ||| S:12501 E:12506 ||| JJ
RNA  ||| S:12506 E:12510 ||| NNP
used  ||| S:12510 E:12515 ||| VBD
as  ||| S:12515 E:12518 ||| IN
a  ||| S:12518 E:12528 ||| DT
template  ||| S:12528 E:12537 ||| NN
for  ||| S:12537 E:12541 ||| IN
two  ||| S:12541 E:12545 ||| CD
distinct  ||| S:12545 E:12554 ||| JJ
cDNA ||| S:12554 E:12558 ||| JJ
/ ||| S:12558 E:12559 ||| CD
cRNA  ||| S:12559 E:12564 ||| JJ
preparations  ||| S:12564 E:12577 ||| NNS
and  ||| S:12577 E:12589 ||| CC
hybridizations  ||| S:12589 E:12604 ||| NNS
showed  ||| S:12604 E:12611 ||| VBD
a  ||| S:12611 E:12613 ||| DT
high  ||| S:12613 E:12618 ||| JJ
correlation  ||| S:12618 E:12630 ||| NN
coefficient  ||| S:12630 E:12642 ||| NNS
( ||| S:12642 E:12643 ||| -LRB-
R  ||| S:12643 E:12645 ||| NNP
2=  ||| S:12645 E:12656 ||| CD
0.99  ||| S:12656 E:12661 ||| CD
for  ||| S:12661 E:12665 ||| IN
five  ||| S:12665 E:12670 ||| CD
of  ||| S:12670 E:12673 ||| IN
the  ||| S:12673 E:12677 ||| DT
six  ||| S:12677 E:12681 ||| CD
samples ||| S:12681 E:12688 ||| NNS
,  ||| S:12688 E:12690 ||| ,
with  ||| S:12690 E:12695 ||| IN
average  ||| S:12695 E:12703 ||| JJ
R  ||| S:12703 E:12705 ||| NN
2=  ||| S:12705 E:12708 ||| CD
0.978 ||| S:12708 E:12713 ||| CD
)  ||| S:12713 E:12723 ||| -RRB-
( ||| S:12723 E:12724 ||| -LRB-
Fig.  ||| S:12724 E:12729 ||| CD
1 ||| S:12729 E:12730 ||| CD
) ||| S:12730 E:12731 ||| -RRB-
.  ||| S:12731 E:12733 ||| .
The  ||| S:12733 E:12737 ||| DT
large  ||| S:12737 E:12743 ||| JJ
muscle  ||| S:12743 E:12750 ||| NN
group  ||| S:12750 E:12756 ||| NN
profiles  ||| S:12756 E:12765 ||| NNS
( ||| S:12765 E:12766 ||| -LRB-
FBooth  ||| S:12766 E:12773 ||| JJ
samples ||| S:12773 E:12780 ||| NNS
)  ||| S:12780 E:12790 ||| -RRB-
showed  ||| S:12790 E:12797 ||| VBD
excellent  ||| S:12797 E:12807 ||| JJ
correlation ||| S:12807 E:12818 ||| NN
,  ||| S:12818 E:12820 ||| ,
both  ||| S:12820 E:12825 ||| DT
with  ||| S:12825 E:12830 ||| IN
respect  ||| S:12830 E:12838 ||| NN
to  ||| S:12838 E:12849 ||| TO
diagnosis ||| S:12849 E:12858 ||| NN
;  ||| S:12858 E:12860 ||| :
however  ||| S:12860 E:12868 ||| RB
here  ||| S:12868 E:12873 ||| RB
there  ||| S:12873 E:12879 ||| EX
was  ||| S:12879 E:12883 ||| VBD
no  ||| S:12883 E:12886 ||| DT
sampling  ||| S:12886 E:12895 ||| JJ
error  ||| S:12895 E:12901 ||| NN
as  ||| S:12901 E:12904 ||| IN
the  ||| S:12904 E:12916 ||| DT
entire  ||| S:12916 E:12923 ||| JJ
muscle  ||| S:12923 E:12930 ||| NN
group  ||| S:12930 E:12936 ||| NN
was  ||| S:12936 E:12940 ||| VBD
used  ||| S:12940 E:12945 ||| VBN
rather  ||| S:12945 E:12952 ||| RB
than  ||| S:12952 E:12957 ||| IN
isolated  ||| S:12957 E:12966 ||| JJ
biopsies ||| S:12966 E:12974 ||| NNS
.  ||| S:12974 E:12984 ||| .
Finally ||| S:12984 E:12991 ||| RB
,  ||| S:12991 E:12993 ||| ,
the  ||| S:12993 E:12997 ||| DT
parallel  ||| S:12997 E:13006 ||| JJ
tissue  ||| S:13006 E:13013 ||| NN
culture  ||| S:13013 E:13021 ||| NN
experiments  ||| S:13021 E:13033 ||| NNS
( ||| S:13033 E:13034 ||| -LRB-
VSM  ||| S:13034 E:13046 ||| NNP
samples ||| S:13046 E:13053 ||| NNS
)  ||| S:13053 E:13055 ||| -RRB-
showed  ||| S:13055 E:13062 ||| VBD
greater  ||| S:13062 E:13070 ||| JJR
variability  ||| S:13070 E:13082 ||| NN
between  ||| S:13082 E:13090 ||| IN
duplicates ||| S:13090 E:13100 ||| NN
,  ||| S:13100 E:13110 ||| ,
suggesting  ||| S:13110 E:13121 ||| VBG
that  ||| S:13121 E:13126 ||| DT
tissue  ||| S:13126 E:13133 ||| NN
culture  ||| S:13133 E:13141 ||| NN
conditions  ||| S:13141 E:13152 ||| NNS
may  ||| S:13152 E:13156 ||| MD
be  ||| S:13156 E:13159 ||| VB
more  ||| S:13159 E:13172 ||| RBR
subject  ||| S:13172 E:13180 ||| JJ
to  ||| S:13180 E:13183 ||| TO
variability  ||| S:13183 E:13195 ||| VB
than  ||| S:13195 E:13209 ||| IN
in  ||| S:13209 E:13212 ||| IN
vivo  ||| S:13212 E:13217 ||| JJ
tissues  ||| S:13217 E:13225 ||| NNS
( ||| S:13225 E:13226 ||| -LRB-
Fig.  ||| S:13226 E:13231 ||| CD
1 ||| S:13231 E:13232 ||| CD
) ||| S:13232 E:13233 ||| -RRB-
.  ||| S:13233 E:13235 ||| .
This  ||| S:13235 E:13240 ||| DT
murine  ||| S:13240 E:13255 ||| JJ
data  ||| S:13255 E:13260 ||| NN
shows  ||| S:13260 E:13266 ||| VBZ
that  ||| S:13266 E:13271 ||| DT
variability  ||| S:13271 E:13283 ||| NN
from  ||| S:13283 E:13288 ||| IN
different  ||| S:13288 E:13298 ||| JJ
cDNA-cRNA  ||| S:13298 E:13316 ||| JJ
reactions  ||| S:13316 E:13326 ||| NNS
is  ||| S:13326 E:13329 ||| VBZ
very  ||| S:13329 E:13334 ||| RB
low  ||| S:13334 E:13338 ||| JJ
( ||| S:13338 E:13339 ||| -LRB-
R  ||| S:13339 E:13341 ||| NNP
2=  ||| S:13341 E:13344 ||| NNP
0.978 ||| S:13344 E:13349 ||| NNP
) ||| S:13349 E:13350 ||| -RRB-
.  ||| S:13350 E:13360 ||| .
To  ||| S:13360 E:13363 ||| TO
analyze  ||| S:13363 E:13371 ||| VB
the  ||| S:13371 E:13375 ||| DT
impact  ||| S:13375 E:13382 ||| NN
of  ||| S:13382 E:13385 ||| IN
intra-patient  ||| S:13385 E:13399 ||| JJ
variability  ||| S:13399 E:13419 ||| NNS
( ||| S:13419 E:13420 ||| -LRB-
tissue  ||| S:13420 E:13427 ||| FW
heterogeneity ||| S:13427 E:13440 ||| FW
) ||| S:13440 E:13441 ||| -RRB-
,  ||| S:13441 E:13443 ||| ,
inter-patient  ||| S:13443 E:13457 ||| JJ
variability  ||| S:13457 E:13477 ||| NNS
( ||| S:13477 E:13478 ||| -LRB-
polymorphic  ||| S:13478 E:13490 ||| JJ
noise  ||| S:13490 E:13496 ||| NN
in  ||| S:13496 E:13499 ||| IN
outbred  ||| S:13499 E:13507 ||| JJ
populations ||| S:13507 E:13518 ||| NNS
) ||| S:13518 E:13519 ||| -RRB-
,  ||| S:13519 E:13521 ||| ,
and  ||| S:13521 E:13525 ||| CC
the  ||| S:13525 E:13529 ||| DT
effect  ||| S:13529 E:13544 ||| NN
of  ||| S:13544 E:13547 ||| IN
sample  ||| S:13547 E:13554 ||| NN
mixing  ||| S:13554 E:13561 ||| NN
on  ||| S:13561 E:13564 ||| IN
the  ||| S:13564 E:13568 ||| DT
sensitivity  ||| S:13568 E:13580 ||| NN
of  ||| S:13580 E:13583 ||| IN
detection  ||| S:13583 E:13593 ||| NN
of  ||| S:13593 E:13596 ||| IN
gene  ||| S:13596 E:13609 ||| NN
expression  ||| S:13609 E:13620 ||| NN
differences  ||| S:13620 E:13632 ||| NNS
between  ||| S:13632 E:13640 ||| IN
patient  ||| S:13640 E:13648 ||| JJ
groups ||| S:13648 E:13654 ||| NNS
,  ||| S:13654 E:13656 ||| ,
we  ||| S:13656 E:13659 ||| PRP
conducted  ||| S:13659 E:13677 ||| VBD
a  ||| S:13677 E:13679 ||| DT
series  ||| S:13679 E:13686 ||| NN
of  ||| S:13686 E:13689 ||| IN
individual  ||| S:13689 E:13700 ||| JJ
and  ||| S:13700 E:13704 ||| CC
mixed  ||| S:13704 E:13710 ||| JJ
profiling  ||| S:13710 E:13720 ||| NNS
( ||| S:13720 E:13721 ||| -LRB-
Table  ||| S:13721 E:13727 ||| NNP
1 ||| S:13727 E:13728 ||| CD
) ||| S:13728 E:13729 ||| -RRB-
.  ||| S:13729 E:13739 ||| .
Muscle  ||| S:13739 E:13746 ||| NN
biopsies  ||| S:13746 E:13755 ||| NNS
from  ||| S:13755 E:13760 ||| IN
five  ||| S:13760 E:13765 ||| CD
4-6  ||| S:13765 E:13769 ||| CD
yr  ||| S:13769 E:13772 ||| CD
old  ||| S:13772 E:13776 ||| JJ
DMD  ||| S:13776 E:13780 ||| NN
patients ||| S:13780 E:13788 ||| NNS
,  ||| S:13788 E:13790 ||| ,
and  ||| S:13790 E:13794 ||| CC
five  ||| S:13794 E:13807 ||| CD
10-12  ||| S:13807 E:13813 ||| CD
yr  ||| S:13813 E:13816 ||| CD
old  ||| S:13816 E:13820 ||| JJ
patients  ||| S:13820 E:13829 ||| NNS
were  ||| S:13829 E:13834 ||| VBD
selected ||| S:13834 E:13842 ||| VBN
,  ||| S:13842 E:13844 ||| ,
each  ||| S:13844 E:13849 ||| DT
biopsy  ||| S:13849 E:13856 ||| JJ
split  ||| S:13856 E:13862 ||| NN
into  ||| S:13862 E:13875 ||| IN
two  ||| S:13875 E:13879 ||| CD
parts ||| S:13879 E:13884 ||| NNS
,  ||| S:13884 E:13886 ||| ,
and  ||| S:13886 E:13890 ||| CC
RNA  ||| S:13890 E:13894 ||| NNP
isolated  ||| S:13894 E:13903 ||| VBD
independently  ||| S:13903 E:13917 ||| RB
from  ||| S:13917 E:13922 ||| IN
each  ||| S:13922 E:13927 ||| DT
of  ||| S:13927 E:13930 ||| IN
the  ||| S:13930 E:13942 ||| DT
20  ||| S:13942 E:13945 ||| CD
biopsy  ||| S:13945 E:13952 ||| CD
fragments ||| S:13952 E:13961 ||| NNS
.  ||| S:13961 E:13963 ||| .
For  ||| S:13963 E:13967 ||| IN
these  ||| S:13967 E:13973 ||| DT
ten  ||| S:13973 E:13977 ||| JJ
DMD  ||| S:13977 E:13981 ||| NN
patients ||| S:13981 E:13989 ||| NNS
,  ||| S:13989 E:13991 ||| ,
the  ||| S:13991 E:13995 ||| DT
two  ||| S:13995 E:14007 ||| CD
different  ||| S:14007 E:14017 ||| JJ
regions  ||| S:14017 E:14025 ||| NNS
of  ||| S:14025 E:14028 ||| IN
the  ||| S:14028 E:14032 ||| DT
same  ||| S:14032 E:14037 ||| JJ
biopsy  ||| S:14037 E:14044 ||| NN
were  ||| S:14044 E:14049 ||| VBD
expression  ||| S:14049 E:14068 ||| NN
profiled  ||| S:14068 E:14077 ||| VBD
both  ||| S:14077 E:14082 ||| DT
individually  ||| S:14082 E:14095 ||| NN
( ||| S:14095 E:14096 ||| -LRB-
20  ||| S:14096 E:14099 ||| CD
profiles ||| S:14099 E:14107 ||| NNS
) ||| S:14107 E:14108 ||| -RRB-
,  ||| S:14108 E:14110 ||| ,
and  ||| S:14110 E:14114 ||| CC
also  ||| S:14114 E:14119 ||| RB
mixed  ||| S:14119 E:14133 ||| VBN
into  ||| S:14133 E:14138 ||| IN
four  ||| S:14138 E:14143 ||| CD
pools  ||| S:14143 E:14149 ||| NNS
where  ||| S:14149 E:14155 ||| WRB
each  ||| S:14155 E:14160 ||| DT
pool  ||| S:14160 E:14165 ||| NN
originated  ||| S:14165 E:14176 ||| VBN
from  ||| S:14176 E:14181 ||| IN
distinct  ||| S:14181 E:14198 ||| JJ
RNA  ||| S:14198 E:14202 ||| NNP
samples  ||| S:14202 E:14210 ||| NNS
( ||| S:14210 E:14211 ||| -LRB-
Table  ||| S:14211 E:14217 ||| NNP
1 ||| S:14217 E:14218 ||| CD
) ||| S:14218 E:14219 ||| -RRB-
.  ||| S:14219 E:14221 ||| .
The  ||| S:14221 E:14225 ||| DT
resulting  ||| S:14225 E:14235 ||| VBG
profiles  ||| S:14235 E:14244 ||| NNS
were  ||| S:14244 E:14249 ||| VBD
also  ||| S:14249 E:14262 ||| RB
compared  ||| S:14262 E:14271 ||| VBN
to  ||| S:14271 E:14274 ||| TO
previously  ||| S:14274 E:14285 ||| RB
reported  ||| S:14285 E:14294 ||| VBD
mixed  ||| S:14294 E:14300 ||| VBN
6-9  ||| S:14300 E:14304 ||| CD
yr  ||| S:14304 E:14307 ||| CD
old  ||| S:14307 E:14311 ||| JJ
DMD  ||| S:14311 E:14323 ||| NNP
patient  ||| S:14323 E:14331 ||| NN
cRNAs ||| S:14331 E:14336 ||| NN
,  ||| S:14336 E:14338 ||| ,
and  ||| S:14338 E:14342 ||| CC
mixed  ||| S:14342 E:14348 ||| JJ
6-9  ||| S:14348 E:14352 ||| CD
yr  ||| S:14352 E:14355 ||| CD
old  ||| S:14355 E:14359 ||| JJ
control  ||| S:14359 E:14367 ||| NN
cRNAs  ||| S:14367 E:14373 ||| NNS
[  ||| S:14373 E:14375 ||| -LRB-
23  ||| S:14375 E:14378 ||| CD
]  ||| S:14378 E:14380 ||| -RRB-
,  ||| S:14380 E:14390 ||| ,
as  ||| S:14390 E:14393 ||| RB
mentioned  ||| S:14393 E:14403 ||| VBN
above ||| S:14403 E:14408 ||| IN
.  ||| S:14408 E:14418 ||| .
As  ||| S:14418 E:14421 ||| IN
an  ||| S:14421 E:14424 ||| DT
initial  ||| S:14424 E:14432 ||| JJ
statistical  ||| S:14432 E:14444 ||| JJ
analysis ||| S:14444 E:14452 ||| NN
,  ||| S:14452 E:14454 ||| ,
we  ||| S:14454 E:14457 ||| PRP
used  ||| S:14457 E:14462 ||| VBD
Affymetrix  ||| S:14462 E:14481 ||| NNP
software  ||| S:14481 E:14490 ||| NN
to  ||| S:14490 E:14493 ||| TO
define  ||| S:14493 E:14500 ||| VB
genes  ||| S:14500 E:14506 ||| NNS
that  ||| S:14506 E:14511 ||| WDT
showed  ||| S:14511 E:14518 ||| VBD
expression  ||| S:14518 E:14529 ||| NN
changes  ||| S:14529 E:14545 ||| NNS
( ||| S:14545 E:14546 ||| -LRB-
Increased ||| S:14546 E:14555 ||| NNP
,  ||| S:14555 E:14557 ||| ,
Decreased  ||| S:14557 E:14567 ||| NNP
or  ||| S:14567 E:14570 ||| CC
Marginal ||| S:14570 E:14578 ||| NNP
)  ||| S:14578 E:14580 ||| -RRB-
in  ||| S:14580 E:14583 ||| IN
expression  ||| S:14583 E:14594 ||| NN
levels  ||| S:14594 E:14609 ||| NNS
between  ||| S:14609 E:14617 ||| IN
pairs  ||| S:14617 E:14623 ||| NNS
of  ||| S:14623 E:14626 ||| IN
profiles  ||| S:14626 E:14635 ||| NNS
( ||| S:14635 E:14636 ||| -LRB-
difference  ||| S:14636 E:14647 ||| NN
analyses ||| S:14647 E:14655 ||| NNS
) ||| S:14655 E:14656 ||| -RRB-
.  ||| S:14656 E:14658 ||| .
This  ||| S:14658 E:14671 ||| DT
method  ||| S:14671 E:14678 ||| NN
of  ||| S:14678 E:14681 ||| IN
data  ||| S:14681 E:14686 ||| NN
interpretation  ||| S:14686 E:14701 ||| NN
showed  ||| S:14701 E:14708 ||| VBD
that  ||| S:14708 E:14713 ||| IN
some  ||| S:14713 E:14718 ||| DT
muscle  ||| S:14718 E:14733 ||| NN
biopsies  ||| S:14733 E:14742 ||| NNS
showed  ||| S:14742 E:14749 ||| VBD
very  ||| S:14749 E:14754 ||| RB
little  ||| S:14754 E:14761 ||| JJ
variance  ||| S:14761 E:14770 ||| NN
between  ||| S:14770 E:14778 ||| IN
different  ||| S:14778 E:14796 ||| JJ
regions  ||| S:14796 E:14804 ||| NNS
of  ||| S:14804 E:14807 ||| IN
the  ||| S:14807 E:14811 ||| DT
same  ||| S:14811 E:14816 ||| JJ
biopsy ||| S:14816 E:14822 ||| NN
,  ||| S:14822 E:14824 ||| ,
while  ||| S:14824 E:14830 ||| IN
other  ||| S:14830 E:14836 ||| JJ
patient  ||| S:14836 E:14844 ||| NN
biopsies  ||| S:14844 E:14861 ||| NNS
showed  ||| S:14861 E:14868 ||| VBD
considerable  ||| S:14868 E:14881 ||| JJ
variability  ||| S:14881 E:14893 ||| NNS
( ||| S:14893 E:14894 ||| -LRB-
see  ||| S:14894 E:14898 ||| FW
Fig.  ||| S:14898 E:14903 ||| FW
2for  ||| S:14903 E:14916 ||| FW
representative  ||| S:14916 E:14931 ||| FW
scatter  ||| S:14931 E:14939 ||| FW
graphs ||| S:14939 E:14945 ||| FW
) ||| S:14945 E:14946 ||| -RRB-
.  ||| S:14946 E:14948 ||| .
Expressing  ||| S:14948 E:14959 ||| VBG
this  ||| S:14959 E:14964 ||| DT
variance  ||| S:14964 E:14973 ||| NN
as  ||| S:14973 E:14984 ||| IN
a  ||| S:14984 E:14986 ||| DT
percentage  ||| S:14986 E:14997 ||| NN
of  ||| S:14997 E:15000 ||| IN
"Diff  ||| S:15000 E:15006 ||| CD
Calls ||| S:15006 E:15011 ||| NNS
"  ||| S:15011 E:15013 ||| ''
between  ||| S:15013 E:15021 ||| IN
the  ||| S:15021 E:15025 ||| DT
two  ||| S:15025 E:15029 ||| CD
regions  ||| S:15029 E:15037 ||| NNS
of  ||| S:15037 E:15040 ||| IN
the  ||| S:15040 E:15052 ||| DT
same  ||| S:15052 E:15057 ||| JJ
biopsy ||| S:15057 E:15063 ||| NN
,  ||| S:15063 E:15065 ||| ,
as  ||| S:15065 E:15068 ||| RB
determined  ||| S:15068 E:15079 ||| VBN
by  ||| S:15079 E:15082 ||| IN
Affymetrix  ||| S:15082 E:15093 ||| NNP
default  ||| S:15093 E:15109 ||| NN
algorithms ||| S:15109 E:15119 ||| NN
,  ||| S:15119 E:15121 ||| ,
we  ||| S:15121 E:15124 ||| PRP
found  ||| S:15124 E:15130 ||| VBD
considerable  ||| S:15130 E:15143 ||| JJ
variability  ||| S:15143 E:15155 ||| NN
in  ||| S:15155 E:15158 ||| IN
the  ||| S:15158 E:15170 ||| DT
similarity  ||| S:15170 E:15181 ||| NN
of  ||| S:15181 E:15184 ||| IN
profiles ||| S:15184 E:15192 ||| NNS
,  ||| S:15192 E:15194 ||| ,
with  ||| S:15194 E:15199 ||| IN
values  ||| S:15199 E:15206 ||| NNS
ranging  ||| S:15206 E:15214 ||| VBG
from  ||| S:15214 E:15219 ||| IN
1.5 ||| S:15219 E:15222 ||| CD
%  ||| S:15222 E:15224 ||| NN
to  ||| S:15224 E:15235 ||| TO
18 ||| S:15235 E:15237 ||| CD
%  ||| S:15237 E:15239 ||| NN
of  ||| S:15239 E:15242 ||| IN
the  ||| S:15242 E:15246 ||| DT
4,601  ||| S:15246 E:15252 ||| JJ
probe  ||| S:15252 E:15258 ||| NN
sets  ||| S:15258 E:15263 ||| VBZ
studied  ||| S:15263 E:15271 ||| VBN
( ||| S:15271 E:15272 ||| -LRB-
4.99 ||| S:15272 E:15276 ||| CD
%  ||| S:15276 E:15278 ||| NN
±  ||| S:15278 E:15280 ||| CD
4.94 ||| S:15280 E:15284 ||| CD
% ||| S:15284 E:15285 ||| NN
) ||| S:15285 E:15286 ||| -RRB-
.  ||| S:15286 E:15288 ||| .
This  ||| S:15288 E:15301 ||| DT
data  ||| S:15301 E:15306 ||| NN
suggests  ||| S:15306 E:15315 ||| VBZ
that  ||| S:15315 E:15320 ||| DT
tissue  ||| S:15320 E:15327 ||| NN
heterogeneity  ||| S:15327 E:15341 ||| NNS
( ||| S:15341 E:15342 ||| -LRB-
intra-patient  ||| S:15342 E:15364 ||| JJ
variability ||| S:15364 E:15375 ||| NN
)  ||| S:15375 E:15377 ||| -RRB-
can  ||| S:15377 E:15381 ||| MD
be  ||| S:15381 E:15384 ||| VB
a  ||| S:15384 E:15386 ||| DT
major  ||| S:15386 E:15392 ||| JJ
source  ||| S:15392 E:15399 ||| NN
of  ||| S:15399 E:15402 ||| IN
variation  ||| S:15402 E:15412 ||| NN
in  ||| S:15412 E:15423 ||| IN
expression  ||| S:15423 E:15434 ||| NN
profiling  ||| S:15434 E:15444 ||| NN
experiments ||| S:15444 E:15455 ||| NNS
,  ||| S:15455 E:15457 ||| ,
even  ||| S:15457 E:15462 ||| RB
when  ||| S:15462 E:15467 ||| WRB
using  ||| S:15467 E:15481 ||| VBG
relatively  ||| S:15481 E:15492 ||| RB
large  ||| S:15492 E:15498 ||| JJ
pieces  ||| S:15498 E:15505 ||| NNS
( ||| S:15505 E:15506 ||| -LRB-
50  ||| S:15506 E:15509 ||| CD
mg ||| S:15509 E:15511 ||| CD
)  ||| S:15511 E:15513 ||| -RRB-
of  ||| S:15513 E:15516 ||| IN
relatively  ||| S:15516 E:15527 ||| RB
homogeneous  ||| S:15527 E:15547 ||| JJ
tissues  ||| S:15547 E:15555 ||| NNS
( ||| S:15555 E:15556 ||| -LRB-
such  ||| S:15556 E:15561 ||| JJ
as  ||| S:15561 E:15564 ||| IN
muscle ||| S:15564 E:15570 ||| NN
) ||| S:15570 E:15571 ||| -RRB-
.  ||| S:15571 E:15581 ||| .
The  ||| S:15581 E:15585 ||| DT
most  ||| S:15585 E:15590 ||| RBS
common  ||| S:15590 E:15597 ||| JJ
strategy  ||| S:15597 E:15606 ||| NN
for  ||| S:15606 E:15610 ||| IN
interpreting  ||| S:15610 E:15623 ||| VBG
Affymetrix  ||| S:15623 E:15642 ||| JJ
microarray  ||| S:15642 E:15653 ||| JJ
data  ||| S:15653 E:15658 ||| NN
is  ||| S:15658 E:15661 ||| VBZ
to  ||| S:15661 E:15664 ||| TO
use  ||| S:15664 E:15668 ||| VB
two  ||| S:15668 E:15672 ||| CD
profile  ||| S:15672 E:15680 ||| NN
comparisons ||| S:15680 E:15691 ||| NNS
,  ||| S:15691 E:15693 ||| ,
with  ||| S:15693 E:15698 ||| IN
an  ||| S:15698 E:15709 ||| DT
arbitrary  ||| S:15709 E:15719 ||| JJ
threshold  ||| S:15719 E:15729 ||| NN
for  ||| S:15729 E:15733 ||| IN
"significant  ||| S:15733 E:15746 ||| CD
fold-change ||| S:15746 E:15757 ||| JJ
"  ||| S:15757 E:15759 ||| ''
in  ||| S:15759 E:15770 ||| IN
expression  ||| S:15770 E:15781 ||| NN
levels ||| S:15781 E:15787 ||| NNS
.  ||| S:15787 E:15789 ||| .
Typically ||| S:15789 E:15798 ||| RB
,  ||| S:15798 E:15800 ||| ,
multiple  ||| S:15800 E:15809 ||| JJ
arrays  ||| S:15809 E:15816 ||| NNS
are  ||| S:15816 E:15820 ||| VBP
compared ||| S:15820 E:15828 ||| VBN
,  ||| S:15828 E:15838 ||| ,
with  ||| S:15838 E:15843 ||| IN
those  ||| S:15843 E:15849 ||| DT
gene  ||| S:15849 E:15854 ||| NN
expression  ||| S:15854 E:15865 ||| NN
changes  ||| S:15865 E:15873 ||| NNS
showing  ||| S:15873 E:15881 ||| VBG
the  ||| S:15881 E:15885 ||| DT
most  ||| S:15885 E:15898 ||| RBS
consistent  ||| S:15898 E:15909 ||| JJ
fold  ||| S:15909 E:15914 ||| JJ
changes  ||| S:15914 E:15922 ||| NNS
prioritized ||| S:15922 E:15933 ||| NN
,  ||| S:15933 E:15935 ||| ,
although  ||| S:15935 E:15944 ||| IN
other  ||| S:15944 E:15950 ||| JJ
methods  ||| S:15950 E:15966 ||| NNS
have  ||| S:15966 E:15971 ||| VBP
been  ||| S:15971 E:15976 ||| VBN
reported  ||| S:15976 E:15985 ||| VBN
[  ||| S:15985 E:15987 ||| -LRB-
13  ||| S:15987 E:15990 ||| CD
22  ||| S:15990 E:15993 ||| CD
26  ||| S:15993 E:15996 ||| CD
27  ||| S:15996 E:15999 ||| CD
]  ||| S:15999 E:16001 ||| -RRB-
.  ||| S:16001 E:16003 ||| .
To  ||| S:16003 E:16006 ||| TO
study  ||| S:16006 E:16012 ||| VB
inter-patient  ||| S:16012 E:16034 ||| JJ
variability ||| S:16034 E:16045 ||| NN
,  ||| S:16045 E:16047 ||| ,
we  ||| S:16047 E:16050 ||| PRP
defined  ||| S:16050 E:16058 ||| VBD
the  ||| S:16058 E:16062 ||| DT
gene  ||| S:16062 E:16067 ||| NN
expression  ||| S:16067 E:16078 ||| NN
changes  ||| S:16078 E:16094 ||| NNS
surviving  ||| S:16094 E:16104 ||| VBG
four  ||| S:16104 E:16109 ||| CD
pairwise  ||| S:16109 E:16118 ||| CD
comparisons  ||| S:16118 E:16130 ||| NNS
with  ||| S:16130 E:16135 ||| IN
mixed  ||| S:16135 E:16141 ||| JJ
control  ||| S:16141 E:16157 ||| NN
samples ||| S:16157 E:16164 ||| NNS
,  ||| S:16164 E:16166 ||| ,
as  ||| S:16166 E:16169 ||| IN
we  ||| S:16169 E:16172 ||| PRP
have  ||| S:16172 E:16177 ||| VBP
previously  ||| S:16177 E:16188 ||| RB
described  ||| S:16188 E:16198 ||| VBN
[  ||| S:16198 E:16200 ||| -LRB-
23  ||| S:16200 E:16203 ||| CD
]  ||| S:16203 E:16205 ||| -RRB-
.  ||| S:16205 E:16207 ||| .
Briefly ||| S:16207 E:16214 ||| RB
,  ||| S:16214 E:16224 ||| ,
four  ||| S:16224 E:16229 ||| CD
comparisons  ||| S:16229 E:16241 ||| NNS
were  ||| S:16241 E:16246 ||| VBD
done  ||| S:16246 E:16251 ||| VBN
by  ||| S:16251 E:16254 ||| IN
Affymetrix  ||| S:16254 E:16265 ||| NNP
software  ||| S:16265 E:16274 ||| NN
( ||| S:16274 E:16275 ||| -LRB-
eg ||| S:16275 E:16277 ||| NN
.  ||| S:16277 E:16279 ||| .
DMD  ||| S:16279 E:16291 ||| NNP
1a  ||| S:16291 E:16294 ||| FW
versus  ||| S:16294 E:16301 ||| FW
control  ||| S:16301 E:16309 ||| FW
1a ||| S:16309 E:16311 ||| FW
;  ||| S:16311 E:16313 ||| :
DMD  ||| S:16313 E:16317 ||| FW
1a  ||| S:16317 E:16320 ||| FW
versus  ||| S:16320 E:16327 ||| FW
control  ||| S:16327 E:16335 ||| FW
1b ||| S:16335 E:16337 ||| FW
;  ||| S:16337 E:16339 ||| :
DMD1b  ||| S:16339 E:16353 ||| FW
versus  ||| S:16353 E:16360 ||| FW
control  ||| S:16360 E:16368 ||| FW
1a ||| S:16368 E:16370 ||| FW
;  ||| S:16370 E:16372 ||| :
DMD1b  ||| S:16372 E:16378 ||| FW
versus  ||| S:16378 E:16385 ||| FW
control  ||| S:16385 E:16393 ||| FW
1b ||| S:16393 E:16395 ||| FW
) ||| S:16395 E:16396 ||| -RRB-
.  ||| S:16396 E:16398 ||| .
The  ||| S:16398 E:16402 ||| DT
four  ||| S:16402 E:16407 ||| CD
data  ||| S:16407 E:16420 ||| NN
sets  ||| S:16420 E:16425 ||| NNS
were  ||| S:16425 E:16430 ||| VBD
then  ||| S:16430 E:16435 ||| RB
compared ||| S:16435 E:16443 ||| VBN
,  ||| S:16443 E:16445 ||| ,
with  ||| S:16445 E:16450 ||| IN
only  ||| S:16450 E:16455 ||| RB
those  ||| S:16455 E:16461 ||| DT
gene  ||| S:16461 E:16466 ||| NN
expression  ||| S:16466 E:16485 ||| NN
changes  ||| S:16485 E:16493 ||| NNS
that  ||| S:16493 E:16498 ||| WDT
showed  ||| S:16498 E:16505 ||| VBD
> ||| S:16505 E:16506 ||| CD
2-fold  ||| S:16506 E:16513 ||| CD
change  ||| S:16513 E:16520 ||| NN
in  ||| S:16520 E:16523 ||| IN
all  ||| S:16523 E:16527 ||| DT
four  ||| S:16527 E:16540 ||| CD
comparisons  ||| S:16540 E:16552 ||| NNS
( ||| S:16552 E:16553 ||| -LRB-
four  ||| S:16553 E:16558 ||| CD
comparison  ||| S:16558 E:16569 ||| NN
survival  ||| S:16569 E:16578 ||| NN
method ||| S:16578 E:16584 ||| NN
) ||| S:16584 E:16585 ||| -RRB-
.  ||| S:16585 E:16587 ||| .
The  ||| S:16587 E:16591 ||| DT
number  ||| S:16591 E:16606 ||| NN
of  ||| S:16606 E:16609 ||| IN
surviving  ||| S:16609 E:16619 ||| VBG
diff  ||| S:16619 E:16624 ||| JJ
calls  ||| S:16624 E:16630 ||| NNS
by  ||| S:16630 E:16633 ||| IN
this  ||| S:16633 E:16638 ||| DT
method  ||| S:16638 E:16645 ||| NN
ranged  ||| S:16645 E:16652 ||| VBD
from  ||| S:16652 E:16657 ||| IN
250  ||| S:16657 E:16661 ||| CD
to  ||| S:16661 E:16672 ||| TO
463  ||| S:16672 E:16676 ||| CD
( ||| S:16676 E:16677 ||| -LRB-
355  ||| S:16677 E:16681 ||| CD
±  ||| S:16681 E:16683 ||| CD
80 ||| S:16683 E:16685 ||| CD
)  ||| S:16685 E:16687 ||| -RRB-
( ||| S:16687 E:16688 ||| -LRB-
Table  ||| S:16688 E:16694 ||| NNP
1 ||| S:16694 E:16695 ||| CD
) ||| S:16695 E:16696 ||| -RRB-
.  ||| S:16696 E:16698 ||| .
Interestingly ||| S:16698 E:16711 ||| RB
,  ||| S:16711 E:16713 ||| ,
those  ||| S:16713 E:16719 ||| DT
patients  ||| S:16719 E:16736 ||| NNS
showing  ||| S:16736 E:16744 ||| VBG
considerable  ||| S:16744 E:16757 ||| JJ
variation  ||| S:16757 E:16767 ||| NN
between  ||| S:16767 E:16775 ||| IN
different  ||| S:16775 E:16785 ||| JJ
regions  ||| S:16785 E:16793 ||| NNS
of  ||| S:16793 E:16804 ||| IN
the  ||| S:16804 E:16808 ||| DT
same  ||| S:16808 E:16813 ||| JJ
biopsy  ||| S:16813 E:16820 ||| NN
did  ||| S:16820 E:16824 ||| VBD
not  ||| S:16824 E:16828 ||| RB
show  ||| S:16828 E:16833 ||| VB
a  ||| S:16833 E:16835 ||| DT
corresponding  ||| S:16835 E:16849 ||| JJ
decrease  ||| S:16849 E:16858 ||| NN
in  ||| S:16858 E:16869 ||| IN
the  ||| S:16869 E:16873 ||| DT
number  ||| S:16873 E:16880 ||| NN
of  ||| S:16880 E:16883 ||| IN
gene  ||| S:16883 E:16888 ||| NN
expression  ||| S:16888 E:16899 ||| NN
changes  ||| S:16899 E:16907 ||| NNS
surviving  ||| S:16907 E:16917 ||| VBG
the  ||| S:16917 E:16929 ||| DT
iterative  ||| S:16929 E:16939 ||| JJ
comparisons  ||| S:16939 E:16951 ||| NNS
to  ||| S:16951 E:16954 ||| TO
controls  ||| S:16954 E:16963 ||| NNS
( ||| S:16963 E:16964 ||| -LRB-
Table  ||| S:16964 E:16970 ||| NNP
1 ||| S:16970 E:16971 ||| CD
) ||| S:16971 E:16972 ||| -RRB-
.  ||| S:16972 E:16974 ||| .
This  ||| S:16974 E:16979 ||| DT
suggests  ||| S:16979 E:16996 ||| VBZ
( ||| S:16996 E:16997 ||| -LRB-
but  ||| S:16997 E:17001 ||| CC
does  ||| S:17001 E:17006 ||| VBZ
not  ||| S:17006 E:17010 ||| RB
prove ||| S:17010 E:17015 ||| VB
)  ||| S:17015 E:17017 ||| -RRB-
the  ||| S:17017 E:17021 ||| DT
most  ||| S:17021 E:17026 ||| RBS
significant  ||| S:17026 E:17038 ||| JJ
changes  ||| S:17038 E:17046 ||| NNS
might  ||| S:17046 E:17052 ||| MD
be  ||| S:17052 E:17063 ||| VB
shared ||| S:17063 E:17069 ||| VBN
,  ||| S:17069 E:17071 ||| ,
independent  ||| S:17071 E:17083 ||| JJ
of  ||| S:17083 E:17086 ||| IN
tissue  ||| S:17086 E:17093 ||| NN
variability  ||| S:17093 E:17105 ||| NNS
( ||| S:17105 E:17106 ||| -LRB-
see  ||| S:17106 E:17110 ||| VB
below ||| S:17110 E:17115 ||| IN
) ||| S:17115 E:17116 ||| -RRB-
.  ||| S:17116 E:17126 ||| .
A  ||| S:17126 E:17128 ||| DT
different  ||| S:17128 E:17138 ||| JJ
statistical  ||| S:17138 E:17150 ||| JJ
method  ||| S:17150 E:17157 ||| NN
to  ||| S:17157 E:17160 ||| TO
determine  ||| S:17160 E:17170 ||| VB
the  ||| S:17170 E:17174 ||| DT
effect  ||| S:17174 E:17189 ||| NN
of  ||| S:17189 E:17192 ||| IN
the  ||| S:17192 E:17196 ||| DT
different  ||| S:17196 E:17206 ||| JJ
variables  ||| S:17206 E:17216 ||| NNS
under  ||| S:17216 E:17222 ||| IN
study  ||| S:17222 E:17228 ||| NN
is  ||| S:17228 E:17231 ||| VBZ
to  ||| S:17231 E:17234 ||| TO
perform  ||| S:17234 E:17250 ||| VB
hierarchical  ||| S:17250 E:17263 ||| JJ
cluster  ||| S:17263 E:17271 ||| NN
analysis  ||| S:17271 E:17280 ||| NN
using  ||| S:17280 E:17286 ||| VBG
nearest  ||| S:17286 E:17294 ||| JJS
neighbor  ||| S:17294 E:17311 ||| NN
statistical  ||| S:17311 E:17323 ||| JJ
methods  ||| S:17323 E:17331 ||| NNS
[  ||| S:17331 E:17333 ||| -LRB-
25  ||| S:17333 E:17336 ||| CD
]  ||| S:17336 E:17338 ||| -RRB-
.  ||| S:17338 E:17340 ||| .
Here ||| S:17340 E:17344 ||| RB
,  ||| S:17344 E:17346 ||| ,
we  ||| S:17346 E:17349 ||| PRP
subjected  ||| S:17349 E:17359 ||| VBD
all  ||| S:17359 E:17371 ||| DT
profiles  ||| S:17371 E:17380 ||| NN
to  ||| S:17380 E:17383 ||| TO
unsupervised  ||| S:17383 E:17396 ||| VB
cluster  ||| S:17396 E:17404 ||| JJ
analysis ||| S:17404 E:17412 ||| NN
,  ||| S:17412 E:17414 ||| ,
as  ||| S:17414 E:17417 ||| IN
a  ||| S:17417 E:17419 ||| DT
means  ||| S:17419 E:17425 ||| NNS
of  ||| S:17425 E:17436 ||| IN
determining  ||| S:17436 E:17448 ||| NNS
which  ||| S:17448 E:17454 ||| WDT
variables  ||| S:17454 E:17464 ||| NNS
had  ||| S:17464 E:17468 ||| VBD
the  ||| S:17468 E:17472 ||| DT
greatest  ||| S:17472 E:17481 ||| JJS
effect  ||| S:17481 E:17488 ||| NN
( ||| S:17488 E:17489 ||| -LRB-
e.g.  ||| S:17489 E:17502 ||| FW
intra-patient  ||| S:17502 E:17516 ||| FW
variability  ||| S:17516 E:17528 ||| FW
[ ||| S:17528 E:17529 ||| -LRB-
different  ||| S:17529 E:17539 ||| JJ
regions  ||| S:17539 E:17547 ||| NNS
of  ||| S:17547 E:17550 ||| IN
biopsy ||| S:17550 E:17556 ||| CD
] ||| S:17556 E:17557 ||| -RRB-
,  ||| S:17557 E:17567 ||| ,
versus  ||| S:17567 E:17574 ||| FW
diagnosis  ||| S:17574 E:17584 ||| FW
[ ||| S:17584 E:17585 ||| -LRB-
DMD  ||| S:17585 E:17589 ||| NNP
vs  ||| S:17589 E:17592 ||| JJ
control ||| S:17592 E:17599 ||| NN
] ||| S:17599 E:17600 ||| -RRB-
,  ||| S:17600 E:17602 ||| ,
versus  ||| S:17602 E:17609 ||| FW
inter-patient  ||| S:17609 E:17631 ||| FW
variability  ||| S:17631 E:17643 ||| FW
[ ||| S:17643 E:17644 ||| -LRB-
DMD  ||| S:17644 E:17648 ||| NNP
patients  ||| S:17648 E:17657 ||| NNS
in  ||| S:17657 E:17660 ||| IN
same  ||| S:17660 E:17665 ||| JJ
age  ||| S:17665 E:17669 ||| NN
group ||| S:17669 E:17674 ||| NN
] ||| S:17674 E:17675 ||| -RRB-
,  ||| S:17675 E:17677 ||| ,
versus  ||| S:17677 E:17684 ||| CC
age  ||| S:17684 E:17688 ||| NN
of  ||| S:17688 E:17699 ||| IN
patient ||| S:17699 E:17706 ||| NN
) ||| S:17706 E:17707 ||| -RRB-
.  ||| S:17707 E:17709 ||| .
For  ||| S:17709 E:17713 ||| IN
this  ||| S:17713 E:17718 ||| DT
analysis ||| S:17718 E:17726 ||| NN
,  ||| S:17726 E:17728 ||| ,
we  ||| S:17728 E:17731 ||| PRP
used  ||| S:17731 E:17736 ||| VBD
the  ||| S:17736 E:17740 ||| DT
fluorescence  ||| S:17740 E:17761 ||| JJ
intensity  ||| S:17761 E:17771 ||| NN
of  ||| S:17771 E:17774 ||| IN
each  ||| S:17774 E:17779 ||| DT
probe  ||| S:17779 E:17785 ||| NN
set  ||| S:17785 E:17789 ||| NN
( ||| S:17789 E:17790 ||| -LRB-
Average  ||| S:17790 E:17798 ||| NNP
difference ||| S:17798 E:17808 ||| NN
) ||| S:17808 E:17809 ||| -RRB-
,  ||| S:17809 E:17811 ||| ,
after  ||| S:17811 E:17825 ||| IN
data  ||| S:17825 E:17830 ||| NNS
scrubbing  ||| S:17830 E:17840 ||| VBP
to  ||| S:17840 E:17843 ||| TO
remove  ||| S:17843 E:17850 ||| VB
genes  ||| S:17850 E:17856 ||| NNS
that  ||| S:17856 E:17861 ||| WDT
showed  ||| S:17861 E:17868 ||| VBD
expression  ||| S:17868 E:17887 ||| NN
levels  ||| S:17887 E:17894 ||| NNS
near  ||| S:17894 E:17899 ||| IN
background  ||| S:17899 E:17910 ||| NN
( ||| S:17910 E:17911 ||| -LRB-
"Absent ||| S:17911 E:17918 ||| NNP
"  ||| S:17918 E:17920 ||| ''
Calls ||| S:17920 E:17925 ||| VBZ
)  ||| S:17925 E:17927 ||| -RRB-
for  ||| S:17927 E:17931 ||| IN
all  ||| S:17931 E:17935 ||| DT
profiles  ||| S:17935 E:17952 ||| NNS
( ||| S:17952 E:17953 ||| -LRB-
Fig.  ||| S:17953 E:17958 ||| CD
3 ||| S:17958 E:17959 ||| CD
) ||| S:17959 E:17960 ||| -RRB-
.  ||| S:17960 E:17962 ||| .
This  ||| S:17962 E:17967 ||| DT
analysis  ||| S:17967 E:17976 ||| NN
shows  ||| S:17976 E:17982 ||| NNS
that  ||| S:17982 E:17987 ||| IN
duplicate  ||| S:17987 E:17997 ||| JJ
profiles  ||| S:17997 E:18006 ||| NNS
of  ||| S:18006 E:18017 ||| IN
the  ||| S:18017 E:18021 ||| DT
same  ||| S:18021 E:18026 ||| JJ
cRNA  ||| S:18026 E:18031 ||| JJ
hybridization  ||| S:18031 E:18045 ||| JJ
solution  ||| S:18045 E:18054 ||| NN
are  ||| S:18054 E:18058 ||| VBP
the  ||| S:18058 E:18062 ||| DT
most  ||| S:18062 E:18067 ||| RBS
highly  ||| S:18067 E:18082 ||| RB
related  ||| S:18082 E:18090 ||| VBN
( ||| S:18090 E:18091 ||| -LRB-
Patient  ||| S:18091 E:18099 ||| NNP
3  ||| S:18099 E:18101 ||| CD
a  ||| S:18101 E:18103 ||| DT
and  ||| S:18103 E:18107 ||| CC
duplicate  ||| S:18107 E:18117 ||| NNS
( ||| S:18117 E:18118 ||| -LRB-
3a-d ||| S:18118 E:18122 ||| NNP
) ||| S:18122 E:18123 ||| -RRB-
;  ||| S:18123 E:18125 ||| :
3b  ||| S:18125 E:18128 ||| CD
and  ||| S:18128 E:18132 ||| CC
duplicate  ||| S:18132 E:18150 ||| NNS
( ||| S:18150 E:18151 ||| -LRB-
3b-d ||| S:18151 E:18155 ||| NNP
) ||| S:18155 E:18156 ||| -RRB-
) ||| S:18156 E:18157 ||| -RRB-
,  ||| S:18157 E:18159 ||| ,
consistent  ||| S:18159 E:18170 ||| JJ
with  ||| S:18170 E:18175 ||| IN
the  ||| S:18175 E:18179 ||| DT
high  ||| S:18179 E:18184 ||| JJ
correlation  ||| S:18184 E:18196 ||| NN
found  ||| S:18196 E:18202 ||| VBD
by  ||| S:18202 E:18205 ||| IN
the  ||| S:18205 E:18217 ||| DT
comparisons  ||| S:18217 E:18229 ||| NNS
using  ||| S:18229 E:18235 ||| VBG
Affymetrix  ||| S:18235 E:18246 ||| NNP
Microarray  ||| S:18246 E:18257 ||| NNP
Suite  ||| S:18257 E:18263 ||| NNP
software  ||| S:18263 E:18280 ||| NN
described  ||| S:18280 E:18290 ||| VBD
above ||| S:18290 E:18295 ||| RB
.  ||| S:18295 E:18297 ||| .
Again ||| S:18297 E:18302 ||| RB
,  ||| S:18302 E:18304 ||| ,
this  ||| S:18304 E:18309 ||| DT
reflects  ||| S:18309 E:18318 ||| VBZ
the  ||| S:18318 E:18322 ||| DT
low  ||| S:18322 E:18326 ||| JJ
amount  ||| S:18326 E:18333 ||| NN
of  ||| S:18333 E:18344 ||| IN
combined  ||| S:18344 E:18353 ||| JJ
experimental  ||| S:18353 E:18366 ||| JJ
variability  ||| S:18366 E:18378 ||| JJ
intrinsic  ||| S:18378 E:18388 ||| NN
to  ||| S:18388 E:18391 ||| TO
the  ||| S:18391 E:18403 ||| DT
laboratory  ||| S:18403 E:18414 ||| NN
processing  ||| S:18414 E:18425 ||| NN
of  ||| S:18425 E:18428 ||| IN
RNA ||| S:18428 E:18431 ||| NNP
,  ||| S:18431 E:18433 ||| ,
cDNA ||| S:18433 E:18437 ||| NNP
,  ||| S:18437 E:18439 ||| ,
cRNA  ||| S:18439 E:18444 ||| JJ
and  ||| S:18444 E:18456 ||| CC
hybridization ||| S:18456 E:18469 ||| NN
.  ||| S:18469 E:18479 ||| .
When  ||| S:18479 E:18484 ||| WRB
comparing  ||| S:18484 E:18494 ||| VBG
two  ||| S:18494 E:18498 ||| CD
different  ||| S:18498 E:18508 ||| JJ
regions  ||| S:18508 E:18516 ||| NNS
of  ||| S:18516 E:18519 ||| IN
the  ||| S:18519 E:18523 ||| DT
same  ||| S:18523 E:18528 ||| JJ
biopsy  ||| S:18528 E:18543 ||| NNS
[ ||| S:18543 E:18544 ||| -LRB-
intra-patient  ||| S:18544 E:18558 ||| JJ
variability ||| S:18558 E:18569 ||| NN
] ||| S:18569 E:18570 ||| -RRB-
,  ||| S:18570 E:18572 ||| ,
we  ||| S:18572 E:18575 ||| PRP
found  ||| S:18575 E:18581 ||| VBD
widely  ||| S:18581 E:18588 ||| RB
varying  ||| S:18588 E:18604 ||| VBG
results ||| S:18604 E:18611 ||| NNS
,  ||| S:18611 E:18613 ||| ,
depending  ||| S:18613 E:18623 ||| VBG
on  ||| S:18623 E:18626 ||| IN
the  ||| S:18626 E:18630 ||| DT
patient  ||| S:18630 E:18638 ||| NN
studied  ||| S:18638 E:18646 ||| VBD
( ||| S:18646 E:18647 ||| -LRB-
Fig.  ||| S:18647 E:18652 ||| CD
3 ||| S:18652 E:18653 ||| CD
) ||| S:18653 E:18654 ||| -RRB-
.  ||| S:18654 E:18656 ||| .
For  ||| S:18656 E:18668 ||| IN
example ||| S:18668 E:18675 ||| NN
,  ||| S:18675 E:18677 ||| ,
some  ||| S:18677 E:18682 ||| DT
individual  ||| S:18682 E:18693 ||| JJ
patients  ||| S:18693 E:18702 ||| NNS
showed  ||| S:18702 E:18709 ||| VBD
very  ||| S:18709 E:18714 ||| RB
closely  ||| S:18714 E:18730 ||| RB
related  ||| S:18730 E:18738 ||| VBN
profiles  ||| S:18738 E:18747 ||| NNS
that  ||| S:18747 E:18752 ||| WDT
approached  ||| S:18752 E:18763 ||| VBD
the  ||| S:18763 E:18767 ||| DT
similarity  ||| S:18767 E:18778 ||| NN
of  ||| S:18778 E:18789 ||| IN
duplicate  ||| S:18789 E:18799 ||| JJ
arrays  ||| S:18799 E:18806 ||| NN
on  ||| S:18806 E:18809 ||| IN
the  ||| S:18809 E:18813 ||| DT
same  ||| S:18813 E:18818 ||| JJ
cRNA  ||| S:18818 E:18823 ||| NN
( ||| S:18823 E:18824 ||| -LRB-
Fig.  ||| S:18824 E:18829 ||| CD
2 ||| S:18829 E:18830 ||| CD
;  ||| S:18830 E:18832 ||| :
profiles  ||| S:18832 E:18841 ||| CD
6a ||| S:18841 E:18843 ||| CD
,  ||| S:18843 E:18845 ||| ,
6b ||| S:18845 E:18847 ||| NNP
;  ||| S:18847 E:18857 ||| :
10a ||| S:18857 E:18860 ||| CD
,  ||| S:18860 E:18862 ||| ,
10b ||| S:18862 E:18865 ||| CD
) ||| S:18865 E:18866 ||| -RRB-
.  ||| S:18866 E:18868 ||| .
On  ||| S:18868 E:18871 ||| IN
the  ||| S:18871 E:18875 ||| DT
other  ||| S:18875 E:18881 ||| JJ
hand ||| S:18881 E:18885 ||| NN
,  ||| S:18885 E:18887 ||| ,
some  ||| S:18887 E:18892 ||| DT
patients  ||| S:18892 E:18901 ||| NNS
showed  ||| S:18901 E:18908 ||| VBD
very  ||| S:18908 E:18921 ||| RB
distantly  ||| S:18921 E:18931 ||| JJ
related  ||| S:18931 E:18939 ||| JJ
profiles  ||| S:18939 E:18948 ||| NNS
for  ||| S:18948 E:18952 ||| IN
two  ||| S:18952 E:18956 ||| CD
regions  ||| S:18956 E:18964 ||| NNS
of  ||| S:18964 E:18967 ||| IN
the  ||| S:18967 E:18971 ||| DT
same  ||| S:18971 E:18984 ||| JJ
biopsy  ||| S:18984 E:18991 ||| NNS
( ||| S:18991 E:18992 ||| -LRB-
Fig.  ||| S:18992 E:18997 ||| CD
3 ||| S:18997 E:18998 ||| CD
;  ||| S:18998 E:19000 ||| :
profiles  ||| S:19000 E:19009 ||| CD
1a ||| S:19009 E:19011 ||| CD
,  ||| S:19011 E:19013 ||| ,
1b ||| S:19013 E:19015 ||| NNP
;  ||| S:19015 E:19017 ||| :
4a ||| S:19017 E:19019 ||| CD
,  ||| S:19019 E:19021 ||| ,
4b ||| S:19021 E:19023 ||| NNP
;  ||| S:19023 E:19025 ||| :
9a ||| S:19025 E:19027 ||| CD
,  ||| S:19027 E:19029 ||| ,
9b ||| S:19029 E:19031 ||| CD
) ||| S:19031 E:19032 ||| -RRB-
.  ||| S:19032 E:19042 ||| .
Importantly ||| S:19042 E:19053 ||| RB
,  ||| S:19053 E:19055 ||| ,
the  ||| S:19055 E:19059 ||| DT
variation  ||| S:19059 E:19069 ||| NN
caused  ||| S:19069 E:19076 ||| VBN
by  ||| S:19076 E:19079 ||| IN
intra-patient  ||| S:19079 E:19093 ||| JJ
tissue  ||| S:19093 E:19108 ||| NN
variation  ||| S:19108 E:19118 ||| NN
often  ||| S:19118 E:19124 ||| RB
overshadowed  ||| S:19124 E:19137 ||| VBN
all  ||| S:19137 E:19141 ||| DT
other  ||| S:19141 E:19147 ||| JJ
variables ||| S:19147 E:19156 ||| NNS
.  ||| S:19156 E:19158 ||| .
For  ||| S:19158 E:19170 ||| IN
example ||| S:19170 E:19177 ||| NN
,  ||| S:19177 E:19179 ||| ,
a  ||| S:19179 E:19181 ||| DT
profile  ||| S:19181 E:19189 ||| NN
from  ||| S:19189 E:19194 ||| IN
DMD  ||| S:19194 E:19198 ||| NNP
patient  ||| S:19198 E:19206 ||| NN
9  ||| S:19206 E:19208 ||| CD
( ||| S:19208 E:19209 ||| -LRB-
9a ||| S:19209 E:19211 ||| NNP
)  ||| S:19211 E:19213 ||| -RRB-
clustered  ||| S:19213 E:19223 ||| VBN
with  ||| S:19223 E:19236 ||| IN
the  ||| S:19236 E:19240 ||| DT
normal  ||| S:19240 E:19247 ||| JJ
controls ||| S:19247 E:19255 ||| NNS
,  ||| S:19255 E:19257 ||| ,
rather  ||| S:19257 E:19264 ||| RB
than  ||| S:19264 E:19269 ||| IN
with  ||| S:19269 E:19274 ||| IN
the  ||| S:19274 E:19278 ||| DT
other  ||| S:19278 E:19284 ||| JJ
DMD  ||| S:19284 E:19296 ||| NN
patients  ||| S:19296 E:19305 ||| NNS
( ||| S:19305 E:19306 ||| -LRB-
Fig.  ||| S:19306 E:19311 ||| CD
3 ||| S:19311 E:19312 ||| CD
) ||| S:19312 E:19313 ||| -RRB-
.  ||| S:19313 E:19315 ||| .
The  ||| S:19315 E:19319 ||| DT
histopathology  ||| S:19319 E:19334 ||| NN
of  ||| S:19334 E:19337 ||| IN
this  ||| S:19337 E:19342 ||| DT
patient  ||| S:19342 E:19350 ||| NN
was  ||| S:19350 E:19362 ||| VBD
noted  ||| S:19362 E:19368 ||| VBN
as  ||| S:19368 E:19371 ||| IN
being  ||| S:19371 E:19377 ||| VBG
unusually  ||| S:19377 E:19387 ||| RB
variable  ||| S:19387 E:19396 ||| VBN
in  ||| S:19396 E:19399 ||| IN
severity  ||| S:19399 E:19408 ||| NN
prior  ||| S:19408 E:19414 ||| RB
to  ||| S:19414 E:19425 ||| TO
expression  ||| S:19425 E:19436 ||| NN
profiling ||| S:19436 E:19445 ||| NN
.  ||| S:19445 E:19447 ||| .
Also ||| S:19447 E:19451 ||| RB
,  ||| S:19451 E:19453 ||| ,
unsupervised  ||| S:19453 E:19466 ||| JJ
clustering  ||| S:19466 E:19477 ||| NN
was  ||| S:19477 E:19489 ||| VBD
unable  ||| S:19489 E:19496 ||| JJ
to  ||| S:19496 E:19499 ||| TO
group  ||| S:19499 E:19505 ||| NN
patients  ||| S:19505 E:19514 ||| NNS
of  ||| S:19514 E:19517 ||| IN
similar  ||| S:19517 E:19525 ||| JJ
ages ||| S:19525 E:19529 ||| NNS
,  ||| S:19529 E:19531 ||| ,
despite  ||| S:19531 E:19539 ||| IN
DMD  ||| S:19539 E:19551 ||| NNP
showing  ||| S:19551 E:19559 ||| VBG
a  ||| S:19559 E:19561 ||| DT
progressive  ||| S:19561 E:19573 ||| JJ
clinical  ||| S:19573 E:19582 ||| JJ
course ||| S:19582 E:19588 ||| NN
.  ||| S:19588 E:19590 ||| .
We  ||| S:19590 E:19593 ||| PRP
conclude  ||| S:19593 E:19602 ||| VBP
that  ||| S:19602 E:19615 ||| IN
intra-patient  ||| S:19615 E:19629 ||| JJ
tissue  ||| S:19629 E:19636 ||| NN
heterogeneity  ||| S:19636 E:19650 ||| NN
is  ||| S:19650 E:19653 ||| VBZ
a  ||| S:19653 E:19655 ||| DT
major  ||| S:19655 E:19661 ||| JJ
source  ||| S:19661 E:19668 ||| NN
of  ||| S:19668 E:19679 ||| IN
experimental  ||| S:19679 E:19692 ||| JJ
variability  ||| S:19692 E:19704 ||| NN
in  ||| S:19704 E:19707 ||| IN
expression  ||| S:19707 E:19718 ||| NN
profiling ||| S:19718 E:19727 ||| NN
,  ||| S:19727 E:19729 ||| ,
and  ||| S:19729 E:19733 ||| CC
must  ||| S:19733 E:19746 ||| MD
be  ||| S:19746 E:19749 ||| VB
considered  ||| S:19749 E:19760 ||| VBN
in  ||| S:19760 E:19763 ||| IN
experimental  ||| S:19763 E:19776 ||| JJ
design ||| S:19776 E:19782 ||| NN
.  ||| S:19782 E:19792 ||| .
The  ||| S:19792 E:19796 ||| DT
above  ||| S:19796 E:19802 ||| JJ
findings  ||| S:19802 E:19811 ||| NNS
suggested  ||| S:19811 E:19821 ||| VBD
that  ||| S:19821 E:19826 ||| IN
both  ||| S:19826 E:19831 ||| DT
intra-patient  ||| S:19831 E:19853 ||| JJ
variability  ||| S:19853 E:19865 ||| NNS
( ||| S:19865 E:19866 ||| -LRB-
tissue  ||| S:19866 E:19873 ||| FW
heterogeneity ||| S:19873 E:19886 ||| FW
)  ||| S:19886 E:19888 ||| -RRB-
and  ||| S:19888 E:19892 ||| CC
inter-patient  ||| S:19892 E:19914 ||| JJ
variability  ||| S:19914 E:19926 ||| NNS
( ||| S:19926 E:19927 ||| -LRB-
polymorphic  ||| S:19927 E:19939 ||| JJ
noise ||| S:19939 E:19944 ||| NN
)  ||| S:19944 E:19946 ||| -RRB-
had  ||| S:19946 E:19950 ||| VBD
major  ||| S:19950 E:19956 ||| JJ
effects  ||| S:19956 E:19964 ||| NNS
on  ||| S:19964 E:19967 ||| IN
the  ||| S:19967 E:19979 ||| DT
expression  ||| S:19979 E:19990 ||| NN
profiles ||| S:19990 E:19998 ||| NNS
.  ||| S:19998 E:20000 ||| .
One  ||| S:20000 E:20004 ||| CD
method  ||| S:20004 E:20011 ||| NN
to  ||| S:20011 E:20014 ||| TO
control  ||| S:20014 E:20022 ||| VB
for  ||| S:20022 E:20026 ||| IN
these  ||| S:20026 E:20040 ||| DT
sources  ||| S:20040 E:20048 ||| NNS
of  ||| S:20048 E:20051 ||| IN
noise  ||| S:20051 E:20057 ||| NN
is  ||| S:20057 E:20060 ||| VBZ
to  ||| S:20060 E:20063 ||| TO
analyze  ||| S:20063 E:20071 ||| VB
large  ||| S:20071 E:20077 ||| JJ
numbers  ||| S:20077 E:20085 ||| NNS
of  ||| S:20085 E:20088 ||| IN
profiles ||| S:20088 E:20096 ||| NNS
,  ||| S:20096 E:20106 ||| ,
both  ||| S:20106 E:20111 ||| DT
on  ||| S:20111 E:20114 ||| IN
multiple  ||| S:20114 E:20123 ||| JJ
patients ||| S:20123 E:20131 ||| NNS
,  ||| S:20131 E:20133 ||| ,
and  ||| S:20133 E:20137 ||| CC
on  ||| S:20137 E:20140 ||| IN
multiple  ||| S:20140 E:20149 ||| JJ
regions  ||| S:20149 E:20157 ||| NNS
of  ||| S:20157 E:20168 ||| IN
tissue  ||| S:20168 E:20175 ||| NN
from  ||| S:20175 E:20180 ||| IN
each  ||| S:20180 E:20185 ||| DT
patient ||| S:20185 E:20192 ||| NN
.  ||| S:20192 E:20194 ||| .
This  ||| S:20194 E:20199 ||| DT
would  ||| S:20199 E:20205 ||| MD
allow  ||| S:20205 E:20211 ||| VB
determinations  ||| S:20211 E:20234 ||| VBN
of  ||| S:20234 E:20237 ||| IN
p  ||| S:20237 E:20239 ||| JJ
values  ||| S:20239 E:20246 ||| NNS
and  ||| S:20246 E:20250 ||| CC
statistical  ||| S:20250 E:20262 ||| JJ
significance  ||| S:20262 E:20275 ||| NN
for  ||| S:20275 E:20279 ||| IN
a  ||| S:20279 E:20281 ||| DT
single  ||| S:20281 E:20296 ||| JJ
controlled  ||| S:20296 E:20307 ||| JJ
variable  ||| S:20307 E:20316 ||| NN
under  ||| S:20316 E:20322 ||| IN
study  ||| S:20322 E:20328 ||| NN
( ||| S:20328 E:20329 ||| -LRB-
e.g.  ||| S:20329 E:20334 ||| NNP
DMD  ||| S:20334 E:20338 ||| NNP
vs  ||| S:20338 E:20341 ||| NN
controls ||| S:20341 E:20349 ||| NNS
) ||| S:20349 E:20350 ||| -RRB-
.  ||| S:20350 E:20352 ||| .
An  ||| S:20352 E:20363 ||| DT
alternative  ||| S:20363 E:20375 ||| JJ
method  ||| S:20375 E:20382 ||| NN
is  ||| S:20382 E:20385 ||| VBZ
to  ||| S:20385 E:20388 ||| TO
experimentally  ||| S:20388 E:20403 ||| RB
normalize  ||| S:20403 E:20413 ||| VB
these  ||| S:20413 E:20427 ||| DT
variables  ||| S:20427 E:20437 ||| NNS
through  ||| S:20437 E:20445 ||| IN
mixing  ||| S:20445 E:20452 ||| VBG
of  ||| S:20452 E:20455 ||| IN
samples  ||| S:20455 E:20463 ||| NNS
from  ||| S:20463 E:20468 ||| IN
patient  ||| S:20468 E:20476 ||| JJ
groups ||| S:20476 E:20482 ||| NNS
;  ||| S:20482 E:20492 ||| :
such  ||| S:20492 E:20497 ||| JJ
mixing  ||| S:20497 E:20504 ||| NN
would  ||| S:20504 E:20510 ||| MD
be  ||| S:20510 E:20513 ||| VB
expected  ||| S:20513 E:20522 ||| VBN
to  ||| S:20522 E:20525 ||| TO
average  ||| S:20525 E:20533 ||| VB
out  ||| S:20533 E:20537 ||| RP
both  ||| S:20537 E:20542 ||| DT
intra-  ||| S:20542 E:20557 ||| JJ
and  ||| S:20557 E:20561 ||| CC
inter-patient  ||| S:20561 E:20575 ||| JJ
variation ||| S:20575 E:20584 ||| NN
.  ||| S:20584 E:20586 ||| .
The  ||| S:20586 E:20590 ||| DT
expectation  ||| S:20590 E:20602 ||| NN
is  ||| S:20602 E:20605 ||| VBZ
that  ||| S:20605 E:20610 ||| IN
the  ||| S:20610 E:20622 ||| DT
most  ||| S:20622 E:20627 ||| RBS
significant  ||| S:20627 E:20639 ||| JJ
and  ||| S:20639 E:20643 ||| CC
dramatic  ||| S:20643 E:20652 ||| JJ
gene  ||| S:20652 E:20657 ||| NN
expression  ||| S:20657 E:20668 ||| NN
changes  ||| S:20668 E:20676 ||| NNS
would  ||| S:20676 E:20690 ||| MD
still  ||| S:20690 E:20696 ||| RB
be  ||| S:20696 E:20699 ||| VB
identified ||| S:20699 E:20709 ||| VBN
,  ||| S:20709 E:20711 ||| ,
while  ||| S:20711 E:20717 ||| IN
using  ||| S:20717 E:20723 ||| VBG
many  ||| S:20723 E:20728 ||| JJ
less  ||| S:20728 E:20733 ||| JJR
profiles  ||| S:20733 E:20742 ||| NNS
( ||| S:20742 E:20743 ||| -LRB-
and  ||| S:20743 E:20755 ||| CC
thus  ||| S:20755 E:20760 ||| RB
a  ||| S:20760 E:20762 ||| DT
substantial  ||| S:20762 E:20774 ||| JJ
reduction  ||| S:20774 E:20784 ||| NN
in  ||| S:20784 E:20787 ||| IN
cost  ||| S:20787 E:20792 ||| NN
of  ||| S:20792 E:20795 ||| IN
the  ||| S:20795 E:20799 ||| DT
analyses ||| S:20799 E:20807 ||| NN
) ||| S:20807 E:20808 ||| -RRB-
.  ||| S:20808 E:20818 ||| .
To  ||| S:20818 E:20821 ||| TO
test  ||| S:20821 E:20826 ||| VB
for  ||| S:20826 E:20830 ||| IN
the  ||| S:20830 E:20834 ||| DT
relative  ||| S:20834 E:20843 ||| JJ
sensitivity  ||| S:20843 E:20855 ||| NN
of  ||| S:20855 E:20858 ||| IN
interpretation  ||| S:20858 E:20881 ||| NN
of  ||| S:20881 E:20884 ||| IN
sample  ||| S:20884 E:20891 ||| FW
mixing  ||| S:20891 E:20898 ||| FW
versus  ||| S:20898 E:20905 ||| FW
individual  ||| S:20905 E:20916 ||| JJ
profiles ||| S:20916 E:20924 ||| NNS
,  ||| S:20924 E:20926 ||| ,
we  ||| S:20926 E:20929 ||| PRP
mixed  ||| S:20929 E:20943 ||| VBD
together  ||| S:20943 E:20952 ||| RP
the  ||| S:20952 E:20956 ||| DT
10  ||| S:20956 E:20959 ||| CD
cRNAs  ||| S:20959 E:20965 ||| NN
for  ||| S:20965 E:20969 ||| IN
the  ||| S:20969 E:20973 ||| DT
two  ||| S:20973 E:20977 ||| CD
different  ||| S:20977 E:20987 ||| JJ
age  ||| S:20987 E:20991 ||| NN
groups  ||| S:20991 E:20998 ||| NNS
of  ||| S:20998 E:21009 ||| IN
DMD  ||| S:21009 E:21013 ||| NNP
patients  ||| S:21013 E:21022 ||| NNS
( ||| S:21022 E:21023 ||| -LRB-
samples  ||| S:21023 E:21031 ||| FW
1a  ||| S:21031 E:21034 ||| FW
-  ||| S:21034 E:21036 ||| :
5b ||| S:21036 E:21038 ||| CD
;  ||| S:21038 E:21040 ||| :
samples  ||| S:21040 E:21048 ||| CD
6a  ||| S:21048 E:21051 ||| CD
-  ||| S:21051 E:21053 ||| :
10b ||| S:21053 E:21056 ||| CD
) ||| S:21056 E:21057 ||| -RRB-
.  ||| S:21057 E:21059 ||| .
For  ||| S:21059 E:21063 ||| IN
this  ||| S:21063 E:21076 ||| DT
analysis ||| S:21076 E:21084 ||| NN
,  ||| S:21084 E:21086 ||| ,
we  ||| S:21086 E:21089 ||| PRP
also  ||| S:21089 E:21094 ||| RB
generated  ||| S:21094 E:21104 ||| VBN
expression  ||| S:21104 E:21115 ||| NN
profiles  ||| S:21115 E:21124 ||| NNS
for  ||| S:21124 E:21128 ||| IN
two  ||| S:21128 E:21140 ||| CD
additional  ||| S:21140 E:21151 ||| JJ
groups  ||| S:21151 E:21158 ||| NNS
of  ||| S:21158 E:21161 ||| IN
control  ||| S:21161 E:21169 ||| NN
individuals ||| S:21169 E:21180 ||| NNS
.  ||| S:21180 E:21182 ||| .
One  ||| S:21182 E:21186 ||| PRP
was  ||| S:21186 E:21190 ||| VBD
a  ||| S:21190 E:21192 ||| DT
second  ||| S:21192 E:21207 ||| JJ
set  ||| S:21207 E:21211 ||| NN
of  ||| S:21211 E:21214 ||| IN
five  ||| S:21214 E:21219 ||| CD
normal  ||| S:21219 E:21226 ||| JJ
male  ||| S:21226 E:21231 ||| FW
biopsies  ||| S:21231 E:21240 ||| FW
ages  ||| S:21240 E:21245 ||| FW
5-12  ||| S:21245 E:21250 ||| FW
yrs  ||| S:21250 E:21254 ||| FW
( ||| S:21254 E:21255 ||| -LRB-
controls  ||| S:21255 E:21272 ||| FW
2a ||| S:21272 E:21274 ||| FW
,  ||| S:21274 E:21276 ||| ,
2b ||| S:21276 E:21278 ||| CD
) ||| S:21278 E:21279 ||| -RRB-
,  ||| S:21279 E:21281 ||| ,
and  ||| S:21281 E:21285 ||| CC
the  ||| S:21285 E:21289 ||| DT
third  ||| S:21289 E:21295 ||| JJ
control  ||| S:21295 E:21303 ||| NN
set  ||| S:21303 E:21307 ||| NN
was  ||| S:21307 E:21311 ||| VBD
three  ||| S:21311 E:21317 ||| CD
normal  ||| S:21317 E:21332 ||| JJ
age-matched  ||| S:21332 E:21344 ||| JJ
female  ||| S:21344 E:21351 ||| JJ
biopsies  ||| S:21351 E:21360 ||| FW
ages  ||| S:21360 E:21365 ||| FW
4-13  ||| S:21365 E:21370 ||| FW
yrs  ||| S:21370 E:21374 ||| FW
( ||| S:21374 E:21375 ||| -LRB-
controls  ||| S:21375 E:21384 ||| FW
3a ||| S:21384 E:21386 ||| FW
,  ||| S:21386 E:21388 ||| ,
3b ||| S:21388 E:21390 ||| CD
)  ||| S:21390 E:21400 ||| -RRB-
( ||| S:21400 E:21401 ||| -LRB-
Fig.  ||| S:21401 E:21406 ||| CD
4 ||| S:21406 E:21407 ||| CD
) ||| S:21407 E:21408 ||| -RRB-
.  ||| S:21408 E:21410 ||| .
As  ||| S:21410 E:21413 ||| RB
with  ||| S:21413 E:21418 ||| IN
the  ||| S:21418 E:21422 ||| DT
original  ||| S:21422 E:21431 ||| JJ
male  ||| S:21431 E:21436 ||| JJ
control  ||| S:21436 E:21444 ||| NN
group  ||| S:21444 E:21450 ||| NN
( ||| S:21450 E:21451 ||| -LRB-
control  ||| S:21451 E:21467 ||| NN
1a ||| S:21467 E:21469 ||| NN
,  ||| S:21469 E:21471 ||| ,
1b ||| S:21471 E:21473 ||| CD
) ||| S:21473 E:21474 ||| -RRB-
,  ||| S:21474 E:21476 ||| ,
two  ||| S:21476 E:21480 ||| CD
different  ||| S:21480 E:21490 ||| JJ
regions  ||| S:21490 E:21498 ||| NNS
of  ||| S:21498 E:21501 ||| IN
each  ||| S:21501 E:21506 ||| DT
biopsy  ||| S:21506 E:21513 ||| NN
were  ||| S:21513 E:21526 ||| VBD
processed  ||| S:21526 E:21536 ||| VBN
independently  ||| S:21536 E:21550 ||| RB
through  ||| S:21550 E:21558 ||| IN
the  ||| S:21558 E:21562 ||| DT
biotinylated  ||| S:21562 E:21575 ||| JJ
cRNA  ||| S:21575 E:21580 ||| JJ
step ||| S:21580 E:21584 ||| NN
,  ||| S:21584 E:21594 ||| ,
and  ||| S:21594 E:21598 ||| CC
then  ||| S:21598 E:21603 ||| RB
equimolar  ||| S:21603 E:21613 ||| JJ
amounts  ||| S:21613 E:21621 ||| NNS
of  ||| S:21621 E:21624 ||| IN
cRNA  ||| S:21624 E:21629 ||| JJ
mixed  ||| S:21629 E:21635 ||| JJ
for  ||| S:21635 E:21639 ||| IN
hybridization  ||| S:21639 E:21661 ||| VBG
to  ||| S:21661 E:21664 ||| TO
the  ||| S:21664 E:21668 ||| DT
MuscleChip ||| S:21668 E:21678 ||| JJ
.  ||| S:21678 E:21688 ||| .
All  ||| S:21688 E:21692 ||| DT
34  ||| S:21692 E:21695 ||| CD
profiles  ||| S:21695 E:21704 ||| NNS
( ||| S:21704 E:21705 ||| -LRB-
both  ||| S:21705 E:21710 ||| DT
individual  ||| S:21710 E:21721 ||| JJ
and  ||| S:21721 E:21725 ||| CC
mixed  ||| S:21725 E:21731 ||| JJ
samples ||| S:21731 E:21738 ||| NNS
)  ||| S:21738 E:21740 ||| -RRB-
were  ||| S:21740 E:21753 ||| VBD
again  ||| S:21753 E:21759 ||| RB
analyzed  ||| S:21759 E:21768 ||| VBN
by  ||| S:21768 E:21771 ||| IN
unsupervised  ||| S:21771 E:21784 ||| FW
hierarchical  ||| S:21784 E:21797 ||| FW
clustering  ||| S:21797 E:21816 ||| FW
( ||| S:21816 E:21817 ||| -LRB-
Fig.  ||| S:21817 E:21822 ||| CD
4 ||| S:21822 E:21823 ||| CD
)  ||| S:21823 E:21825 ||| -RRB-
[  ||| S:21825 E:21827 ||| -LRB-
25  ||| S:21827 E:21830 ||| CD
]  ||| S:21830 E:21832 ||| -RRB-
.  ||| S:21832 E:21834 ||| .
As  ||| S:21834 E:21837 ||| RB
described  ||| S:21837 E:21847 ||| VBN
above ||| S:21847 E:21852 ||| IN
,  ||| S:21852 E:21854 ||| ,
we  ||| S:21854 E:21857 ||| PRP
scrubbed  ||| S:21857 E:21866 ||| VBD
the  ||| S:21866 E:21878 ||| DT
profiles  ||| S:21878 E:21887 ||| NN
to  ||| S:21887 E:21890 ||| TO
eliminate  ||| S:21890 E:21900 ||| VB
all  ||| S:21900 E:21904 ||| DT
genes  ||| S:21904 E:21910 ||| NNS
showing  ||| S:21910 E:21918 ||| VBG
expression  ||| S:21918 E:21929 ||| NN
levels  ||| S:21929 E:21944 ||| NNS
consistently  ||| S:21944 E:21957 ||| RB
at  ||| S:21957 E:21960 ||| IN
or  ||| S:21960 E:21963 ||| CC
below  ||| S:21963 E:21969 ||| IN
background  ||| S:21969 E:21980 ||| NN
hybridization  ||| S:21980 E:22002 ||| NN
intensities  ||| S:22002 E:22014 ||| NN
by  ||| S:22014 E:22017 ||| IN
requiring  ||| S:22017 E:22027 ||| VBG
each  ||| S:22027 E:22032 ||| DT
gene  ||| S:22032 E:22037 ||| NN
to  ||| S:22037 E:22040 ||| TO
show  ||| S:22040 E:22045 ||| VB
a  ||| S:22045 E:22047 ||| DT
"Present  ||| S:22047 E:22056 ||| NNP
Call ||| S:22056 E:22060 ||| NNP
"  ||| S:22060 E:22070 ||| ''
in  ||| S:22070 E:22073 ||| IN
one  ||| S:22073 E:22077 ||| CD
or  ||| S:22077 E:22080 ||| CC
more  ||| S:22080 E:22085 ||| JJR
of  ||| S:22085 E:22088 ||| IN
the  ||| S:22088 E:22092 ||| DT
34  ||| S:22092 E:22095 ||| CD
profiles ||| S:22095 E:22103 ||| NNS
.  ||| S:22103 E:22113 ||| .
As  ||| S:22113 E:22116 ||| RB
above ||| S:22116 E:22121 ||| RB
,  ||| S:22121 E:22123 ||| ,
duplicate  ||| S:22123 E:22133 ||| JJ
profiles  ||| S:22133 E:22142 ||| NNS
using  ||| S:22142 E:22148 ||| VBG
the  ||| S:22148 E:22152 ||| DT
same  ||| S:22152 E:22157 ||| JJ
cRNA  ||| S:22157 E:22170 ||| JJ
hybridization  ||| S:22170 E:22184 ||| JJ
solution  ||| S:22184 E:22193 ||| NN
on  ||| S:22193 E:22196 ||| IN
different  ||| S:22196 E:22206 ||| JJ
arrays ||| S:22206 E:22212 ||| NN
,  ||| S:22212 E:22214 ||| ,
whether  ||| S:22214 E:22222 ||| IN
mixed  ||| S:22222 E:22236 ||| JJ
or  ||| S:22236 E:22239 ||| CC
individual  ||| S:22239 E:22250 ||| JJ
samples ||| S:22250 E:22257 ||| NNS
,  ||| S:22257 E:22259 ||| ,
showed  ||| S:22259 E:22266 ||| VBD
very  ||| S:22266 E:22271 ||| RB
highly  ||| S:22271 E:22278 ||| RB
correlated  ||| S:22278 E:22297 ||| JJ
results  ||| S:22297 E:22305 ||| NNS
( ||| S:22305 E:22306 ||| -LRB-
very  ||| S:22306 E:22311 ||| RB
low  ||| S:22311 E:22315 ||| JJ
branch  ||| S:22315 E:22322 ||| NN
on  ||| S:22322 E:22325 ||| IN
dendrogram ||| S:22325 E:22335 ||| CD
)  ||| S:22335 E:22337 ||| -RRB-
( ||| S:22337 E:22338 ||| -LRB-
Fig.  ||| S:22338 E:22343 ||| CD
4 ||| S:22343 E:22344 ||| CD
;  ||| S:22344 E:22346 ||| :
mix  ||| S:22346 E:22350 ||| CD
5-6  ||| S:22350 E:22362 ||| CD
yrs ||| S:22362 E:22365 ||| NN
,  ||| S:22365 E:22367 ||| ,
mix  ||| S:22367 E:22371 ||| NN
10-12  ||| S:22371 E:22377 ||| CD
yrs ||| S:22377 E:22380 ||| NNS
;  ||| S:22380 E:22382 ||| :
patient  ||| S:22382 E:22390 ||| CD
3a ||| S:22390 E:22392 ||| CD
/ ||| S:22392 E:22393 ||| CD
3a-d ||| S:22393 E:22397 ||| CD
;  ||| S:22397 E:22399 ||| :
patient  ||| S:22399 E:22407 ||| CD
3b ||| S:22407 E:22409 ||| CD
/ ||| S:22409 E:22410 ||| CD
3b-d ||| S:22410 E:22414 ||| CD
) ||| S:22414 E:22415 ||| -RRB-
.  ||| S:22415 E:22417 ||| .
As  ||| S:22417 E:22428 ||| RB
above ||| S:22428 E:22433 ||| RB
,  ||| S:22433 E:22435 ||| ,
this  ||| S:22435 E:22440 ||| DT
indicates  ||| S:22440 E:22450 ||| VBZ
that  ||| S:22450 E:22455 ||| DT
experimental  ||| S:22455 E:22468 ||| JJ
variability  ||| S:22468 E:22480 ||| NN
from  ||| S:22480 E:22493 ||| IN
laboratory  ||| S:22493 E:22504 ||| NN
procedures  ||| S:22504 E:22515 ||| NNS
or  ||| S:22515 E:22518 ||| CC
different  ||| S:22518 E:22528 ||| JJ
arrays  ||| S:22528 E:22535 ||| NN
is  ||| S:22535 E:22538 ||| VBZ
a  ||| S:22538 E:22540 ||| DT
relatively  ||| S:22540 E:22559 ||| RB
minor  ||| S:22559 E:22565 ||| JJ
factor  ||| S:22565 E:22572 ||| NN
in  ||| S:22572 E:22575 ||| IN
interpretation  ||| S:22575 E:22590 ||| NN
of  ||| S:22590 E:22593 ||| IN
results ||| S:22593 E:22600 ||| NNS
.  ||| S:22600 E:22602 ||| .
Mixed  ||| S:22602 E:22608 ||| JJ
samples  ||| S:22608 E:22624 ||| NNS
from  ||| S:22624 E:22629 ||| IN
different  ||| S:22629 E:22639 ||| JJ
regions  ||| S:22639 E:22647 ||| NNS
of  ||| S:22647 E:22650 ||| IN
the  ||| S:22650 E:22654 ||| DT
same  ||| S:22654 E:22659 ||| JJ
biopsies  ||| S:22659 E:22668 ||| NNS
showed  ||| S:22668 E:22675 ||| VBD
the  ||| S:22675 E:22687 ||| DT
same ||| S:22687 E:22691 ||| JJ
,  ||| S:22691 E:22693 ||| ,
or  ||| S:22693 E:22696 ||| CC
only  ||| S:22696 E:22701 ||| RB
slightly  ||| S:22701 E:22710 ||| RB
more  ||| S:22710 E:22715 ||| JJR
variation  ||| S:22715 E:22725 ||| NN
( ||| S:22725 E:22726 ||| -LRB-
mixed  ||| S:22726 E:22732 ||| JJ
controls  ||| S:22732 E:22741 ||| NNS
c1 ||| S:22741 E:22743 ||| RB
,  ||| S:22743 E:22753 ||| ,
c2 ||| S:22753 E:22755 ||| NNP
,  ||| S:22755 E:22757 ||| ,
and  ||| S:22757 E:22761 ||| CC
c3 ||| S:22761 E:22763 ||| NNP
,  ||| S:22763 E:22765 ||| ,
mixed  ||| S:22765 E:22771 ||| JJ
DMD  ||| S:22771 E:22775 ||| NNP
6-9  ||| S:22775 E:22779 ||| CD
yrs ||| S:22779 E:22782 ||| CD
) ||| S:22782 E:22783 ||| -RRB-
.  ||| S:22783 E:22785 ||| .
This  ||| S:22785 E:22790 ||| DT
showed  ||| S:22790 E:22797 ||| VBD
that  ||| S:22797 E:22802 ||| DT
sample  ||| S:22802 E:22817 ||| NN
mixing  ||| S:22817 E:22824 ||| NN
does  ||| S:22824 E:22829 ||| VBZ
indeed  ||| S:22829 E:22836 ||| RB
average  ||| S:22836 E:22844 ||| JJ
out  ||| S:22844 E:22848 ||| IN
tissue  ||| S:22848 E:22855 ||| NN
heterogeneity  ||| S:22855 E:22877 ||| NNS
( ||| S:22877 E:22878 ||| -LRB-
intra-patient  ||| S:22878 E:22892 ||| JJ
variability ||| S:22892 E:22903 ||| NN
) ||| S:22903 E:22904 ||| -RRB-
,  ||| S:22904 E:22906 ||| ,
as  ||| S:22906 E:22909 ||| RB
well  ||| S:22909 E:22914 ||| RB
as  ||| S:22914 E:22917 ||| IN
inter-patient  ||| S:22917 E:22939 ||| JJ
variability ||| S:22939 E:22950 ||| NN
.  ||| S:22950 E:22952 ||| .
We  ||| S:22952 E:22955 ||| PRP
noted  ||| S:22955 E:22961 ||| VBD
that  ||| S:22961 E:22966 ||| IN
all  ||| S:22966 E:22970 ||| DT
of  ||| S:22970 E:22973 ||| IN
the  ||| S:22973 E:22977 ||| DT
controls  ||| S:22977 E:22986 ||| NNS
( ||| S:22986 E:22987 ||| -LRB-
both  ||| S:22987 E:22992 ||| DT
male  ||| S:22992 E:23005 ||| NN
and  ||| S:23005 E:23009 ||| CC
female ||| S:23009 E:23015 ||| JJ
)  ||| S:23015 E:23017 ||| -RRB-
clustered  ||| S:23017 E:23027 ||| VBN
in  ||| S:23027 E:23030 ||| IN
the  ||| S:23030 E:23034 ||| DT
same  ||| S:23034 E:23039 ||| JJ
branch  ||| S:23039 E:23046 ||| NN
of  ||| S:23046 E:23049 ||| IN
the  ||| S:23049 E:23053 ||| DT
dendrogram ||| S:23053 E:23063 ||| NN
,  ||| S:23063 E:23073 ||| ,
while  ||| S:23073 E:23079 ||| IN
the  ||| S:23079 E:23083 ||| DT
four  ||| S:23083 E:23088 ||| CD
of  ||| S:23088 E:23091 ||| IN
the  ||| S:23091 E:23095 ||| DT
six  ||| S:23095 E:23099 ||| CD
mixed  ||| S:23099 E:23105 ||| JJ
DMD  ||| S:23105 E:23109 ||| NNP
profiles  ||| S:23109 E:23118 ||| VBD
clustered  ||| S:23118 E:23128 ||| VBN
just  ||| S:23128 E:23141 ||| RB
one  ||| S:23141 E:23145 ||| CD
level  ||| S:23145 E:23151 ||| NN
away  ||| S:23151 E:23156 ||| RB
from  ||| S:23156 E:23161 ||| IN
the  ||| S:23161 E:23165 ||| DT
controls ||| S:23165 E:23173 ||| NNS
,  ||| S:23173 E:23175 ||| ,
separately  ||| S:23175 E:23186 ||| RB
from  ||| S:23186 E:23191 ||| IN
the  ||| S:23191 E:23195 ||| DT
other  ||| S:23195 E:23209 ||| JJ
DMD  ||| S:23209 E:23213 ||| NN
profiles ||| S:23213 E:23221 ||| NNS
.  ||| S:23221 E:23223 ||| .
This  ||| S:23223 E:23228 ||| DT
analysis  ||| S:23228 E:23237 ||| NN
suggests  ||| S:23237 E:23246 ||| VBZ
that  ||| S:23246 E:23251 ||| IN
there  ||| S:23251 E:23257 ||| EX
is  ||| S:23257 E:23268 ||| VBZ
considerable  ||| S:23268 E:23281 ||| JJ
variability  ||| S:23281 E:23293 ||| NN
in  ||| S:23293 E:23296 ||| IN
the  ||| S:23296 E:23300 ||| DT
progressive  ||| S:23300 E:23312 ||| JJ
tissue  ||| S:23312 E:23327 ||| NN
pathology  ||| S:23327 E:23337 ||| VBZ
induced  ||| S:23337 E:23345 ||| VBN
by  ||| S:23345 E:23348 ||| IN
dystrophin  ||| S:23348 E:23359 ||| JJ
deficiency ||| S:23359 E:23369 ||| NN
,  ||| S:23369 E:23371 ||| ,
both  ||| S:23371 E:23376 ||| DT
within  ||| S:23376 E:23383 ||| IN
a  ||| S:23383 E:23393 ||| DT
patient ||| S:23393 E:23400 ||| NN
,  ||| S:23400 E:23402 ||| ,
and  ||| S:23402 E:23406 ||| CC
between  ||| S:23406 E:23414 ||| IN
patients ||| S:23414 E:23422 ||| NNS
.  ||| S:23422 E:23432 ||| .
To  ||| S:23432 E:23435 ||| TO
test  ||| S:23435 E:23440 ||| VB
the  ||| S:23440 E:23444 ||| DT
sensitivity  ||| S:23444 E:23456 ||| NN
and  ||| S:23456 E:23460 ||| CC
specificity  ||| S:23460 E:23472 ||| NN
of  ||| S:23472 E:23475 ||| IN
sample  ||| S:23475 E:23482 ||| FW
mixing  ||| S:23482 E:23497 ||| FW
versus  ||| S:23497 E:23504 ||| FW
individual  ||| S:23504 E:23515 ||| FW
profiling ||| S:23515 E:23524 ||| FW
,  ||| S:23524 E:23526 ||| ,
we  ||| S:23526 E:23529 ||| PRP
defined  ||| S:23529 E:23537 ||| VBD
differentially  ||| S:23537 E:23560 ||| VBN
expressed  ||| S:23560 E:23570 ||| VBN
genes  ||| S:23570 E:23576 ||| NNS
using  ||| S:23576 E:23582 ||| VBG
a  ||| S:23582 E:23584 ||| DT
two  ||| S:23584 E:23588 ||| CD
group  ||| S:23588 E:23594 ||| NN
t-test  ||| S:23594 E:23601 ||| NNS
( ||| S:23601 E:23602 ||| -LRB-
GeneSpring  ||| S:23602 E:23613 ||| NNP
[  ||| S:23613 E:23615 ||| -LRB-
28  ||| S:23615 E:23626 ||| CD
29  ||| S:23626 E:23629 ||| CD
]  ||| S:23629 E:23631 ||| CD
) ||| S:23631 E:23632 ||| -RRB-
,  ||| S:23632 E:23634 ||| ,
comparing  ||| S:23634 E:23644 ||| VBG
all  ||| S:23644 E:23648 ||| DT
6  ||| S:23648 E:23650 ||| CD
mixed  ||| S:23650 E:23656 ||| JJ
control  ||| S:23656 E:23664 ||| NN
profiles  ||| S:23664 E:23673 ||| NNS
and  ||| S:23673 E:23677 ||| CC
the  ||| S:23677 E:23681 ||| DT
10  ||| S:23681 E:23692 ||| CD
individual  ||| S:23692 E:23703 ||| JJ
5-6  ||| S:23703 E:23707 ||| CD
yr  ||| S:23707 E:23710 ||| CD
old  ||| S:23710 E:23714 ||| JJ
DMD  ||| S:23714 E:23718 ||| NN
profiles ||| S:23718 E:23726 ||| NNS
.  ||| S:23726 E:23728 ||| .
Genes  ||| S:23728 E:23734 ||| NNS
were  ||| S:23734 E:23739 ||| VBD
retained  ||| S:23739 E:23756 ||| VBN
that  ||| S:23756 E:23761 ||| IN
met  ||| S:23761 E:23765 ||| VBN
specific  ||| S:23765 E:23774 ||| JJ
p  ||| S:23774 E:23776 ||| JJ
value  ||| S:23776 E:23782 ||| NN
thresholds  ||| S:23782 E:23793 ||| NN
between  ||| S:23793 E:23801 ||| IN
the  ||| S:23801 E:23805 ||| DT
two  ||| S:23805 E:23809 ||| CD
sets  ||| S:23809 E:23822 ||| NNS
of  ||| S:23822 E:23825 ||| IN
profiles ||| S:23825 E:23833 ||| NNS
.  ||| S:23833 E:23835 ||| .
In  ||| S:23835 E:23838 ||| IN
parallel ||| S:23838 E:23846 ||| NN
,  ||| S:23846 E:23848 ||| ,
we  ||| S:23848 E:23851 ||| PRP
compared  ||| S:23851 E:23860 ||| VBD
the  ||| S:23860 E:23864 ||| DT
two  ||| S:23864 E:23868 ||| CD
corresponding  ||| S:23868 E:23890 ||| JJ
mixed  ||| S:23890 E:23896 ||| JJ
5-6  ||| S:23896 E:23900 ||| CD
yr  ||| S:23900 E:23903 ||| CD
old  ||| S:23903 E:23907 ||| JJ
DMD  ||| S:23907 E:23911 ||| NN
profiles  ||| S:23911 E:23920 ||| NNS
to  ||| S:23920 E:23923 ||| TO
the  ||| S:23923 E:23927 ||| DT
same  ||| S:23927 E:23932 ||| JJ
6  ||| S:23932 E:23934 ||| CD
mixed  ||| S:23934 E:23940 ||| JJ
control  ||| S:23940 E:23956 ||| NN
profiles ||| S:23956 E:23964 ||| NNS
.  ||| S:23964 E:23974 ||| .
Comparison  ||| S:23974 E:23985 ||| NN
of  ||| S:23985 E:23988 ||| IN
10  ||| S:23988 E:23991 ||| CD
individual  ||| S:23991 E:24002 ||| JJ
5-6  ||| S:24002 E:24006 ||| FW
yr  ||| S:24006 E:24009 ||| FW
Duchenne  ||| S:24009 E:24018 ||| FW
dystrophy  ||| S:24018 E:24036 ||| FW
profiles  ||| S:24036 E:24045 ||| FW
to  ||| S:24045 E:24048 ||| TO
6  ||| S:24048 E:24050 ||| CD
mixed  ||| S:24050 E:24056 ||| JJ
controls  ||| S:24056 E:24065 ||| NNS
revealed  ||| S:24065 E:24074 ||| VBD
1,498  ||| S:24074 E:24080 ||| CD
genes  ||| S:24080 E:24086 ||| NNS
showing  ||| S:24086 E:24102 ||| VBG
differential  ||| S:24102 E:24115 ||| JJ
expression  ||| S:24115 E:24126 ||| NN
with  ||| S:24126 E:24131 ||| IN
p  ||| S:24131 E:24133 ||| CD
< ||| S:24133 E:24135 ||| SYM
0.05  ||| S:24135 E:24140 ||| CD
( ||| S:24140 E:24141 ||| -LRB-
Fig.  ||| S:24141 E:24146 ||| CD
5 ||| S:24146 E:24147 ||| CD
) ||| S:24147 E:24148 ||| -RRB-
.  ||| S:24148 E:24158 ||| .
Comparison  ||| S:24158 E:24169 ||| NN
of  ||| S:24169 E:24172 ||| IN
the  ||| S:24172 E:24176 ||| DT
two  ||| S:24176 E:24180 ||| CD
mixed  ||| S:24180 E:24186 ||| JJ
Duchenne  ||| S:24186 E:24195 ||| JJ
dystrophy  ||| S:24195 E:24205 ||| JJ
profiles  ||| S:24205 E:24214 ||| NNS
to  ||| S:24214 E:24225 ||| TO
the  ||| S:24225 E:24229 ||| DT
6  ||| S:24229 E:24231 ||| CD
mixed  ||| S:24231 E:24237 ||| JJ
controls  ||| S:24237 E:24246 ||| NNS
showed  ||| S:24246 E:24253 ||| VBD
1,350  ||| S:24253 E:24259 ||| CD
genes  ||| S:24259 E:24265 ||| NNS
with  ||| S:24265 E:24270 ||| IN
p  ||| S:24270 E:24272 ||| CD
< ||| S:24272 E:24274 ||| SYM
0.05  ||| S:24274 E:24287 ||| CD
( ||| S:24287 E:24288 ||| -LRB-
Fig.  ||| S:24288 E:24293 ||| NNP
5A ||| S:24293 E:24295 ||| NNP
) ||| S:24295 E:24296 ||| -RRB-
.  ||| S:24296 E:24298 ||| .
Comparison  ||| S:24298 E:24309 ||| NN
of  ||| S:24309 E:24312 ||| IN
the  ||| S:24312 E:24316 ||| DT
two  ||| S:24316 E:24320 ||| CD
gene  ||| S:24320 E:24325 ||| NN
lists  ||| S:24325 E:24331 ||| NNS
showed  ||| S:24331 E:24338 ||| VBD
that  ||| S:24338 E:24343 ||| IN
61 ||| S:24343 E:24345 ||| CD
%  ||| S:24345 E:24355 ||| NN
of  ||| S:24355 E:24358 ||| IN
differentially  ||| S:24358 E:24373 ||| JJ
regulated  ||| S:24373 E:24383 ||| JJ
genes  ||| S:24383 E:24389 ||| NNS
detected  ||| S:24389 E:24398 ||| VBD
by  ||| S:24398 E:24401 ||| IN
the  ||| S:24401 E:24405 ||| DT
10  ||| S:24405 E:24416 ||| CD
individual  ||| S:24416 E:24427 ||| JJ
profiles  ||| S:24427 E:24436 ||| NNS
were  ||| S:24436 E:24441 ||| VBD
also  ||| S:24441 E:24446 ||| RB
detected  ||| S:24446 E:24455 ||| VBN
by  ||| S:24455 E:24458 ||| IN
the  ||| S:24458 E:24462 ||| DT
two  ||| S:24462 E:24466 ||| CD
mixed  ||| S:24466 E:24480 ||| JJ
profiles ||| S:24480 E:24488 ||| NNS
.  ||| S:24488 E:24490 ||| .
This  ||| S:24490 E:24495 ||| DT
suggests  ||| S:24495 E:24504 ||| VBZ
that  ||| S:24504 E:24509 ||| IN
the  ||| S:24509 E:24513 ||| DT
sensitivity  ||| S:24513 E:24525 ||| NN
and  ||| S:24525 E:24537 ||| CC
specificity  ||| S:24537 E:24549 ||| NN
of  ||| S:24549 E:24552 ||| IN
using  ||| S:24552 E:24558 ||| VBG
mixed  ||| S:24558 E:24564 ||| JJ
samples  ||| S:24564 E:24572 ||| NNS
is  ||| S:24572 E:24575 ||| VBZ
approximately  ||| S:24575 E:24589 ||| RB
half  ||| S:24589 E:24602 ||| PDT
that  ||| S:24602 E:24607 ||| DT
of  ||| S:24607 E:24610 ||| IN
individual  ||| S:24610 E:24621 ||| JJ
profiles ||| S:24621 E:24629 ||| NNS
.  ||| S:24629 E:24631 ||| .
However ||| S:24631 E:24638 ||| RB
,  ||| S:24638 E:24640 ||| ,
there  ||| S:24640 E:24646 ||| EX
was  ||| S:24646 E:24650 ||| VBD
a  ||| S:24650 E:24652 ||| DT
rapid  ||| S:24652 E:24666 ||| JJ
shift  ||| S:24666 E:24672 ||| NN
in  ||| S:24672 E:24675 ||| IN
specificity  ||| S:24675 E:24687 ||| NN
and  ||| S:24687 E:24691 ||| CC
sensitivity  ||| S:24691 E:24703 ||| NN
as  ||| S:24703 E:24706 ||| IN
stringency  ||| S:24706 E:24717 ||| NN
of  ||| S:24717 E:24720 ||| IN
the  ||| S:24720 E:24732 ||| DT
analysis  ||| S:24732 E:24741 ||| NN
was  ||| S:24741 E:24745 ||| VBD
increased ||| S:24745 E:24754 ||| VBN
.  ||| S:24754 E:24756 ||| .
Raising  ||| S:24756 E:24764 ||| VBG
the  ||| S:24764 E:24768 ||| DT
statistical  ||| S:24768 E:24780 ||| JJ
threshold  ||| S:24780 E:24798 ||| NN
to  ||| S:24798 E:24801 ||| TO
p  ||| S:24801 E:24803 ||| CD
< ||| S:24803 E:24805 ||| SYM
0.0001  ||| S:24805 E:24812 ||| CD
for  ||| S:24812 E:24816 ||| IN
individual  ||| S:24816 E:24827 ||| JJ
profiles ||| S:24827 E:24835 ||| NNS
,  ||| S:24835 E:24837 ||| ,
while  ||| S:24837 E:24843 ||| IN
keeping  ||| S:24843 E:24851 ||| VBG
the  ||| S:24851 E:24863 ||| DT
threshold  ||| S:24863 E:24873 ||| NN
for  ||| S:24873 E:24877 ||| IN
mixed  ||| S:24877 E:24883 ||| JJ
profiles  ||| S:24883 E:24892 ||| NNS
at  ||| S:24892 E:24895 ||| IN
p  ||| S:24895 E:24897 ||| CD
< ||| S:24897 E:24899 ||| SYM
0.05  ||| S:24899 E:24904 ||| CD
as  ||| S:24904 E:24907 ||| IN
required  ||| S:24907 E:24916 ||| VBN
by  ||| S:24916 E:24927 ||| IN
the  ||| S:24927 E:24931 ||| DT
small  ||| S:24931 E:24937 ||| JJ
number  ||| S:24937 E:24944 ||| NN
of  ||| S:24944 E:24947 ||| IN
data  ||| S:24947 E:24952 ||| NN
points  ||| S:24952 E:24959 ||| NNS
( ||| S:24959 E:24960 ||| -LRB-
Fig.  ||| S:24960 E:24965 ||| NNP
5B ||| S:24965 E:24967 ||| NNP
) ||| S:24967 E:24968 ||| -RRB-
,  ||| S:24968 E:24970 ||| ,
resulted  ||| S:24970 E:24979 ||| VBD
in  ||| S:24979 E:24982 ||| IN
a  ||| S:24982 E:24992 ||| DT
sensitivity  ||| S:24992 E:25004 ||| NN
of  ||| S:25004 E:25007 ||| IN
86 ||| S:25007 E:25009 ||| CD
%  ||| S:25009 E:25011 ||| NN
for  ||| S:25011 E:25015 ||| IN
mixed  ||| S:25015 E:25021 ||| JJ
samples  ||| S:25021 E:25029 ||| NNS
( ||| S:25029 E:25030 ||| -LRB-
351  ||| S:25030 E:25034 ||| CD
of  ||| S:25034 E:25037 ||| IN
408  ||| S:25037 E:25041 ||| CD
genes  ||| S:25041 E:25047 ||| NNS
p  ||| S:25047 E:25057 ||| VBD
< ||| S:25057 E:25059 ||| SYM
0.0001  ||| S:25059 E:25066 ||| CD
detected ||| S:25066 E:25074 ||| CD
) ||| S:25074 E:25075 ||| -RRB-
.  ||| S:25075 E:25077 ||| .
In  ||| S:25077 E:25080 ||| IN
conclusion ||| S:25080 E:25090 ||| NN
,  ||| S:25090 E:25092 ||| ,
mixing  ||| S:25092 E:25099 ||| VBG
detected  ||| S:25099 E:25108 ||| VBN
about  ||| S:25108 E:25122 ||| IN
two  ||| S:25122 E:25126 ||| CD
thirds  ||| S:25126 E:25133 ||| NNS
of  ||| S:25133 E:25136 ||| IN
statistically  ||| S:25136 E:25150 ||| JJ
significant  ||| S:25150 E:25162 ||| JJ
changes  ||| S:25162 E:25170 ||| NNS
( ||| S:25170 E:25171 ||| -LRB-
p  ||| S:25171 E:25173 ||| CD
< ||| S:25173 E:25174 ||| SYM
0.05 ||| S:25183 E:25187 ||| CD
) ||| S:25187 E:25188 ||| -RRB-
.  ||| S:25188 E:25190 ||| .
Mixing  ||| S:25190 E:25197 ||| NNP
was  ||| S:25197 E:25201 ||| VBD
a  ||| S:25201 E:25203 ||| DT
relatively  ||| S:25203 E:25214 ||| RB
sensitive  ||| S:25214 E:25224 ||| JJ
method  ||| S:25224 E:25231 ||| NN
of  ||| S:25231 E:25242 ||| IN
detecting  ||| S:25242 E:25252 ||| VBG
the  ||| S:25252 E:25256 ||| DT
most  ||| S:25256 E:25261 ||| RBS
highly  ||| S:25261 E:25268 ||| RB
significant  ||| S:25268 E:25280 ||| JJ
changes  ||| S:25280 E:25288 ||| NNS
( ||| S:25288 E:25289 ||| -LRB-
p  ||| S:25289 E:25291 ||| FW
< ||| S:25291 E:25292 ||| SYM
0.0001 ||| S:25301 E:25307 ||| FW
)  ||| S:25307 E:25309 ||| -RRB-
( ||| S:25309 E:25310 ||| -LRB-
86 ||| S:25310 E:25312 ||| CD
%  ||| S:25312 E:25314 ||| NN
of  ||| S:25314 E:25317 ||| IN
changes  ||| S:25317 E:25325 ||| NNS
detected ||| S:25325 E:25333 ||| VBN
) ||| S:25333 E:25334 ||| -RRB-
,  ||| S:25334 E:25336 ||| ,
however  ||| S:25336 E:25344 ||| RB
it  ||| S:25344 E:25347 ||| PRP
was  ||| S:25347 E:25351 ||| VBD
not  ||| S:25351 E:25355 ||| RB
very  ||| S:25355 E:25368 ||| RB
specific ||| S:25368 E:25376 ||| JJ
;  ||| S:25376 E:25378 ||| :
as  ||| S:25378 E:25381 ||| IN
many  ||| S:25381 E:25386 ||| JJ
as  ||| S:25386 E:25389 ||| IN
one  ||| S:25389 E:25393 ||| CD
third  ||| S:25393 E:25399 ||| JJ
of  ||| S:25399 E:25402 ||| IN
gene  ||| S:25402 E:25407 ||| NN
expression  ||| S:25407 E:25418 ||| NN
changes  ||| S:25418 E:25434 ||| NNS
showing  ||| S:25434 E:25442 ||| VBG
p  ||| S:25442 E:25444 ||| CD
< ||| S:25444 E:25446 ||| SYM
0.05  ||| S:25446 E:25451 ||| CD
in  ||| S:25451 E:25454 ||| IN
mixed  ||| S:25454 E:25460 ||| JJ
samples  ||| S:25460 E:25468 ||| NNS
were  ||| S:25468 E:25473 ||| VBD
not  ||| S:25473 E:25477 ||| RB
confirmed  ||| S:25477 E:25487 ||| VBN
by  ||| S:25487 E:25498 ||| IN
individual  ||| S:25498 E:25509 ||| JJ
profiles ||| S:25509 E:25517 ||| NNS
.  ||| S:25517 E:25527 ||| .
Use  ||| S:25527 E:25531 ||| NN
of  ||| S:25531 E:25534 ||| IN
t-test  ||| S:25534 E:25541 ||| JJ
measurements  ||| S:25541 E:25554 ||| NNS
is  ||| S:25554 E:25557 ||| VBZ
expected  ||| S:25557 E:25566 ||| VBN
to  ||| S:25566 E:25569 ||| TO
contain  ||| S:25569 E:25585 ||| VB
significant  ||| S:25585 E:25597 ||| JJ
amounts  ||| S:25597 E:25605 ||| NNS
of  ||| S:25605 E:25608 ||| IN
noise ||| S:25608 E:25613 ||| NN
,  ||| S:25613 E:25615 ||| ,
due  ||| S:25615 E:25619 ||| JJ
to  ||| S:25619 E:25622 ||| TO
the  ||| S:25622 E:25626 ||| DT
very  ||| S:25626 E:25631 ||| RB
large  ||| S:25631 E:25637 ||| JJ
number  ||| S:25637 E:25652 ||| NN
of  ||| S:25652 E:25655 ||| IN
comparisons  ||| S:25655 E:25667 ||| NNS
involved  ||| S:25667 E:25676 ||| VBN
in  ||| S:25676 E:25679 ||| IN
array  ||| S:25679 E:25685 ||| NN
studies ||| S:25685 E:25692 ||| NNS
;  ||| S:25692 E:25694 ||| :
a  ||| S:25694 E:25696 ||| DT
value  ||| S:25696 E:25702 ||| NN
of  ||| S:25702 E:25705 ||| IN
p  ||| S:25705 E:25707 ||| CD
=  ||| S:25707 E:25717 ||| SYM
0.05  ||| S:25717 E:25722 ||| CD
means  ||| S:25722 E:25728 ||| NNS
that  ||| S:25728 E:25733 ||| IN
as  ||| S:25733 E:25736 ||| IN
many  ||| S:25736 E:25741 ||| JJ
as  ||| S:25741 E:25744 ||| IN
5 ||| S:25744 E:25745 ||| CD
%  ||| S:25745 E:25747 ||| NN
of  ||| S:25747 E:25750 ||| IN
gene  ||| S:25750 E:25755 ||| NN
expression  ||| S:25755 E:25766 ||| NN
changes  ||| S:25766 E:25782 ||| NNS
are  ||| S:25782 E:25786 ||| VBP
expected  ||| S:25786 E:25795 ||| VBN
to  ||| S:25795 E:25798 ||| TO
be  ||| S:25798 E:25801 ||| VB
identified  ||| S:25801 E:25812 ||| VBN
by  ||| S:25812 E:25815 ||| IN
"chance ||| S:25815 E:25822 ||| NNP
" ||| S:25822 E:25823 ||| ''
,  ||| S:25823 E:25825 ||| ,
and  ||| S:25825 E:25829 ||| CC
thereby  ||| S:25829 E:25837 ||| RB
not  ||| S:25837 E:25849 ||| RB
reflect  ||| S:25849 E:25857 ||| VB
true  ||| S:25857 E:25862 ||| JJ
differences  ||| S:25862 E:25874 ||| NNS
between  ||| S:25874 E:25882 ||| IN
samples ||| S:25882 E:25889 ||| NNS
.  ||| S:25889 E:25891 ||| .
We  ||| S:25891 E:25894 ||| PRP
have  ||| S:25894 E:25907 ||| VBP
previously  ||| S:25907 E:25918 ||| RB
reported  ||| S:25918 E:25927 ||| VBD
a  ||| S:25927 E:25929 ||| DT
very  ||| S:25929 E:25934 ||| RB
simple ||| S:25934 E:25940 ||| JJ
,  ||| S:25940 E:25942 ||| ,
yet  ||| S:25942 E:25946 ||| RB
potentially  ||| S:25946 E:25958 ||| RB
more  ||| S:25958 E:25971 ||| RBR
stringent  ||| S:25971 E:25981 ||| JJ
method  ||| S:25981 E:25988 ||| NN
for  ||| S:25988 E:25992 ||| IN
data  ||| S:25992 E:25997 ||| NN
analysis  ||| S:25997 E:26006 ||| NN
of  ||| S:26006 E:26009 ||| IN
small  ||| S:26009 E:26015 ||| JJ
numbers  ||| S:26015 E:26023 ||| NNS
of  ||| S:26023 E:26034 ||| IN
expression  ||| S:26034 E:26045 ||| NN
profiles ||| S:26045 E:26053 ||| NNS
,  ||| S:26053 E:26055 ||| ,
using  ||| S:26055 E:26061 ||| VBG
duplicate  ||| S:26061 E:26071 ||| JJ
profiles  ||| S:26071 E:26080 ||| NNS
for  ||| S:26080 E:26084 ||| IN
control  ||| S:26084 E:26100 ||| NN
and  ||| S:26100 E:26104 ||| CC
experimental  ||| S:26104 E:26117 ||| JJ
samples ||| S:26117 E:26124 ||| NNS
,  ||| S:26124 E:26126 ||| ,
and  ||| S:26126 E:26130 ||| CC
then  ||| S:26130 E:26135 ||| RB
identifying  ||| S:26135 E:26147 ||| VBG
those  ||| S:26147 E:26153 ||| DT
genes  ||| S:26153 E:26167 ||| NNS
that  ||| S:26167 E:26172 ||| WDT
show  ||| S:26172 E:26177 ||| VBP
consistent  ||| S:26177 E:26188 ||| JJ
changes  ||| S:26188 E:26196 ||| NNS
> ||| S:26196 E:26197 ||| CD
2-fold  ||| S:26197 E:26204 ||| CD
in  ||| S:26204 E:26207 ||| IN
the  ||| S:26207 E:26211 ||| DT
four  ||| S:26211 E:26224 ||| CD
possible  ||| S:26224 E:26233 ||| JJ
pair-wise  ||| S:26233 E:26243 ||| JJ
data  ||| S:26243 E:26248 ||| NN
comparisons  ||| S:26248 E:26260 ||| NNS
( ||| S:26260 E:26261 ||| -LRB-
four  ||| S:26261 E:26266 ||| CD
comparison  ||| S:26266 E:26285 ||| NN
survival  ||| S:26285 E:26294 ||| NN
method ||| S:26294 E:26300 ||| NN
)  ||| S:26300 E:26302 ||| -RRB-
[  ||| S:26302 E:26304 ||| -LRB-
23  ||| S:26304 E:26307 ||| CD
]  ||| S:26307 E:26309 ||| -RRB-
.  ||| S:26309 E:26311 ||| .
A  ||| S:26311 E:26313 ||| DT
similar  ||| S:26313 E:26321 ||| JJ
pair-wise  ||| S:26321 E:26331 ||| JJ
comparison  ||| S:26331 E:26350 ||| NN
method ||| S:26350 E:26356 ||| NN
,  ||| S:26356 E:26358 ||| ,
using  ||| S:26358 E:26364 ||| VBG
a  ||| S:26364 E:26366 ||| DT
less  ||| S:26366 E:26371 ||| RBR
stringent  ||| S:26371 E:26381 ||| JJ
average  ||| S:26381 E:26389 ||| JJ
fold-change  ||| S:26389 E:26409 ||| JJ
analysis ||| S:26409 E:26417 ||| NN
,  ||| S:26417 E:26419 ||| ,
was  ||| S:26419 E:26423 ||| VBD
recently  ||| S:26423 E:26432 ||| RB
reported  ||| S:26432 E:26441 ||| VBN
for  ||| S:26441 E:26445 ||| IN
muscle  ||| S:26445 E:26452 ||| NN
from  ||| S:26452 E:26457 ||| IN
aging  ||| S:26457 E:26463 ||| VBG
and  ||| S:26463 E:26475 ||| CC
calorie-restricted  ||| S:26475 E:26494 ||| JJ
mouse  ||| S:26494 E:26500 ||| NN
muscle  ||| S:26500 E:26507 ||| NN
[  ||| S:26507 E:26509 ||| -LRB-
13  ||| S:26509 E:26512 ||| CD
]  ||| S:26512 E:26514 ||| -RRB-
.  ||| S:26514 E:26524 ||| .
To  ||| S:26524 E:26527 ||| TO
investigate  ||| S:26527 E:26539 ||| VB
the  ||| S:26539 E:26543 ||| DT
validity  ||| S:26543 E:26552 ||| NN
of  ||| S:26552 E:26555 ||| IN
this  ||| S:26555 E:26560 ||| DT
approach  ||| S:26560 E:26569 ||| NN
we  ||| S:26569 E:26572 ||| PRP
compared  ||| S:26572 E:26589 ||| VBD
the  ||| S:26589 E:26593 ||| DT
sensitivity  ||| S:26593 E:26605 ||| NN
and  ||| S:26605 E:26609 ||| CC
specificity  ||| S:26609 E:26621 ||| NN
of  ||| S:26621 E:26624 ||| IN
t-test  ||| S:26624 E:26631 ||| JJ
detection  ||| S:26631 E:26641 ||| NN
of  ||| S:26641 E:26652 ||| IN
expression  ||| S:26652 E:26663 ||| NN
changes  ||| S:26663 E:26671 ||| NNS
versus  ||| S:26671 E:26678 ||| IN
the  ||| S:26678 E:26682 ||| DT
four-pairwise  ||| S:26682 E:26696 ||| JJ
survival  ||| S:26696 E:26713 ||| NN
method ||| S:26713 E:26719 ||| NN
.  ||| S:26719 E:26721 ||| .
Two  ||| S:26721 E:26725 ||| CD
sample  ||| S:26725 E:26732 ||| NN
t-test  ||| S:26732 E:26739 ||| NN
of  ||| S:26739 E:26742 ||| IN
the  ||| S:26742 E:26746 ||| DT
10  ||| S:26746 E:26749 ||| CD
individual  ||| S:26749 E:26760 ||| JJ
Duchenne  ||| S:26760 E:26777 ||| JJ
dystrophy  ||| S:26777 E:26787 ||| NNS
profiles  ||| S:26787 E:26796 ||| VBP
compared  ||| S:26796 E:26805 ||| VBN
to  ||| S:26805 E:26808 ||| TO
the  ||| S:26808 E:26812 ||| DT
6  ||| S:26812 E:26814 ||| CD
mixed  ||| S:26814 E:26820 ||| JJ
control  ||| S:26820 E:26828 ||| NN
profiles  ||| S:26828 E:26845 ||| NNS
revealed  ||| S:26845 E:26854 ||| VBD
1,498  ||| S:26854 E:26860 ||| CD
genes  ||| S:26860 E:26866 ||| NNS
showing  ||| S:26866 E:26874 ||| VBG
p  ||| S:26874 E:26876 ||| CD
< ||| S:26876 E:26878 ||| SYM
0.05  ||| S:26878 E:26883 ||| CD
as  ||| S:26883 E:26886 ||| IN
above ||| S:26886 E:26891 ||| JJ
.  ||| S:26891 E:26893 ||| .
In  ||| S:26893 E:26904 ||| IN
parallel ||| S:26904 E:26912 ||| NN
,  ||| S:26912 E:26914 ||| ,
the  ||| S:26914 E:26918 ||| DT
mixed  ||| S:26918 E:26924 ||| JJ
DMD  ||| S:26924 E:26928 ||| NNP
duplicate  ||| S:26928 E:26938 ||| NN
profiles  ||| S:26938 E:26947 ||| NNS
were  ||| S:26947 E:26952 ||| VBD
compared  ||| S:26952 E:26961 ||| VBN
to  ||| S:26961 E:26972 ||| TO
a  ||| S:26972 E:26974 ||| DT
single  ||| S:26974 E:26981 ||| JJ
pair  ||| S:26981 E:26986 ||| NN
of  ||| S:26986 E:26989 ||| IN
mixed  ||| S:26989 E:26995 ||| JJ
control  ||| S:26995 E:27003 ||| NN
sample  ||| S:27003 E:27010 ||| NN
profiles  ||| S:27010 E:27019 ||| NNS
( ||| S:27019 E:27020 ||| -LRB-
c1a ||| S:27020 E:27023 ||| NNP
,  ||| S:27023 E:27025 ||| ,
c1b ||| S:27025 E:27028 ||| CD
) ||| S:27028 E:27029 ||| -RRB-
,  ||| S:27029 E:27039 ||| ,
using  ||| S:27039 E:27045 ||| VBG
the  ||| S:27045 E:27049 ||| DT
pairwise  ||| S:27049 E:27058 ||| JJ
comparison  ||| S:27058 E:27069 ||| NN
survival  ||| S:27069 E:27078 ||| NN
method  ||| S:27078 E:27085 ||| NN
[  ||| S:27085 E:27087 ||| -LRB-
23  ||| S:27087 E:27090 ||| CD
]  ||| S:27090 E:27092 ||| -RRB-
.  ||| S:27092 E:27102 ||| .
Briefly ||| S:27102 E:27109 ||| RB
,  ||| S:27109 E:27111 ||| ,
four  ||| S:27111 E:27116 ||| CD
comparisons  ||| S:27116 E:27128 ||| NNS
were  ||| S:27128 E:27133 ||| VBD
done  ||| S:27133 E:27138 ||| VBN
( ||| S:27138 E:27139 ||| -LRB-
DMD  ||| S:27139 E:27143 ||| FW
1a  ||| S:27143 E:27146 ||| FW
versus  ||| S:27146 E:27153 ||| FW
control  ||| S:27153 E:27169 ||| FW
1a ||| S:27169 E:27171 ||| FW
;  ||| S:27171 E:27173 ||| :
DMD1b  ||| S:27173 E:27179 ||| FW
versus  ||| S:27179 E:27186 ||| FW
control  ||| S:27186 E:27194 ||| FW
1a ||| S:27194 E:27196 ||| FW
;  ||| S:27196 E:27198 ||| :
DMD  ||| S:27198 E:27202 ||| FW
1a  ||| S:27202 E:27205 ||| FW
versus  ||| S:27205 E:27212 ||| FW
control  ||| S:27212 E:27220 ||| FW
1b ||| S:27220 E:27222 ||| FW
;  ||| S:27222 E:27232 ||| :
DMD1b  ||| S:27232 E:27238 ||| FW
versus  ||| S:27238 E:27245 ||| FW
control  ||| S:27245 E:27253 ||| FW
1b ||| S:27253 E:27255 ||| FW
) ||| S:27255 E:27256 ||| -RRB-
,  ||| S:27256 E:27258 ||| ,
and  ||| S:27258 E:27262 ||| CC
only  ||| S:27262 E:27267 ||| RB
those  ||| S:27267 E:27273 ||| DT
genes  ||| S:27273 E:27279 ||| NNS
retained  ||| S:27279 E:27296 ||| VBD
which  ||| S:27296 E:27302 ||| WDT
showed  ||| S:27302 E:27309 ||| VBD
> ||| S:27309 E:27310 ||| CD
2-fold  ||| S:27310 E:27317 ||| CD
change  ||| S:27317 E:27324 ||| NN
in  ||| S:27324 E:27327 ||| IN
all  ||| S:27327 E:27331 ||| DT
four  ||| S:27331 E:27336 ||| CD
comparisons ||| S:27336 E:27347 ||| NNS
.  ||| S:27347 E:27357 ||| .
This  ||| S:27357 E:27362 ||| DT
method  ||| S:27362 E:27369 ||| NN
was  ||| S:27369 E:27373 ||| VBD
indeed  ||| S:27373 E:27380 ||| RB
considerably  ||| S:27380 E:27393 ||| RB
more  ||| S:27393 E:27398 ||| RBR
specific  ||| S:27398 E:27407 ||| JJ
in  ||| S:27407 E:27418 ||| IN
identifying  ||| S:27418 E:27430 ||| VBG
significant  ||| S:27430 E:27442 ||| JJ
( ||| S:27442 E:27443 ||| -LRB-
p  ||| S:27443 E:27445 ||| CD
< ||| S:27445 E:27447 ||| SYM
0.05 ||| S:27447 E:27451 ||| CD
)  ||| S:27451 E:27453 ||| -RRB-
gene  ||| S:27453 E:27458 ||| NN
expression  ||| S:27458 E:27477 ||| NN
changes  ||| S:27477 E:27485 ||| NNS
( ||| S:27485 E:27486 ||| -LRB-
Fig.  ||| S:27486 E:27491 ||| NNP
6A ||| S:27491 E:27493 ||| NNP
)  ||| S:27493 E:27495 ||| -RRB-
with  ||| S:27495 E:27500 ||| IN
85 ||| S:27500 E:27502 ||| CD
%  ||| S:27502 E:27504 ||| NN
of  ||| S:27504 E:27507 ||| IN
gene  ||| S:27507 E:27512 ||| NN
expression  ||| S:27512 E:27523 ||| NN
changes  ||| S:27523 E:27531 ||| NNS
in  ||| S:27531 E:27542 ||| IN
the  ||| S:27542 E:27546 ||| DT
mixed  ||| S:27546 E:27552 ||| JJ
profiles  ||| S:27552 E:27561 ||| NNS
verified  ||| S:27561 E:27570 ||| VBN
by  ||| S:27570 E:27573 ||| IN
individual  ||| S:27573 E:27584 ||| JJ
profiles  ||| S:27584 E:27593 ||| NNS
( ||| S:27593 E:27594 ||| -LRB-
p  ||| S:27594 E:27596 ||| CD
< ||| S:27596 E:27597 ||| SYM
0.05 ||| S:27606 E:27610 ||| CD
) ||| S:27610 E:27611 ||| -RRB-
.  ||| S:27611 E:27613 ||| .
The  ||| S:27613 E:27617 ||| DT
sensitivity  ||| S:27617 E:27629 ||| NN
of  ||| S:27629 E:27632 ||| IN
this  ||| S:27632 E:27637 ||| DT
method  ||| S:27637 E:27644 ||| NN
depended  ||| S:27644 E:27653 ||| VBD
on  ||| S:27653 E:27656 ||| IN
the  ||| S:27656 E:27668 ||| DT
p-value  ||| S:27668 E:27676 ||| JJ
threshold  ||| S:27676 E:27686 ||| NN
for  ||| S:27686 E:27690 ||| IN
the  ||| S:27690 E:27694 ||| DT
individual  ||| S:27694 E:27705 ||| JJ
profiles ||| S:27705 E:27713 ||| NNS
,  ||| S:27713 E:27715 ||| ,
but  ||| S:27715 E:27719 ||| CC
only  ||| S:27719 E:27732 ||| RB
reached  ||| S:27732 E:27740 ||| VBN
a  ||| S:27740 E:27742 ||| DT
maximum  ||| S:27742 E:27750 ||| NN
of  ||| S:27750 E:27753 ||| IN
49 ||| S:27753 E:27755 ||| CD
%  ||| S:27755 E:27757 ||| NN
sensitivity  ||| S:27757 E:27769 ||| NN
at  ||| S:27769 E:27772 ||| IN
p  ||| S:27772 E:27774 ||| CD
< ||| S:27774 E:27776 ||| SYM
0.0001  ||| S:27776 E:27783 ||| CD
( ||| S:27783 E:27784 ||| -LRB-
Fig.  ||| S:27784 E:27797 ||| NNP
6B ||| S:27797 E:27799 ||| NNP
) ||| S:27799 E:27800 ||| -RRB-
.  ||| S:27800 E:27810 ||| .
The  ||| S:27810 E:27814 ||| DT
results  ||| S:27814 E:27822 ||| NNS
above  ||| S:27822 E:27828 ||| IN
suggested  ||| S:27828 E:27838 ||| VBN
that  ||| S:27838 E:27843 ||| IN
analysis  ||| S:27843 E:27852 ||| NN
of  ||| S:27852 E:27855 ||| IN
mixed  ||| S:27855 E:27869 ||| JJ
samples  ||| S:27869 E:27877 ||| NNS
using  ||| S:27877 E:27883 ||| VBG
t-test  ||| S:27883 E:27890 ||| JJ
methods  ||| S:27890 E:27898 ||| NNS
was  ||| S:27898 E:27902 ||| VBD
relatively  ||| S:27902 E:27913 ||| RB
sensitive  ||| S:27913 E:27923 ||| JJ
but  ||| S:27923 E:27935 ||| CC
non-specific ||| S:27935 E:27947 ||| JJ
,  ||| S:27947 E:27949 ||| ,
while  ||| S:27949 E:27955 ||| IN
analysis  ||| S:27955 E:27964 ||| NN
of  ||| S:27964 E:27967 ||| IN
the  ||| S:27967 E:27971 ||| DT
same  ||| S:27971 E:27976 ||| JJ
mixed  ||| S:27976 E:27982 ||| JJ
profiles  ||| S:27982 E:27991 ||| NNS
by  ||| S:27991 E:28002 ||| IN
2-fold  ||| S:28002 E:28009 ||| CD
survival  ||| S:28009 E:28018 ||| NN
method  ||| S:28018 E:28025 ||| NN
was  ||| S:28025 E:28029 ||| VBD
relatively  ||| S:28029 E:28040 ||| RB
specific  ||| S:28040 E:28049 ||| JJ
but  ||| S:28049 E:28061 ||| CC
insensitive ||| S:28061 E:28072 ||| NN
.  ||| S:28072 E:28074 ||| .
To  ||| S:28074 E:28077 ||| TO
confirm  ||| S:28077 E:28085 ||| VB
this  ||| S:28085 E:28090 ||| DT
conclusion ||| S:28090 E:28100 ||| NN
,  ||| S:28100 E:28102 ||| ,
we  ||| S:28102 E:28105 ||| PRP
directly  ||| S:28105 E:28122 ||| RB
compared  ||| S:28122 E:28131 ||| VBN
the  ||| S:28131 E:28135 ||| DT
sensitivity  ||| S:28135 E:28147 ||| NN
and  ||| S:28147 E:28151 ||| CC
specificity  ||| S:28151 E:28163 ||| NN
of  ||| S:28163 E:28166 ||| IN
the  ||| S:28166 E:28170 ||| DT
four  ||| S:28170 E:28183 ||| CD
pairwise  ||| S:28183 E:28192 ||| JJ
comparison  ||| S:28192 E:28203 ||| NN
method  ||| S:28203 E:28210 ||| NN
to  ||| S:28210 E:28213 ||| TO
more  ||| S:28213 E:28218 ||| RBR
standard  ||| S:28218 E:28227 ||| JJ
t-test  ||| S:28227 E:28234 ||| JJ
methods  ||| S:28234 E:28250 ||| NNS
( ||| S:28250 E:28251 ||| -LRB-
Fig.  ||| S:28251 E:28256 ||| NNP
7A ||| S:28256 E:28258 ||| NNP
) ||| S:28258 E:28259 ||| -RRB-
.  ||| S:28259 E:28261 ||| .
We  ||| S:28261 E:28264 ||| PRP
found  ||| S:28264 E:28270 ||| VBD
that  ||| S:28270 E:28275 ||| IN
the  ||| S:28275 E:28279 ||| DT
pairwise  ||| S:28279 E:28288 ||| JJ
survival  ||| S:28288 E:28297 ||| NN
method  ||| S:28297 E:28304 ||| NN
was  ||| S:28304 E:28316 ||| VBD
indeed  ||| S:28316 E:28323 ||| RB
highly  ||| S:28323 E:28330 ||| RB
specific ||| S:28330 E:28338 ||| JJ
,  ||| S:28338 E:28340 ||| ,
with  ||| S:28340 E:28345 ||| IN
97 ||| S:28345 E:28347 ||| CD
%  ||| S:28347 E:28349 ||| NN
of  ||| S:28349 E:28352 ||| IN
changes  ||| S:28352 E:28360 ||| NNS
identified  ||| S:28360 E:28371 ||| VBN
by  ||| S:28371 E:28382 ||| IN
this  ||| S:28382 E:28387 ||| DT
method  ||| S:28387 E:28394 ||| NN
also  ||| S:28394 E:28399 ||| RB
detected  ||| S:28399 E:28408 ||| VBN
by  ||| S:28408 E:28411 ||| IN
t-test ||| S:28411 E:28417 ||| JJ
.  ||| S:28417 E:28419 ||| .
However ||| S:28419 E:28426 ||| RB
,  ||| S:28426 E:28428 ||| ,
as  ||| S:28428 E:28431 ||| RB
predicted ||| S:28431 E:28440 ||| VBD
,  ||| S:28440 E:28450 ||| ,
it  ||| S:28450 E:28453 ||| PRP
was  ||| S:28453 E:28457 ||| VBD
not  ||| S:28457 E:28461 ||| RB
very  ||| S:28461 E:28466 ||| RB
sensitive ||| S:28466 E:28475 ||| JJ
,  ||| S:28475 E:28477 ||| ,
with  ||| S:28477 E:28482 ||| IN
only  ||| S:28482 E:28487 ||| RB
30 ||| S:28487 E:28489 ||| CD
%  ||| S:28489 E:28491 ||| NN
of  ||| S:28491 E:28494 ||| IN
the  ||| S:28494 E:28498 ||| DT
expression  ||| S:28498 E:28517 ||| NN
changes  ||| S:28517 E:28525 ||| NNS
with  ||| S:28525 E:28530 ||| IN
p  ||| S:28530 E:28532 ||| CD
< ||| S:28532 E:28534 ||| SYM
0.05  ||| S:28534 E:28539 ||| CD
identified  ||| S:28539 E:28550 ||| VBN
by  ||| S:28550 E:28553 ||| IN
t-test  ||| S:28553 E:28560 ||| JJ
being  ||| S:28560 E:28574 ||| VBG
detected  ||| S:28574 E:28583 ||| VBN
by  ||| S:28583 E:28586 ||| IN
the  ||| S:28586 E:28590 ||| DT
pairwise  ||| S:28590 E:28599 ||| JJ
survival  ||| S:28599 E:28608 ||| NN
method ||| S:28608 E:28614 ||| NN
.  ||| S:28614 E:28616 ||| .
Comparison  ||| S:28616 E:28627 ||| NN
of  ||| S:28627 E:28630 ||| IN
all  ||| S:28630 E:28642 ||| DT
three  ||| S:28642 E:28648 ||| CD
analysis  ||| S:28648 E:28657 ||| NN
methods  ||| S:28657 E:28665 ||| NNS
showed  ||| S:28665 E:28672 ||| VBD
that  ||| S:28672 E:28677 ||| DT
many  ||| S:28677 E:28682 ||| JJ
( ||| S:28682 E:28683 ||| -LRB-
349 ||| S:28683 E:28686 ||| LS
)  ||| S:28686 E:28688 ||| -RRB-
genes  ||| S:28688 E:28702 ||| NNS
expression  ||| S:28702 E:28713 ||| NN
changes  ||| S:28713 E:28721 ||| NNS
were  ||| S:28721 E:28726 ||| VBD
detected  ||| S:28726 E:28735 ||| VBN
by  ||| S:28735 E:28738 ||| IN
all  ||| S:28738 E:28742 ||| DT
three  ||| S:28742 E:28748 ||| CD
methods  ||| S:28748 E:28756 ||| NNS
( ||| S:28756 E:28757 ||| -LRB-
Fig.  ||| S:28757 E:28770 ||| NNP
7B ||| S:28770 E:28772 ||| NNP
) ||| S:28772 E:28773 ||| -RRB-
.  ||| S:28773 E:28797 ||| .
Conclusions  ||| S:28797 E:28817 ||| NNP
Microarray  ||| S:28817 E:28828 ||| NNP
data  ||| S:28828 E:28833 ||| NN
analyses  ||| S:28833 E:28842 ||| NNS
have  ||| S:28842 E:28847 ||| VBP
been  ||| S:28847 E:28852 ||| VBN
criticized  ||| S:28852 E:28863 ||| VBN
as  ||| S:28863 E:28866 ||| IN
being  ||| S:28866 E:28880 ||| VBG
"quite  ||| S:28880 E:28887 ||| CD
elusive  ||| S:28887 E:28895 ||| NN
about  ||| S:28895 E:28901 ||| IN
measurement  ||| S:28901 E:28913 ||| JJ
reproducibility ||| S:28913 E:28928 ||| NN
"  ||| S:28928 E:28930 ||| ''
[  ||| S:28930 E:28932 ||| -LRB-
30  ||| S:28932 E:28935 ||| CD
]  ||| S:28935 E:28937 ||| -RRB-
.  ||| S:28937 E:28947 ||| .
This  ||| S:28947 E:28952 ||| DT
is  ||| S:28952 E:28955 ||| VBZ
largely  ||| S:28955 E:28963 ||| RB
the  ||| S:28963 E:28967 ||| DT
consequence  ||| S:28967 E:28979 ||| NN
of  ||| S:28979 E:28982 ||| IN
the  ||| S:28982 E:28986 ||| DT
large  ||| S:28986 E:28992 ||| JJ
number  ||| S:28992 E:28999 ||| NN
of  ||| S:28999 E:29010 ||| IN
uncontrolled  ||| S:29010 E:29023 ||| JJ
or  ||| S:29023 E:29026 ||| CC
unknown  ||| S:29026 E:29034 ||| JJ
variables ||| S:29034 E:29043 ||| NNS
,  ||| S:29043 E:29045 ||| ,
and  ||| S:29045 E:29049 ||| CC
the  ||| S:29049 E:29053 ||| DT
prohibitive  ||| S:29053 E:29065 ||| JJ
cost  ||| S:29065 E:29078 ||| NN
of  ||| S:29078 E:29081 ||| IN
isolating  ||| S:29081 E:29091 ||| NN
and  ||| S:29091 E:29095 ||| CC
investigating  ||| S:29095 E:29109 ||| VBG
each  ||| S:29109 E:29114 ||| DT
variable ||| S:29114 E:29122 ||| NN
.  ||| S:29122 E:29124 ||| .
Here ||| S:29124 E:29128 ||| RB
,  ||| S:29128 E:29130 ||| ,
we  ||| S:29130 E:29141 ||| PRP
report  ||| S:29141 E:29148 ||| VBP
the  ||| S:29148 E:29152 ||| DT
systematic  ||| S:29152 E:29163 ||| JJ
isolation  ||| S:29163 E:29173 ||| NN
and  ||| S:29173 E:29177 ||| CC
study  ||| S:29177 E:29183 ||| NN
of  ||| S:29183 E:29186 ||| IN
most  ||| S:29186 E:29191 ||| JJS
variables  ||| S:29191 E:29209 ||| NNS
in  ||| S:29209 E:29212 ||| IN
microarray  ||| S:29212 E:29223 ||| JJ
experiments  ||| S:29223 E:29235 ||| NNS
using  ||| S:29235 E:29241 ||| VBG
Affymetrix  ||| S:29241 E:29252 ||| JJ
oligonucleotide  ||| S:29252 E:29276 ||| JJ
arrays  ||| S:29276 E:29283 ||| NN
and  ||| S:29283 E:29287 ||| CC
human  ||| S:29287 E:29293 ||| JJ
tissue  ||| S:29293 E:29300 ||| NN
biopsies ||| S:29300 E:29308 ||| NNS
.  ||| S:29308 E:29310 ||| .
We  ||| S:29310 E:29313 ||| PRP
found  ||| S:29313 E:29319 ||| VBD
that  ||| S:29319 E:29324 ||| IN
all  ||| S:29324 E:29328 ||| DT
sources  ||| S:29328 E:29344 ||| NNS
of  ||| S:29344 E:29347 ||| IN
experimental  ||| S:29347 E:29360 ||| JJ
variability  ||| S:29360 E:29372 ||| NN
were  ||| S:29372 E:29377 ||| VBD
quite  ||| S:29377 E:29383 ||| RB
minor  ||| S:29383 E:29389 ||| JJ
( ||| S:29389 E:29390 ||| -LRB-
microarray  ||| S:29390 E:29401 ||| FW
R  ||| S:29401 E:29411 ||| NNP
2=  ||| S:29411 E:29414 ||| NNP
0.98-0.99 ||| S:29414 E:29423 ||| NNP
;  ||| S:29423 E:29425 ||| :
probe  ||| S:29425 E:29431 ||| FW
synthesis  ||| S:29431 E:29441 ||| FW
+  ||| S:29441 E:29443 ||| FW
microarray  ||| S:29443 E:29454 ||| FW
R  ||| S:29454 E:29456 ||| NNP
2=  ||| S:29456 E:29459 ||| NNP
0.98-0.99 ||| S:29459 E:29468 ||| NNP
) ||| S:29468 E:29469 ||| -RRB-
.  ||| S:29469 E:29479 ||| .
On  ||| S:29479 E:29482 ||| IN
the  ||| S:29482 E:29486 ||| DT
other  ||| S:29486 E:29492 ||| JJ
hand ||| S:29492 E:29496 ||| NN
,  ||| S:29496 E:29498 ||| ,
tissue  ||| S:29498 E:29505 ||| NN
heterogeneity  ||| S:29505 E:29519 ||| NNS
( ||| S:29519 E:29520 ||| -LRB-
intra-patient  ||| S:29520 E:29542 ||| JJ
variation ||| S:29542 E:29551 ||| NN
;  ||| S:29551 E:29553 ||| :
Average  ||| S:29553 E:29561 ||| NNP
R  ||| S:29561 E:29563 ||| NNP
2for  ||| S:29563 E:29568 ||| CD
10  ||| S:29568 E:29571 ||| CD
patients  ||| S:29571 E:29580 ||| NNS
=  ||| S:29580 E:29582 ||| SYM
0.92  ||| S:29582 E:29587 ||| CD
[ ||| S:29587 E:29588 ||| -LRB-
0.85  ||| S:29588 E:29593 ||| CD
to  ||| S:29593 E:29604 ||| TO
0.98 ||| S:29604 E:29608 ||| CD
] ||| S:29608 E:29609 ||| CD
) ||| S:29609 E:29610 ||| -RRB-
,  ||| S:29610 E:29612 ||| ,
and  ||| S:29612 E:29616 ||| CC
differences  ||| S:29616 E:29628 ||| NNS
between  ||| S:29628 E:29636 ||| IN
individual  ||| S:29636 E:29647 ||| JJ
patients  ||| S:29647 E:29656 ||| NNS
( ||| S:29656 E:29657 ||| -LRB-
SNP  ||| S:29657 E:29669 ||| NNP
noise ||| S:29669 E:29674 ||| NN
;  ||| S:29674 E:29676 ||| :
Average  ||| S:29676 E:29684 ||| NNP
R  ||| S:29684 E:29686 ||| NNP
2=  ||| S:29686 E:29689 ||| NNP
0.76  ||| S:29689 E:29694 ||| NNP
[ ||| S:29694 E:29695 ||| -LRB-
0.42  ||| S:29695 E:29700 ||| CD
to  ||| S:29700 E:29703 ||| TO
0.93 ||| S:29703 E:29707 ||| CD
] ||| S:29707 E:29708 ||| CD
)  ||| S:29708 E:29710 ||| -RRB-
were  ||| S:29710 E:29715 ||| VBD
major  ||| S:29715 E:29721 ||| JJ
sources  ||| S:29721 E:29737 ||| NNS
of  ||| S:29737 E:29740 ||| IN
variability  ||| S:29740 E:29752 ||| NN
in  ||| S:29752 E:29755 ||| IN
expression  ||| S:29755 E:29766 ||| NN
profiling ||| S:29766 E:29775 ||| NN
.  ||| S:29775 E:29777 ||| .
Thus ||| S:29777 E:29781 ||| RB
,  ||| S:29781 E:29783 ||| ,
tissue  ||| S:29783 E:29798 ||| NN
heterogeneity  ||| S:29798 E:29812 ||| NNS
and  ||| S:29812 E:29816 ||| CC
SNP  ||| S:29816 E:29820 ||| NNP
noise  ||| S:29820 E:29826 ||| NNS
have  ||| S:29826 E:29831 ||| VBP
a  ||| S:29831 E:29833 ||| DT
high  ||| S:29833 E:29838 ||| JJ
potential  ||| S:29838 E:29848 ||| JJ
to  ||| S:29848 E:29859 ||| TO
obscure  ||| S:29859 E:29867 ||| VB
sought  ||| S:29867 E:29874 ||| VBN
after  ||| S:29874 E:29880 ||| IN
condition-specific  ||| S:29880 E:29899 ||| JJ
gene  ||| S:29899 E:29904 ||| NN
expression  ||| S:29904 E:29923 ||| NN
changes ||| S:29923 E:29930 ||| NNS
,  ||| S:29930 E:29932 ||| ,
particularly  ||| S:29932 E:29945 ||| RB
in  ||| S:29945 E:29948 ||| IN
humans ||| S:29948 E:29954 ||| NNS
,  ||| S:29954 E:29956 ||| ,
where  ||| S:29956 E:29962 ||| WRB
tissue  ||| S:29962 E:29969 ||| NN
samples  ||| S:29969 E:29977 ||| NNS
can  ||| S:29977 E:29989 ||| MD
be  ||| S:29989 E:29992 ||| VB
limiting  ||| S:29992 E:30001 ||| VBG
( ||| S:30001 E:30002 ||| -LRB-
sampling  ||| S:30002 E:30011 ||| JJ
error ||| S:30011 E:30016 ||| NN
) ||| S:30016 E:30017 ||| -RRB-
,  ||| S:30017 E:30019 ||| ,
and  ||| S:30019 E:30023 ||| CC
inter-individual  ||| S:30023 E:30048 ||| JJ
variation  ||| S:30048 E:30058 ||| NN
often  ||| S:30058 E:30064 ||| RB
is  ||| S:30064 E:30067 ||| VBZ
very  ||| S:30067 E:30072 ||| RB
large ||| S:30072 E:30077 ||| JJ
.  ||| S:30077 E:30079 ||| .
We  ||| S:30079 E:30082 ||| PRP
have  ||| S:30082 E:30087 ||| VBP
shown  ||| S:30087 E:30093 ||| VBN
that  ||| S:30093 E:30098 ||| IN
mixing  ||| S:30098 E:30105 ||| VBG
of  ||| S:30105 E:30116 ||| IN
patient  ||| S:30116 E:30124 ||| JJ
samples  ||| S:30124 E:30132 ||| NNS
effectively  ||| S:30132 E:30144 ||| RB
normalizes  ||| S:30144 E:30155 ||| VBN
much  ||| S:30155 E:30160 ||| RB
of  ||| S:30160 E:30163 ||| IN
the  ||| S:30163 E:30167 ||| DT
intra-  ||| S:30167 E:30182 ||| JJ
and  ||| S:30182 E:30186 ||| CC
inter-patient  ||| S:30186 E:30200 ||| JJ
noise ||| S:30200 E:30205 ||| NN
,  ||| S:30205 E:30207 ||| ,
while  ||| S:30207 E:30213 ||| IN
still  ||| S:30213 E:30219 ||| RB
identifying  ||| S:30219 E:30231 ||| VBG
the  ||| S:30231 E:30243 ||| DT
majority  ||| S:30243 E:30252 ||| NN
of  ||| S:30252 E:30255 ||| IN
the  ||| S:30255 E:30259 ||| DT
most  ||| S:30259 E:30264 ||| RBS
significant  ||| S:30264 E:30276 ||| JJ
gene  ||| S:30276 E:30281 ||| NN
expression  ||| S:30281 E:30292 ||| NN
changes  ||| S:30292 E:30308 ||| NNS
that  ||| S:30308 E:30313 ||| WDT
would  ||| S:30313 E:30319 ||| MD
have  ||| S:30319 E:30324 ||| VB
been  ||| S:30324 E:30329 ||| VBN
detected  ||| S:30329 E:30338 ||| VBN
by  ||| S:30338 E:30341 ||| IN
larger  ||| S:30341 E:30348 ||| JJR
numbers  ||| S:30348 E:30356 ||| NNS
of  ||| S:30356 E:30367 ||| IN
individual  ||| S:30367 E:30378 ||| JJ
patient  ||| S:30378 E:30386 ||| NN
profiles ||| S:30386 E:30394 ||| NNS
.  ||| S:30394 E:30396 ||| .
Our  ||| S:30396 E:30400 ||| PRP$
results  ||| S:30400 E:30408 ||| NNS
suggest  ||| S:30408 E:30416 ||| VBP
that  ||| S:30416 E:30429 ||| IN
stringent  ||| S:30429 E:30439 ||| JJ
yet  ||| S:30439 E:30443 ||| RB
robust  ||| S:30443 E:30450 ||| JJ
data  ||| S:30450 E:30455 ||| NNS
can  ||| S:30455 E:30459 ||| MD
be  ||| S:30459 E:30462 ||| VB
generated  ||| S:30462 E:30472 ||| VBN
by  ||| S:30472 E:30475 ||| IN
mixing  ||| S:30475 E:30482 ||| VBG
a  ||| S:30482 E:30492 ||| DT
small  ||| S:30492 E:30498 ||| JJ
number  ||| S:30498 E:30505 ||| NN
of  ||| S:30505 E:30508 ||| IN
individuals  ||| S:30508 E:30520 ||| NNS
with  ||| S:30520 E:30525 ||| IN
a  ||| S:30525 E:30527 ||| DT
defined  ||| S:30527 E:30535 ||| JJ
condition  ||| S:30535 E:30545 ||| NN
( ||| S:30545 E:30546 ||| -LRB-
n  ||| S:30546 E:30548 ||| CD
=  ||| S:30548 E:30558 ||| SYM
5 ||| S:30558 E:30559 ||| CD
) ||| S:30559 E:30560 ||| -RRB-
,  ||| S:30560 E:30562 ||| ,
preferably  ||| S:30562 E:30573 ||| RB
using  ||| S:30573 E:30579 ||| VBG
different  ||| S:30579 E:30589 ||| JJ
regions  ||| S:30589 E:30597 ||| NNS
of  ||| S:30597 E:30600 ||| IN
tissue  ||| S:30600 E:30607 ||| NN
for  ||| S:30607 E:30619 ||| IN
duplicate  ||| S:30619 E:30629 ||| JJ
arrays ||| S:30629 E:30635 ||| NN
.  ||| S:30635 E:30637 ||| .
Controls  ||| S:30637 E:30646 ||| NNS
should  ||| S:30646 E:30653 ||| MD
be  ||| S:30653 E:30656 ||| VB
similarly  ||| S:30656 E:30666 ||| RB
processed ||| S:30666 E:30675 ||| VBN
.  ||| S:30675 E:30685 ||| .
The  ||| S:30685 E:30689 ||| DT
resulting  ||| S:30689 E:30699 ||| VBG
four  ||| S:30699 E:30704 ||| CD
arrays  ||| S:30704 E:30711 ||| NNS
( ||| S:30711 E:30712 ||| -LRB-
2  ||| S:30712 E:30714 ||| CD
controls ||| S:30714 E:30722 ||| NNS
,  ||| S:30722 E:30724 ||| ,
2  ||| S:30724 E:30726 ||| CD
experimental  ||| S:30726 E:30747 ||| JJ
datasets ||| S:30747 E:30755 ||| NN
)  ||| S:30755 E:30757 ||| -RRB-
should  ||| S:30757 E:30764 ||| MD
then  ||| S:30764 E:30769 ||| RB
be  ||| S:30769 E:30772 ||| VB
subjected  ||| S:30772 E:30782 ||| VBN
to  ||| S:30782 E:30785 ||| TO
the  ||| S:30785 E:30789 ||| DT
> ||| S:30789 E:30790 ||| CD
2-fold  ||| S:30790 E:30805 ||| CD
survival  ||| S:30805 E:30814 ||| NN
method ||| S:30814 E:30820 ||| NN
,  ||| S:30820 E:30822 ||| ,
as  ||| S:30822 E:30825 ||| RB
previously  ||| S:30825 E:30836 ||| RB
described  ||| S:30836 E:30846 ||| VBN
[  ||| S:30846 E:30848 ||| -LRB-
23  ||| S:30848 E:30851 ||| CD
]  ||| S:30851 E:30853 ||| -RRB-
.  ||| S:30853 E:30855 ||| .
This  ||| S:30855 E:30860 ||| DT
will  ||| S:30860 E:30873 ||| MD
yield  ||| S:30873 E:30879 ||| VB
a  ||| S:30879 E:30881 ||| DT
stringent  ||| S:30881 E:30891 ||| JJ
set  ||| S:30891 E:30895 ||| NN
of  ||| S:30895 E:30898 ||| IN
expression  ||| S:30898 E:30909 ||| NN
changes  ||| S:30909 E:30917 ||| NNS
that  ||| S:30917 E:30922 ||| WDT
are  ||| S:30922 E:30926 ||| VBP
likely  ||| S:30926 E:30941 ||| JJ
to  ||| S:30941 E:30944 ||| TO
be  ||| S:30944 E:30947 ||| VB
verified  ||| S:30947 E:30956 ||| VBN
by  ||| S:30956 E:30959 ||| IN
larger  ||| S:30959 E:30966 ||| JJR
studies  ||| S:30966 E:30974 ||| NNS
with  ||| S:30974 E:30979 ||| IN
individual  ||| S:30979 E:30990 ||| JJ
arrays ||| S:30990 E:30996 ||| NN
,  ||| S:30996 E:31006 ||| ,
but  ||| S:31006 E:31010 ||| CC
at  ||| S:31010 E:31013 ||| IN
low  ||| S:31013 E:31017 ||| JJ
cost  ||| S:31017 E:31022 ||| NN
as  ||| S:31022 E:31025 ||| IN
only  ||| S:31025 E:31030 ||| RB
four  ||| S:31030 E:31035 ||| CD
arrays  ||| S:31035 E:31042 ||| NNS
are  ||| S:31042 E:31046 ||| VBP
employed ||| S:31046 E:31054 ||| VBN
.  ||| S:31054 E:31056 ||| .
The  ||| S:31056 E:31068 ||| DT
preliminary  ||| S:31068 E:31080 ||| JJ
data  ||| S:31080 E:31085 ||| NNS
from  ||| S:31085 E:31090 ||| IN
just  ||| S:31090 E:31095 ||| RB
four  ||| S:31095 E:31100 ||| CD
mixed  ||| S:31100 E:31106 ||| JJ
profiles  ||| S:31106 E:31115 ||| NNS
( ||| S:31115 E:31116 ||| -LRB-
two  ||| S:31116 E:31128 ||| CD
experimental  ||| S:31128 E:31141 ||| JJ
and  ||| S:31141 E:31145 ||| CC
two  ||| S:31145 E:31149 ||| CD
control ||| S:31149 E:31156 ||| NN
)  ||| S:31156 E:31158 ||| -RRB-
can  ||| S:31158 E:31162 ||| MD
then  ||| S:31162 E:31167 ||| RB
be  ||| S:31167 E:31170 ||| VB
used  ||| S:31170 E:31175 ||| VBN
to  ||| S:31175 E:31178 ||| TO
generate  ||| S:31178 E:31195 ||| VB
functional  ||| S:31195 E:31206 ||| JJ
clusters  ||| S:31206 E:31215 ||| NNS
and  ||| S:31215 E:31219 ||| CC
pathophysiological  ||| S:31219 E:31238 ||| JJ
models ||| S:31238 E:31244 ||| NNS
.  ||| S:31244 E:31246 ||| .
These  ||| S:31246 E:31260 ||| DT
preliminary  ||| S:31260 E:31272 ||| JJ
models  ||| S:31272 E:31279 ||| NNS
can  ||| S:31279 E:31283 ||| MD
then  ||| S:31283 E:31288 ||| RB
direct  ||| S:31288 E:31295 ||| VB
more  ||| S:31295 E:31300 ||| RBR
hypothesis-driven  ||| S:31300 E:31326 ||| JJ
experiments ||| S:31326 E:31337 ||| NNS
,  ||| S:31337 E:31339 ||| ,
or  ||| S:31339 E:31342 ||| CC
more  ||| S:31342 E:31347 ||| RBR
extensive  ||| S:31347 E:31357 ||| JJ
expression  ||| S:31357 E:31368 ||| NN
profiling  ||| S:31368 E:31386 ||| NN
studies ||| S:31386 E:31393 ||| NNS
.  ||| S:31393 E:31417 ||| .
Materials  ||| S:31417 E:31427 ||| NNS
and  ||| S:31427 E:31431 ||| CC
methods  ||| S:31431 E:31458 ||| FW
Expression  ||| S:31458 E:31469 ||| FW
profiling  ||| S:31469 E:31489 ||| FW
Human  ||| S:31489 E:31495 ||| FW
muscle  ||| S:31495 E:31502 ||| FW
biopsy  ||| S:31502 E:31509 ||| FW
samples  ||| S:31509 E:31517 ||| NNS
were  ||| S:31517 E:31522 ||| VBD
diagnostic  ||| S:31522 E:31533 ||| JJ
specimens  ||| S:31533 E:31553 ||| JJ
flash-frozen  ||| S:31553 E:31566 ||| NN
immediately  ||| S:31566 E:31578 ||| RB
after  ||| S:31578 E:31584 ||| IN
surgery  ||| S:31584 E:31592 ||| NN
in  ||| S:31592 E:31595 ||| IN
isopentane  ||| S:31595 E:31616 ||| VBG
cooled  ||| S:31616 E:31623 ||| VBN
in  ||| S:31623 E:31626 ||| IN
liquid  ||| S:31626 E:31633 ||| JJ
nitrogen ||| S:31633 E:31641 ||| NN
,  ||| S:31641 E:31643 ||| ,
with  ||| S:31643 E:31648 ||| IN
storage  ||| S:31648 E:31656 ||| NN
in  ||| S:31656 E:31659 ||| IN
small ||| S:31659 E:31664 ||| JJ
,  ||| S:31664 E:31676 ||| ,
airtight ||| S:31676 E:31684 ||| NN
,  ||| S:31684 E:31686 ||| ,
humidified  ||| S:31686 E:31697 ||| JJ
tubes  ||| S:31697 E:31703 ||| NNS
at  ||| S:31703 E:31706 ||| IN
-80°C  ||| S:31706 E:31712 ||| CD
until  ||| S:31712 E:31718 ||| IN
RNA  ||| S:31718 E:31722 ||| NNP
isolation ||| S:31722 E:31731 ||| NN
.  ||| S:31731 E:31743 ||| .
Duchenne  ||| S:31743 E:31752 ||| JJ
muscular  ||| S:31752 E:31761 ||| JJ
dystrophy  ||| S:31761 E:31771 ||| JJ
patient  ||| S:31771 E:31779 ||| NN
samples  ||| S:31779 E:31787 ||| NNS
were  ||| S:31787 E:31792 ||| VBD
all  ||| S:31792 E:31806 ||| DT
shown  ||| S:31806 E:31812 ||| VBN
to  ||| S:31812 E:31815 ||| TO
have  ||| S:31815 E:31820 ||| VB
complete  ||| S:31820 E:31829 ||| JJ
lack  ||| S:31829 E:31834 ||| NN
of  ||| S:31834 E:31837 ||| IN
dystrophin  ||| S:31837 E:31848 ||| NN
by  ||| S:31848 E:31861 ||| IN
immunostaining  ||| S:31861 E:31876 ||| NN
and ||| S:31876 E:31879 ||| CC
/ ||| S:31879 E:31880 ||| NNP
or  ||| S:31880 E:31883 ||| CC
immunoblot  ||| S:31883 E:31894 ||| JJ
analysis ||| S:31894 E:31902 ||| NN
,  ||| S:31902 E:31904 ||| ,
and  ||| S:31904 E:31908 ||| CC
were  ||| S:31908 E:31913 ||| VBD
shown  ||| S:31913 E:31929 ||| VBN
to  ||| S:31929 E:31932 ||| TO
have  ||| S:31932 E:31937 ||| VB
excellent  ||| S:31937 E:31947 ||| JJ
morphology  ||| S:31947 E:31958 ||| NN
and  ||| S:31958 E:31962 ||| CC
preservation  ||| S:31962 E:31975 ||| NN
of  ||| S:31975 E:31978 ||| IN
tissue ||| S:31978 E:31984 ||| NN
.  ||| S:31984 E:31996 ||| .
Controls  ||| S:31996 E:32005 ||| NNS
included  ||| S:32005 E:32014 ||| VBD
groups  ||| S:32014 E:32021 ||| NNS
of  ||| S:32021 E:32024 ||| IN
males  ||| S:32024 E:32030 ||| NNS
and  ||| S:32030 E:32034 ||| CC
female  ||| S:32034 E:32041 ||| JJ
( ||| S:32041 E:32042 ||| -LRB-
age  ||| S:32042 E:32056 ||| NN
described  ||| S:32056 E:32066 ||| VBD
in  ||| S:32066 E:32069 ||| IN
text ||| S:32069 E:32073 ||| NN
)  ||| S:32073 E:32075 ||| -RRB-
that  ||| S:32075 E:32080 ||| WDT
showed  ||| S:32080 E:32087 ||| VBD
no  ||| S:32087 E:32090 ||| DT
histopathological  ||| S:32090 E:32118 ||| JJ
abnormality ||| S:32118 E:32129 ||| NN
,  ||| S:32129 E:32131 ||| ,
normal  ||| S:32131 E:32138 ||| JJ
dystrophy  ||| S:32138 E:32148 ||| JJ
proteins ||| S:32148 E:32156 ||| NNS
,  ||| S:32156 E:32158 ||| ,
and  ||| S:32158 E:32162 ||| CC
normal  ||| S:32162 E:32169 ||| JJ
serum  ||| S:32169 E:32185 ||| NNS
creatine  ||| S:32185 E:32194 ||| VBP
kinase  ||| S:32194 E:32201 ||| JJ
levels ||| S:32201 E:32207 ||| NNS
.  ||| S:32207 E:32209 ||| .
Biopsy  ||| S:32209 E:32216 ||| JJ
sizes  ||| S:32216 E:32222 ||| NNS
ranged  ||| S:32222 E:32229 ||| VBD
from  ||| S:32229 E:32234 ||| IN
50  ||| S:32234 E:32237 ||| CD
mg  ||| S:32237 E:32240 ||| NN
to  ||| S:32240 E:32253 ||| TO
2  ||| S:32253 E:32255 ||| CD
grams ||| S:32255 E:32260 ||| NNS
,  ||| S:32260 E:32262 ||| ,
with  ||| S:32262 E:32267 ||| IN
approximately  ||| S:32267 E:32281 ||| RB
20-30  ||| S:32281 E:32287 ||| CD
mg  ||| S:32287 E:32290 ||| NNS
used  ||| S:32290 E:32295 ||| VBN
for  ||| S:32295 E:32299 ||| IN
RNA  ||| S:32299 E:32313 ||| NNP
isolation  ||| S:32313 E:32323 ||| NN
( ||| S:32323 E:32324 ||| -LRB-
~10-15  ||| S:32324 E:32331 ||| NNP
micrograms  ||| S:32331 E:32342 ||| NN
of  ||| S:32342 E:32345 ||| IN
total  ||| S:32345 E:32351 ||| JJ
RNA ||| S:32351 E:32354 ||| NNP
) ||| S:32354 E:32355 ||| -RRB-
.  ||| S:32355 E:32357 ||| .
As  ||| S:32357 E:32360 ||| RB
described  ||| S:32360 E:32380 ||| VBN
in  ||| S:32380 E:32383 ||| IN
the  ||| S:32383 E:32387 ||| DT
text ||| S:32387 E:32391 ||| NN
,  ||| S:32391 E:32393 ||| ,
all  ||| S:32393 E:32397 ||| DT
biopsies  ||| S:32397 E:32406 ||| NN
had  ||| S:32406 E:32410 ||| VBD
two  ||| S:32410 E:32414 ||| CD
different  ||| S:32414 E:32424 ||| JJ
regions  ||| S:32424 E:32432 ||| NNS
of  ||| S:32432 E:32445 ||| IN
the  ||| S:32445 E:32449 ||| DT
same  ||| S:32449 E:32454 ||| JJ
biopsy  ||| S:32454 E:32461 ||| JJ
expression  ||| S:32461 E:32472 ||| NN
profiled  ||| S:32472 E:32481 ||| VBZ
separately ||| S:32481 E:32491 ||| RB
.  ||| S:32491 E:32503 ||| .
Details  ||| S:32503 E:32511 ||| NNS
concerning  ||| S:32511 E:32522 ||| VBG
the  ||| S:32522 E:32526 ||| DT
murine  ||| S:32526 E:32533 ||| JJ
profiles  ||| S:32533 E:32542 ||| NNS
will  ||| S:32542 E:32547 ||| MD
be  ||| S:32547 E:32560 ||| VB
published  ||| S:32560 E:32570 ||| VBN
elsewhere ||| S:32570 E:32579 ||| RB
.  ||| S:32579 E:32581 ||| .
In  ||| S:32581 E:32584 ||| IN
this  ||| S:32584 E:32589 ||| DT
report ||| S:32589 E:32595 ||| NN
,  ||| S:32595 E:32597 ||| ,
we  ||| S:32597 E:32600 ||| PRP
used  ||| S:32600 E:32605 ||| VBD
the  ||| S:32605 E:32609 ||| DT
murine  ||| S:32609 E:32626 ||| JJ
profiles  ||| S:32626 E:32635 ||| NNS
simply  ||| S:32635 E:32642 ||| RB
to  ||| S:32642 E:32645 ||| TO
test  ||| S:32645 E:32650 ||| VB
the  ||| S:32650 E:32654 ||| DT
sources  ||| S:32654 E:32662 ||| NNS
of  ||| S:32662 E:32665 ||| IN
variation  ||| S:32665 E:32675 ||| NN
during  ||| S:32675 E:32692 ||| IN
sample  ||| S:32692 E:32699 ||| NN
preparation  ||| S:32699 E:32711 ||| NN
prior  ||| S:32711 E:32717 ||| RB
to  ||| S:32717 E:32720 ||| TO
hybridization  ||| S:32720 E:32734 ||| VB
to  ||| S:32734 E:32747 ||| TO
oligonucleotides ||| S:32747 E:32763 ||| VB
.  ||| S:32763 E:32775 ||| .
RNA  ||| S:32775 E:32779 ||| NNP
isolation  ||| S:32779 E:32789 ||| NN
( ||| S:32789 E:32790 ||| -LRB-
Trizol ||| S:32790 E:32796 ||| NNP
,  ||| S:32796 E:32798 ||| ,
Gibco  ||| S:32798 E:32804 ||| NNP
BRL ||| S:32804 E:32807 ||| NNP
) ||| S:32807 E:32808 ||| -RRB-
,  ||| S:32808 E:32810 ||| ,
RNA  ||| S:32810 E:32814 ||| NNP
purification  ||| S:32814 E:32837 ||| NNS
( ||| S:32837 E:32838 ||| -LRB-
RNAeasy ||| S:32838 E:32845 ||| NNP
,  ||| S:32845 E:32847 ||| ,
Qiagen ||| S:32847 E:32853 ||| NNP
) ||| S:32853 E:32854 ||| -RRB-
,  ||| S:32854 E:32856 ||| ,
cDNA  ||| S:32856 E:32861 ||| JJ
synthesis  ||| S:32861 E:32871 ||| NN
and  ||| S:32871 E:32875 ||| CC
biotinylated  ||| S:32875 E:32888 ||| JJ
cRNA  ||| S:32888 E:32903 ||| NN
were  ||| S:32903 E:32908 ||| VBD
all  ||| S:32908 E:32912 ||| DT
done  ||| S:32912 E:32917 ||| VBN
as  ||| S:32917 E:32920 ||| IN
per  ||| S:32920 E:32924 ||| IN
standard  ||| S:32924 E:32933 ||| JJ
protocols  ||| S:32933 E:32943 ||| NNS
provided  ||| S:32943 E:32952 ||| VBN
by  ||| S:32952 E:32965 ||| IN
Affymetrix  ||| S:32965 E:32976 ||| NNP
Inc ||| S:32976 E:32979 ||| NNP
.  ||| S:32979 E:32981 ||| .
Quality  ||| S:32981 E:32989 ||| NN
control  ||| S:32989 E:32997 ||| NN
methods  ||| S:32997 E:33005 ||| NNS
are  ||| S:33005 E:33009 ||| VBP
described  ||| S:33009 E:33019 ||| VBN
on  ||| S:33019 E:33032 ||| IN
our  ||| S:33032 E:33036 ||| PRP$
web  ||| S:33036 E:33040 ||| JJ
site  ||| S:33040 E:33045 ||| NN
(  ||| S:33045 E:33057 ||| -LRB-
http://microarray.cnmcresearch.org/pga.htm ||| S:33057 E:33099 ||| NNP
) ||| S:33099 E:33100 ||| -RRB-
,  ||| S:33100 E:33102 ||| ,
with  ||| S:33102 E:33107 ||| IN
cRNA  ||| S:33107 E:33122 ||| JJ
amplifications  ||| S:33122 E:33137 ||| NN
of  ||| S:33137 E:33140 ||| IN
between  ||| S:33140 E:33148 ||| IN
5-  ||| S:33148 E:33151 ||| NNP
and  ||| S:33151 E:33155 ||| CC
13-fold  ||| S:33155 E:33163 ||| CD
for  ||| S:33163 E:33167 ||| IN
each  ||| S:33167 E:33172 ||| DT
of  ||| S:33172 E:33175 ||| IN
the  ||| S:33175 E:33189 ||| DT
samples ||| S:33189 E:33196 ||| NNS
.  ||| S:33196 E:33198 ||| .
Ten  ||| S:33198 E:33202 ||| CD
micrograms  ||| S:33202 E:33213 ||| NN
of  ||| S:33213 E:33216 ||| IN
gel-verified  ||| S:33216 E:33229 ||| JJ
fragmented  ||| S:33229 E:33250 ||| JJ
biotinylated  ||| S:33250 E:33263 ||| JJ
cRNA  ||| S:33263 E:33268 ||| NN
were  ||| S:33268 E:33273 ||| VBD
hybridized  ||| S:33273 E:33284 ||| VBN
to  ||| S:33284 E:33287 ||| TO
each  ||| S:33287 E:33292 ||| DT
MuscleChip  ||| S:33292 E:33303 ||| JJ
or  ||| S:33303 E:33316 ||| CC
U74A  ||| S:33316 E:33321 ||| CD
v2  ||| S:33321 E:33324 ||| CD
array ||| S:33324 E:33329 ||| NN
,  ||| S:33329 E:33331 ||| ,
and  ||| S:33331 E:33335 ||| CC
scanning  ||| S:33335 E:33344 ||| VBG
done  ||| S:33344 E:33349 ||| VBN
after  ||| S:33349 E:33365 ||| IN
biotin ||| S:33365 E:33371 ||| FW
/ ||| S:33371 E:33372 ||| FW
avidin ||| S:33372 E:33378 ||| FW
/ ||| S:33378 E:33379 ||| FW
phycoerythrin  ||| S:33379 E:33393 ||| FW
amplification ||| S:33393 E:33406 ||| FW
.  ||| S:33406 E:33408 ||| .
Details  ||| S:33408 E:33416 ||| NNS
on  ||| S:33416 E:33419 ||| IN
the  ||| S:33419 E:33433 ||| DT
specific  ||| S:33433 E:33442 ||| JJ
patients  ||| S:33442 E:33451 ||| NNS
studied ||| S:33451 E:33458 ||| VBN
,  ||| S:33458 E:33460 ||| ,
and  ||| S:33460 E:33464 ||| CC
details  ||| S:33464 E:33472 ||| NNS
for  ||| S:33472 E:33476 ||| IN
each  ||| S:33476 E:33481 ||| DT
GeneChip  ||| S:33481 E:33500 ||| JJ
( ||| S:33500 E:33501 ||| -LRB-
scaling  ||| S:33501 E:33509 ||| JJ
factors ||| S:33509 E:33516 ||| NNS
,  ||| S:33516 E:33518 ||| ,
number  ||| S:33518 E:33525 ||| NN
of  ||| S:33525 E:33528 ||| IN
present  ||| S:33528 E:33536 ||| JJ
calls ||| S:33536 E:33541 ||| NNS
,  ||| S:33541 E:33543 ||| ,
percentage  ||| S:33543 E:33564 ||| NN
difference  ||| S:33564 E:33575 ||| NN
calls  ||| S:33575 E:33581 ||| NNS
between  ||| S:33581 E:33589 ||| IN
each  ||| S:33589 E:33594 ||| DT
duplicate  ||| S:33594 E:33604 ||| JJ
sample ||| S:33604 E:33610 ||| NN
,  ||| S:33610 E:33612 ||| ,
number  ||| S:33612 E:33619 ||| NN
of  ||| S:33619 E:33632 ||| IN
difference  ||| S:33632 E:33643 ||| NN
calls  ||| S:33643 E:33649 ||| VBZ
surviving  ||| S:33649 E:33659 ||| VBG
four  ||| S:33659 E:33664 ||| CD
pair-wise  ||| S:33664 E:33674 ||| JJ
comparisons  ||| S:33674 E:33686 ||| NNS
of  ||| S:33686 E:33699 ||| IN
duplicate  ||| S:33699 E:33709 ||| JJ
chips ||| S:33709 E:33714 ||| NNS
)  ||| S:33714 E:33716 ||| -RRB-
is  ||| S:33716 E:33719 ||| VBZ
provided  ||| S:33719 E:33728 ||| VBN
( ||| S:33728 E:33729 ||| -LRB-
Table  ||| S:33729 E:33735 ||| NNP
1 ||| S:33735 E:33736 ||| CD
) ||| S:33736 E:33737 ||| -RRB-
.  ||| S:33737 E:33739 ||| .
All  ||| S:33739 E:33743 ||| DT
profiling  ||| S:33743 E:33763 ||| JJ
data  ||| S:33763 E:33768 ||| NNS
presented  ||| S:33768 E:33778 ||| VBD
here  ||| S:33778 E:33783 ||| RB
is  ||| S:33783 E:33786 ||| VBZ
available  ||| S:33786 E:33796 ||| JJ
on  ||| S:33796 E:33799 ||| IN
our  ||| S:33799 E:33803 ||| PRP$
web  ||| S:33803 E:33807 ||| JJ
site  ||| S:33807 E:33812 ||| NN
(  ||| S:33812 E:33824 ||| -LRB-
http://microarray.CNMCResearch.org ||| S:33824 E:33858 ||| NNP
;  ||| S:33858 E:33860 ||| :
data  ||| S:33860 E:33865 ||| NNS
link ||| S:33865 E:33869 ||| NN
) ||| S:33869 E:33870 ||| -RRB-
,  ||| S:33870 E:33872 ||| ,
as  ||| S:33872 E:33875 ||| IN
image  ||| S:33875 E:33891 ||| NN
( ||| S:33891 E:33892 ||| -LRB-
.dat ||| S:33892 E:33896 ||| NNP
) ||| S:33896 E:33897 ||| -RRB-
,  ||| S:33897 E:33899 ||| ,
absolute  ||| S:33899 E:33908 ||| JJ
analysis  ||| S:33908 E:33917 ||| NN
( ||| S:33917 E:33918 ||| -LRB-
.chp ||| S:33918 E:33922 ||| NNP
) ||| S:33922 E:33923 ||| -RRB-
,  ||| S:33923 E:33925 ||| ,
and  ||| S:33925 E:33929 ||| CC
ASCII  ||| S:33929 E:33935 ||| NNP
text  ||| S:33935 E:33950 ||| NN
conversions  ||| S:33950 E:33962 ||| NNS
of  ||| S:33962 E:33965 ||| IN
.chp  ||| S:33965 E:33970 ||| NNP
( ||| S:33970 E:33971 ||| -LRB-
.txt ||| S:33971 E:33975 ||| NNP
)  ||| S:33975 E:33977 ||| -RRB-
for  ||| S:33977 E:33981 ||| IN
each  ||| S:33981 E:33986 ||| DT
individual  ||| S:33986 E:33997 ||| JJ
profile  ||| S:33997 E:34015 ||| NN
( ||| S:34015 E:34016 ||| -LRB-
see  ||| S:34016 E:34020 ||| VB
http://microarray.cnmcresearch.org/pga.htmfor  ||| S:34020 E:34066 ||| RB
file  ||| S:34066 E:34081 ||| VB
descriptions  ||| S:34081 E:34094 ||| NNS
and  ||| S:34094 E:34098 ||| CC
use ||| S:34098 E:34101 ||| NN
) ||| S:34101 E:34102 ||| -RRB-
.  ||| S:34102 E:34132 ||| .
Bio-informatic  ||| S:34132 E:34147 ||| JJ
methods  ||| S:34147 E:34165 ||| NNS
Absolute  ||| S:34165 E:34174 ||| JJ
analysis  ||| S:34174 E:34183 ||| NN
( ||| S:34183 E:34184 ||| -LRB-
average  ||| S:34184 E:34192 ||| JJ
difference  ||| S:34192 E:34203 ||| NN
determinations  ||| S:34203 E:34228 ||| NN
for  ||| S:34228 E:34232 ||| IN
each  ||| S:34232 E:34237 ||| DT
probe  ||| S:34237 E:34243 ||| NN
set ||| S:34243 E:34246 ||| NN
)  ||| S:34246 E:34248 ||| -RRB-
was  ||| S:34248 E:34252 ||| VBD
done  ||| S:34252 E:34257 ||| VBN
using  ||| S:34257 E:34263 ||| VBG
Affymetrix  ||| S:34263 E:34274 ||| JJ
default  ||| S:34274 E:34292 ||| NN
parameters ||| S:34292 E:34302 ||| NNS
.  ||| S:34302 E:34304 ||| .
As  ||| S:34304 E:34307 ||| RB
described  ||| S:34307 E:34317 ||| VBN
in  ||| S:34317 E:34320 ||| IN
the  ||| S:34320 E:34324 ||| DT
text ||| S:34324 E:34328 ||| NN
,  ||| S:34328 E:34330 ||| ,
data  ||| S:34330 E:34335 ||| NNS
was  ||| S:34335 E:34339 ||| VBD
analyzed  ||| S:34339 E:34358 ||| VBN
using  ||| S:34358 E:34364 ||| VBG
a  ||| S:34364 E:34366 ||| DT
variety  ||| S:34366 E:34374 ||| NN
of  ||| S:34374 E:34377 ||| IN
methods ||| S:34377 E:34384 ||| NNS
,  ||| S:34384 E:34386 ||| ,
including  ||| S:34386 E:34396 ||| VBG
unsupervised  ||| S:34396 E:34419 ||| JJ
nearest-neighbor  ||| S:34419 E:34436 ||| JJ
hierarchical  ||| S:34436 E:34449 ||| JJ
clustering  ||| S:34449 E:34460 ||| JJ
analyses  ||| S:34460 E:34479 ||| NNS
( ||| S:34479 E:34480 ||| -LRB-
GeneSpring  ||| S:34480 E:34491 ||| NNP
[  ||| S:34491 E:34493 ||| -LRB-
28  ||| S:34493 E:34496 ||| CD
29  ||| S:34496 E:34499 ||| CD
]  ||| S:34499 E:34501 ||| -RRB-
[ ||| S:34501 E:34502 ||| -LRB-
Silicon  ||| S:34502 E:34510 ||| NNP
Genetics ||| S:34510 E:34518 ||| NNP
] ||| S:34518 E:34519 ||| -RRB-
,  ||| S:34519 E:34521 ||| ,
and  ||| S:34521 E:34525 ||| CC
Cluster  ||| S:34525 E:34533 ||| NNP
[  ||| S:34533 E:34545 ||| -LRB-
25  ||| S:34545 E:34548 ||| CD
]  ||| S:34548 E:34550 ||| -RRB-
[ ||| S:34550 E:34551 ||| -LRB-
Stanford  ||| S:34551 E:34560 ||| NNP
University ||| S:34560 E:34570 ||| NNP
] ||| S:34570 E:34571 ||| -RRB-
) ||| S:34571 E:34572 ||| -RRB-
,  ||| S:34572 E:34574 ||| ,
t-test  ||| S:34574 E:34581 ||| NNP
( ||| S:34581 E:34582 ||| -LRB-
GeneSpring ||| S:34582 E:34592 ||| NNP
)  ||| S:34592 E:34594 ||| -RRB-
and  ||| S:34594 E:34608 ||| CC
four-comparison  ||| S:34608 E:34624 ||| JJ
survival  ||| S:34624 E:34633 ||| NN
method  ||| S:34633 E:34640 ||| NN
[  ||| S:34640 E:34642 ||| -LRB-
23  ||| S:34642 E:34645 ||| CD
]  ||| S:34645 E:34647 ||| -RRB-
.  ||| S:34647 E:34649 ||| .
The  ||| S:34649 E:34653 ||| DT
Cluster  ||| S:34653 E:34661 ||| NNP
and  ||| S:34661 E:34675 ||| CC
Tree  ||| S:34675 E:34680 ||| NNP
View  ||| S:34680 E:34685 ||| NNP
software  ||| S:34685 E:34694 ||| NN
were  ||| S:34694 E:34699 ||| VBD
download  ||| S:34699 E:34708 ||| VBN
from  ||| S:34708 E:34723 ||| IN
http://rana.lbl.govand  ||| S:34723 E:34746 ||| CD
installed  ||| S:34746 E:34756 ||| VBN
on  ||| S:34756 E:34759 ||| IN
an  ||| S:34759 E:34762 ||| DT
NT  ||| S:34762 E:34775 ||| NNP
workstation ||| S:34775 E:34786 ||| NN
.  ||| S:34786 E:34812 ||| .
